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Abstract 
The Rab/Ypt/Sec4 family forms the largest branch of the Ras superfamily of 
GTPases, acting as essential regulators of vesicular transport pathways. They are membrane 
associated molecular switches. However, they are intrinsically soluble proteins thus requiring 
a lipid modification for membrane association. This is accomplished by the enzyme Rab 
Geranylgeranyl Transferase (RGGT) which catalyses the transfer of two geranylgeranyl 
isoprenoids to the Rab C-terminus. RGGT absolutely requires an accessory factor termed 
Rab Escort Protein (REP) for activity, which binds non-prenylated Rabs and presents them to 
RGGT. 
I used the large amount of information in the databases resulting from the different 
on-going genome projects to analyse the Rab family and identify the structural determinant for 
REP binding. I defined Rab-conserved sequences that we designate "Rab family" (RabF) 
motifs using the conserved GTP-binding motifs as "landmarks". The Rab-specific regions 
were used to identify new Rab proteins in the databases and suggest rules for nomenclature. 
I found that the RabF motifs are conserved across evolution and propose that positions in the 
RabF motifs mediate (conserved) interactions with general regulators as REP. Sequence and 
structure analysis of the REP family highlights the existence of a conserved surface that is 
likely involved in mediating Rab binding. I used the information gathered from analysis of the 
Rab and REP families to address the formation of the REP:Rab complex. A yeast two hybrid 
REP:Rab binding assay was designed and I used it to test a site directed mutagenesis 
strategy in Rab3 as a model. The result obtained suggest that positions in the RabF motifs 
mediate interactions with REP. Additionally, I designed methods to form, purify and analyse 
REP:Rab complexes in vitro, which can be used either on a analytical or preparative scale. 
From the analysis of the Rab family, I found that RabF regions cluster in and around 
switch I and switch II regions, i.e. the regions that change conformation upon GDP or GTP 
binding. This finding suggest that specificity of Rab-effector interaction cannot be conferred 
solely through the switch regions as is usually inferred. Instead, I propose a model whereby 
an effector binds to RabF (switch) regions to discriminate between nucleotide-bound states 
and simultaneously to other regions that confer specificity to the interaction, possibly Rab 
subfamily (RabSF) specific regions that we also define here. These observation hold true for 
Rab proteins in all organisms studied, are supported by experimental evidence and form the 
basis of criteria for definition of putative orthologies and nomenclature. Furthermore, I 
observed that Rab proteins that exhibit similar functional properties (eg localisation to a given 
compartment), co-segregate in phylogenetic trees and display related gene structures, thus 
suggesting a shared ancestry. I introduce the concept of "Rab functional groups" to describe 
these groups of Rabs which have shared ancestry and similar functional properties. This 
concept will permit informative correlations between similar functional properties and 
sequence conservation, and shed light into the multiplication of Rab proteins that 
accompanied multicellularity. 
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Sumário 
A família de proteínas Rab/Ypt/Sec4 é a mais numerosa das famílias que constituem 
a super-família de pequenas GTPases, e é constituída por proteínas que regulam vias de 
transporte vesicular. As Rab embora sejam proteínas solúveis, funcionam como "switch" 
molecular, associando com o folheto citoplasmático. Esta associação depende de uma 
modificação lipídica catalisada pelo enzima Rab Geranylgeranyl Transferase (RGGT). Este 
enzyme requer uma proteína acessória chamada "Rab Escort Protein"(REP), que se liga a 
Rabs não preniladas e as apresenta ao enzima. 
Eu analisei a família Rab fazendo uso de métodos computacionais e da 
acessibilidade de genomas completamente sequenciados. Eu observei a existência de 
sequências apenas presentes nas proteínas Rab que designei motivos RabF. Estes motivos 
foram utilizados para pesquisar nas bases de dados e identificar novas proteínas desta 
família em vários organismos. Os motivos RabF são conservados em todas as proteínas 
encontradas. Eu proponho que posições conservadas nestes motivos medeiam interacções 
igualmente conservadas entre Rabs e REPs. Análise de sequências e estructuras de 
proteínas REP confirma a existência de uma superfície conservada que toda a evidência 
experimental sugere estar envolvida em ligação a Rabs. Na posse desta informação, um 
ensaio de ligação Rab:REP foi concebido, baseado no sistema "yeast two hybrid", e usado 
para testar mutações em uma Rab modelo, Rab3a. Os resultados obtidos indicam que a 
interacção entre as duas moléculas é de facto mediada por posições nos motivos RabF. 
Ainda relativamente à intreacção entre Rab e REP, eu concebi e implementei métodos que 
permitem, tanto em escala preparativa como analítica, preparar, purificar e analisar 
complexos entre estas duas proteínas in vitro. 
Ao analisar a família Rab, eu observei que os motives RabF mapeiam às regiões da 
proteína que mudam de conformação de acordo com a ligação ao GTP ou GDP, as regiões 
"switch". Esta observação sugere que, ao contrário do que era aceite, a epecificidade das 
interacções entre Rabs e efectores não pode ser só determinada por estas regiões. Outras 
regiões são necessariamente importantes: eu identifiquei regiões que são especificamente 
conservadas em sub-famílias (ie interagem com os mesmos efectores) e que eu proponho 
serem responsáveis pela especificidade das interacções. Esta observação é válida para 
todas as proteínas Rab estudadas, e é incorporada nos critérios de numenclatura que eu 
proponho para esta família. 
Eu observei que Rabs que co-segregam em árvores filogenéticas, tem estructuras 
genéticas semelhantes e, surpreendentemente, propriedades funcionais em comum. Eu 
proponho que estas Rabs formam "grupos funcionais", apresentam uma história evolutiva 
comum e são relacionadas em termos de função. Este novo coneito permite fazer 
correlações informativas entre função e padrões de conservação de sequência, e permitem 
compreender a multiplicação desta família ao longo da evolução. 
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Sommaire 
La famille de protéines Rab/Ypt/Sec4 est la plus nombreuse parmi les familles de la 
super-famille des petites GTPases et est composée de protéines qui régulent les voies de 
transport vésiculaire. Les Rab sont des protéines solubles qui fonctionnent comme des 
"switch" moléculaires, en association avec les membranes cellulaires. Cette association est 
dépendante de l'enzyme "Rab Geranylgeranyl Transferase". Cette enzyme nécessite la 
présence d'une protéine auxiliaire appelé "Rab Escort Protein (REP)" qui s'attache aux Rabs 
non prénilées et les présente à l'enzyme. 
J'ai analysé la famille des Rab avec des méthodes informatiques. J'ai observé 
l'existence de séquences seulement présentes sur les Rabs, que j'ai appelé motifs RabF. 
Ces motifs ont étés utilisés pour chercher dans des bases de données et identifier de 
nouvelles protéines de cette famille. Les motifs RabF sont conservées dans toutes les 
protéines trouvées. Je suggère que les positions conservées dans ces motives détermine les 
interactions entre REP et Rab. L'analyse des séquences et structures de protéines REP 
confirme l'existence d'une surface conservée qui l'évidence expérimentale suggère qu'elle 
soit impliquée dans l'attachment aux Rabs. Avec cette information un essai de attachment 
Rab :REP à été développé basé sur le système "yeast two hybrid" et utilisé pour tester des 
mutations dans les Rab avec la modède la Rab3a. Les résultats indiquent que l'interaction 
entre deux molécules est en effet déterminé par des positions dans les motifs RabF. 
Concernant l'interaction entre Rab et REP, j'ai formulé et établi des méthodes qui permetent 
de préparer, à l'échelle preparative ou analytique, purifier et analyser les complexes 
Rab :REP in vitro. 
J'ai observé que les motifs RabF sont localisés dans les régions "switch". Cette 
observation suggère que, contrairement avec ce qui était accepté, la spécificité des 
interactions entre Rabs et effecteurs ne peut pas être déterminée par ces régions. Autre 
régions sont également importantes : j'ai identifié des régions qui sont spécifiquement 
conservées dans les sous-familles et dont je suggère sont responsables par la spécificité de 
leurs interactions. Cette observation est valide pour toutes les protéines Rab étudiées. 
J'ai observé que les Rabs qui co-ségrèguent en arbres philogénétiques présentent 
des structures génétiques similaires et, étonnament, des fonctions apparentées. Je suggère 
que ces Rabs forment des "groupes fonctionnels", présentnte une histoire évolutive 
communne et sont fonctionnellement apparentées. Ce nouveau concept permet faire des 
corrélations informatives entre fonctions et modèles de conservation de séquences et 
permettent de comprendre l'évolution des protéines de la famille Rab. 
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The progression of the research and the structure of 
this dissertation 
The present thesis represents part of the work performed in the past 4 years 
to complete my PhD dissertation. The first year of work was done at the 
Southwestern Medical Center at Dallas, USA, then the group moved to the UK and 
the second year of research was done at the Imperial College School of Medicine at 
St. Mary's Hospital. We moved again across Hide Park, within London, to a new 
purpose-built research building in South Kensington that now houses the division of 
Biomedical Sciences of the Imperial College School of Medicine. 
This dissertation is organised in five major parts that I hope reflect a logical 
progression for the reader of this work, but that do not always reflect the 
chronological order in which the work was done. I started my experimental work 
using essentially lab bench-based techniques to address questions about the 
biochemistry of the lipid modification of Rab proteins, mainly concentrating on several 
aspects of the formation of the complex between Rabs and Rab Escort Proteins. As 
the work progressed, I realised that a substantial amount of the foundation work 
about the structure/function relationships of the proteins involved in this reaction was 
still to be done. I decided then to start exploring those structure/function issues, using 
computational based approaches. However, instead of obtaining simple and quick 
answers, I uncovered even more questions. As the time (and funding!) I had 
available was limited, I decided to concentrate my efforts in making a study of the 
primary structure of the proteins of interest to this thesis (Rab small GTPases and 
Rab Escort Proteins) and then trying to clarify some of the questions that these 
studies raised. 
Part I is an introduction to the thesis, and consists of a review of the relevant 
literature followed by a statement of the aims of the research. 
Part II of this thesis concerns the Rab family of small GTPases, and is divided 
in two chapters. The first chapter (chapter 11.1) concerns what distinguishes Rab 
proteins from other small GTPase families, which parts of the protein could be 
interacting with specific effectors and general regulators, uncovering a mechanism of 
specificity of binding determination different form the previously accepted. I take this 
analysis a step further in the second chapter (chapter II.2), where I identify and 
annotate the complete Rab families in all organisms which had their genome 
xv 
substantially sequenced and use this information to investigate if the models 
proposed for Rab interactions in the previous chapter are extensible to Rab families 
in other organisms. Also, I attempt to reconstruct the multiplication of Rab proteins 
that accompanies multicellularity. 
Part III concerns Rab Escort Proteins, general regulators of the lipid 
modification and function of the Rab family. I investigate the primary structure 
determinants for the function of these proteins. 
In Parts II and III predictions are made concerning how Rab proteins will 
interact with Rab Escort Proteins. Part IV of this thesis concerns the formation of the 
REP:Rab complex. A substantial amount of work was dedicated to creating tools for 
the study of how lipid and non-lipid modified small GTPases will interact with REPs 
and RabGGTase. These methods are presented as the first chapter of part IV 
(chapter IV. 1). The next chapter (IV.2) is the testing of the previously proposed 
requirement for a step of GTP hydrolysis catalysed by a RabGAP prior to REP:Rab 
complex formation. Finally, in the last chapter of Part IV, a combination of in silico 
methods and experimental methods is used to determine the interface of the 
REP:Rab complex, thus testing the predictions resulting from the work described in 
parts II and III. 
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Part I - Introduction 
Part I - Introduction 
1.1. Rab small GTPases 
GTP binding proteins (G proteins) are involved in a variety of biological phenomena 
and diverge markedly in their primary structure. Well known examples of G proteins are 
members of the Ras-like small GTPases, of which the Rab family is part, heterotrimeric G-
proteins involved in signal transduction from G-protein coupled receptors to second 
messenger generating effectors (see ref for review Mumby, 2000), and translation factors 
like EF-Tu and EF-G (reviewed in Abel and Jurnak, 1996). 
The present work concerns the Rab family of small GTPases, which regulate 
vesicular trafficking pathways. This introduction will thus make a brief review on the history, 
structure, regulation and function of members of the Rab family. Mechanistic aspects of the 
function of small GTPases were first elucidated in members of the Ras family and these 
results will also be discussed when they are essential for the understanding of Rab function. 
Rabs, like other small GTPases are subject to lipid modifications to their C-termini 
which are essential for membrane association and function. For clarity sake, this will be 
discussed independently later in this introduction. 
The motivations and highlighting of the main questions which are address in this 
thesis are presented at the end of this introduction. 
1.1.1. History and nomenclature 
Small GTPases were identified from the Harvey and Kirsten sarcoma virus. These 
were the result of passage through rat cells of virus which lacked oncogenic potential, but 
through recombination events gained oncogenic sequences that were named H-Ras and K-
Ras (Ellis et al., 1981; Ellis et al., 1980; Kirsten and Mayer, 1967; Harvey, 1964). Further 
characterisation of the v-H-ras gene revealed that it corresponded to a mutated, intronless 
form of a cellular protein (Chang et al., 1980), able to bind (Shih et al., 1981) and hydrolyse 
(Gibbs et al., 1984) guanine nucleotides. H-Ras was the first oncogene to be found in human 
tumours, indicating that proto-oncogenes can be activated by two different routes: 
transducing of proto-oncogenes by retroviruses or through somatic or replicative mutations 
(Der et al., 1982; Parada et al., 1982; Santos et al., 1982). 
The first Rab was identified serendipitously as a gene with homology to Ras which 
lied between the actin and tubulin genes of Sacharomyces cerevisae. It was originally 
named YP2 (for Yeast Protein 2) and encoded a protein sharing about 30% identity with 
mammalian Ras protein (Gallwitz et al., 1983). Later the Rho genes were identified first in 
Aplysia and then in humans (Madaule and Axel, 1985). The realisation that Ras and Ras-like 
I - 2 
Part I - Introduction 
proteins belonged to a possibly large and diverse family of proteins prompted researchers to 
employ a variety of approaches to identify new members of this family. 
YP2 was later renamed to YPT1, (standing for Yeast Protein Transport) (Schmitt et 
al., 1986) and defined a new family of small GTPases. The involvement of members of this 
new family in vesicular transport however was only established with the identification of the 
SEC4, the gene mutated in the secretory mutant sec4. This mutant accumulates post-golgi 
vesicles and displays blocked transport to the plasma membrane (Goud et al., 1988; 
Salminen and Novick, 1987). Mammalian homologues of Sec4 and Ypt1 were named Rab 
proteins, describing the organ they were initially identified in (RAt Brain) (Touchot et al., 
1987). 
Rab5b 
Rab5c 
Rab5a 
Rab6a 
Rab6b 
Rab11b 
Rab11a 
RabU 
Rab4b 
Rab4a 
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Figure 1.1- Unrooted distance diagram of selected sequences from the mammalian Ras 
super-family. Distance matrix and tree calculated using the Neighbour-Joining method and 
based on an un-edited Clustal W 1.80 multiple sequence alignment of protein sequences. 
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Today, the Ras superfamily of small GTPases comprises a large group of proteins 
that regulate important cellular processes such as growth, motility and protein trafficking. 
Members of this superfamily are also known as ras-like GTPases, small GTPases or small G 
proteins. A formal definition of the members of this super-family was accorded at the FASEB 
summer research Conference on "Low Molecular Weight GTP-Binding Proteins" (Kahn et 
al., 1992) and defines proteins which have molecular weights in the range of 20-29 KDa, 
present the consensus motifs for GTP-binding proteins (which will be discussed bellow), and 
have recognisable family specific motifs. The division in families is also based on purely 
structural grounds. Five families are recognised (see figure 1.1), but recently a new family 
has been suggested, including the small GTPases Rem/Kir, Rad and Gem. 
Different small GTPases are included into one of the existing families if they show 
above 30% identity with members of that family and if they display specific sequence motifs 
that characterise each family. For Rab proteins, the only family specific characteristic is the 
presence of two C-terminal cysteine residues, the Rab prenylation motif which will be 
discussed later in this introduction. Rabs are numbered according to their discovery, but by 
the time the eight mammalian Rab protein was identified (Rab8a), this criteria failed because 
this proteins displays only one C-terminal cysteine residue which resembles those found in 
the Rho and Ras families (the CAAX box, discussed in the context of Protein Prenylation). 
The identification of Rab-specific sequence motifs that permits the distinction between 
members of this family and any other small GTPase family is the subject of chapter 11.1. 
1.1.2. The Small GTPase Molecular switch 
Small GTP binding proteins share the common characteristic of behaving as 
molecular switches by alternating between two different conformations. When bound to GTP 
the protein is said to be ON, or in the "Active" conformation. Hydrolysis of GTP to GDP 
brings the molecule to the "Inactive" or OFF conformation. 
In the active conformation, small GTPases can bind effectors and transduce 
biological signals. By definition, effectors of small GTPases are proteins which bind only one 
specific GTPase, or a restricted set of GTPases, distinguish between active and inactive 
conformations and only bind to the active conformation (figure 1.2). In the inactive 
conformation, small GTPases can only bind to general regulators, proteins that by definition 
bind all or the majority of the members of one family of small GTPases and recognise and 
bind to the inactive conformation (figure 1.2). The transition between active and inactive 
conformations is tightly regulated by a class GTPase interacting proteins which, for clarity of 
discussion, we term here regulators of nucleotide status, and which will be discussed bellow 
(figure I.2). 
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Figure 1.2 - The small GTPase molecular Switch 
Sequence analysis of small GTPases and the availability of crystal structures for 
some members of this family permitted the identification of consensus GTP binding motifs 
that are conserved throughout the super-family and a conserved fold that is characteristic 
GTP binding proteins. This conserved fold, represented in figure 1.3, consists of a core 
structure of five a-helixes, 5 parallel (3-sheets and one anti-parallel p-strand (Pai et al., 1989; 
for review see Kjeldgaard et al., 1996). 
Figure 1.3 - Topology diagram of the core structure of GTP binding proteins. Adapted from 
(Kjeldgaard et al., 1996). 
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Figure 1.4 - Alignment of model sequences representing selected families of small GTPases 
(Adapted from Pereira-Leal and Seabra, 2000). The PM and G motifs are highlighted in 
green (see text). PM1 has the consensus sequence GxxxxGK[S, T] where [S, J] means S or 
T can be found in that position, and localises in the loop 1, also known as the "P-loop". A 
single conserved T residue localised in loop 2, also known as "effector loop" defines PM2, 
and PM3 localises in j33/loop4 with the consensus sequence DTAGQ. The G1 motif is a 
single conserved F or Y residue in loop 2 (effector loop), G2 localises in /35/loop8 and has 
the consensus GNKxD, and G3 resides in /56/loop10 with the consensus sequence SAK. 
In small GTPases the conserved motifs, highlighted in figure I.4, are named PM1 to 
PM3 and G1 to G3 motifs (see figure 1.4), involved in phosphate and Mg2+ binding and 
guanine binding, respectively (see (Valencia et al., 1991) for review). In Ras proteins, there 
are two regions that change conformation upon GTP binding and hydrolysis, highlighted in 
figure 1.5: Switch I resides in loop 2 (effector loop) and switch II in loop4/a2/loop5. The first 
evidence that Rabs behave in the same way came from limited proteolysis studies in Rab5, 
in which nucleotide dependent conformational changes were detected in the putative Rab 
Switch II region (Nikolova et al., 1998). 
The solution structure of murine Rab3a in the active conformation (Dumas et al., 
1999), followed by the solution structure of Rab6 from Plasmodium falciparum bound to GDP 
(Chattopadhyay et al., 2000) provided evidence for Rabs displaying, like Ras proteins, two 
switch regions. The exact boundaries of these switch regions were recently determined with 
the solution structure of one Rab proteins (Sec4) both in the active and inactive conformation 
(Stroupe and Brunger, 2001). Later in this introduction we will return to the "molecular 
switch" in Rab proteins. 
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Figure 1.5 - Structure of p21 H-Ras:GTP (accession number 121P) and p21 H-Ras:GDP 
(accession number 4Q21), highlighting the Switch regions in red (Switch I) and green (switch 
II). 
1.1.3. Switch ON: GEFs 
The reaction of dissociation of GTP and binding of GTP, termed "exchange", is 
usually very slow, and so is in general the hydrolysis of GTP to GDP . Exchange is catalysed 
by guanine-nucleotide exchange factors (GEFs). Exchange not assisted by these proteins is 
usually termed "intrinsic exchange". 
1.1.3.1. GEF catalysed exchange 
Exchange factors bind exclusively to the GDP bound small GTPases and are thought 
to destabilise the binding to GDP, thus promoting an increase in the off rate of GDP 
(Wittinghofer, 1998; Pan and Wessling-Resnick, 1998). Due to the excess of GTP over GDP 
in the cytosol (Bourne et al., 1991), the increase in the exchange rate has the consequence 
of promoting the binding to GTP. GTP binding results in conformational changes which 
cause the GEF to dissociate from the GTP:small GTPase complex (Wittinghofer, 1998). 
The first insight into how this is accomplished came from the recent solution of the 
crystal structure of the binary complex of H-ras with its exchange factor Sos (Boriack-Sjodin 
et al., 1998). Through interactions with the Switch I, Sos opens the guanine nucleotide-
binding pocket. Through interactions with the Switch II, Sos alters the chemical environment 
of the binding site for the phosphate groups of the nucleotide and the associated magnesium 
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ion, so that their binding is no longer favoured. As Sos does not affect the binding to the 
ribose and base of GTP or GDP, it favours nucleotide release and binding. 
GEFs for different small GTPases are very divergent at the primary and tertiary 
structure level. Not all GEFs have the same structural motifs found in Sos, nor have they 
recognisable conserved sequence motifs. This suggests that different GEFs may promote 
exchange in different ways, and raises the possibility that GEFs for different small GTPases 
evolved independently (see (Cherfils and Chardin, 1999) for review). However, a conserved 
mode of interaction between GEFs and small GTPases has been suggested (Day et al., 
1998), raising the possibility that although the different GEFs may be structural distinct, 
some still undetectable conserved sequence or structural elements may exist, underlying a 
conserved exchange mechanism. 
1.1.3.2. RabGEFs 
Rab activation is a membrane associated event that follows membrane association of 
the prenylated Rab protein and displacement of the general regulator RabGDI (Soldati et al., 
1994; Ullrich et al., 1994). However, exchange factors that act on members of the Rab family 
(RabGEFs) have proved elusive to identify. 
DSS4 and its mammalian counterpart MSS4 were the first molecules to be proposed 
as Rab exchange factors (Moya et al., 1993; Burton et al., 1993). However, there is strong 
evidence that supports a different role for these proteins as general regulators of Rab 
function. They will be discussed together with other general regulators in section 1.1.6. 
Table 1.1 - RabGEPs 
RabGEF Rab specificity Reference 
p619(human) Rab5 (Rosa et al., 1996) 
Rab3-GEP(rat) 
Aex3 (nematode) 
Rab3 
Isoforms 
Rab3 
(Wadaetal., 1997) 
(Iwasaki et al., 1997) 
Sec2(yeast) Sec4 (Walch-Solimena et al., 1997) 
Rabex-5(mouse) Rab5a (Horiuchietal., 1995) 
Vps9(yeast) Ypt5 (Hamaetal.,2001) 
Ric1p:Rgp1p complex(yeast) Ypt6 (Siniossoglou et al., 2000) 
TRAPP complex(yeast) Ypt1 (Wang et al., 2000) 
Vps39(yeast) Ypt7 (Wurmseretal.,2000) 
SopE(salmonela) Rab5 (Mukherjee et al., 2000) 
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The protein p619 is an unusually big protein which is able to catalyse nucleotide 
exchange in both Arf1 and Rab proteins (Rosa et al., 1996). It interacts with clathrin, thus 
suggesting a role in endocytosis (Rosa and Barbacid, 1997). The exact role of p619 is still 
unclear, particularly in the light of its sequence homology to RCC1, an exchange factor for 
the small GTPase Ran which is involved in nuclear-cytoplasmic transport. 
Rab3-GEP is specific for prenylated members of the Rab3 sub-family. This 
requirement for lipid modification is consistent with the observation that exchange happens 
after membrane association of the Rab protein (Soldati et al., 1994; Ullrich et al., 1994). 
However, the same requirement in not observed for all other RabGEFs. 
Rab3-GEP has high sequence homology to the gene product AEX-3, and the fact 
that mutations in the AEX-3 gene cause pre-synaptic defects, namely the accumulation of 
Rab-3 containing vesicles in the cell body, supports an essential, physiological role for the 
Rab3 exchange factor in the regulation of Rab3 activity (Iwasaki et al., 1997). 
In yeast, the null Vps39 mutant exhibits the same phenotype as the ypt7 deletion 
(Nakamura et al., 1997; Wichmann et al., 1992), and the same is true for Vps9 which results 
in the same accumulation of 40-50 nm vesicles as observed for Ypt51 (Burd et al., 1996; 
Horazdovsky et al., 1994). A more dramatic effect is caused by the deletion of sec2 which is 
lethal (Nair et al., 1990). 
RabGEFs for homologous Rab proteins in different organisms seem to be related to 
one another, as is exemplified by Rabex-5 and Vps9, exchange factors for the Rab5/Ypt5 
GTPases, by Rab3-GEP and aex-3, exchange factors for Rab3 and by the fact that R i d p 
and Vps39 have homolgies to proteins in other organisms. In contrast, RabGEFs for different 
Rab proteins show no common trait that could be used to identify novel RabGEFs or that 
could suggest a mechanism of Rab activation. Interestingly, SopE, which also acts as an 
exchange factor for Rab5, does not share any significant homologies with Vps9 or Rabex-5, 
suggesting different evolutionary origins. 
SopE is a secreted salmonella protein which recruits non-prenylated Rab5 to the 
infected phagosome membrane, promoting its fusion with early endosomes, thus avoiding 
transport to lysosomes (Mukherjee et al., 2000). This observation, together with the 
observation that mutations in the exchange factors aex-3, Vps9 and Ric1p/Rgp1p all 
produce mislocalisation of its target Rab, supports the hypothesis that exchange factors may 
play a role in recruiting Rabs to their target membranes. 
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1.1.4. Switch OFF: GAPs 
Switching off the signal being transduced by an active GTPase is acomplished 
through conformational changes resulting from GTP hydrolysis. Intrinsic hydrolysis in some 
GTPases is fast and the GTPase is thought to work as a "time switch" that will switch off 
after some time after activation. Small GTPases fall in the general category of "triggered 
switches" where the intrinsic hydrolysis is slow and GAPs (GTPase Activating Proteins), by 
accelerating the intrinsic hydrolysis rate, shut off the switch (Kjeldgaard et al., 1996). 
Hydrolysis in the absence of GAP is, as mentioned for the exchange reaction, 
termed "intrinsinc hydrolysis". Intrinsinc hydrolysis rates in Rab proteins are in the range of 
(10"3 min"1 to 10"2 min"1) (see for example (Zerial and Huber, 1995). GAP activation can 
increase these rates by a factor of three orders of magnitude (eg (Clabecq et al., 2000). 
GAPs and GEFs provide the cell with a way of regulating when and where the 
molecular switch should be turned on or off. 
1.1.4.1. Switching off 
Several GAPs have been identified and crystallised for different families of small 
GTPases, but until recently no common feature was observed between them that suggested 
a common functional mechanism. However, the observation that oncogenic mutation in Ras 
that lock the GTPase in its active conformation are insensitive to GAP activation, but do not 
affect the formation of the GAP:GTPase complex, indicates that GAP action requires more 
than just binding to the GTPase. 
Experiments using aluminium fluoride (AIF4"), a molecule which binds the small 
GTPase:GDP complex, mimiquing the transition state of the GTPase reaction, showed that 
although the GTPase:GDP complex cannot bind AIF4" on its own (Kahn, 1991), it does so in 
the presence of a GAP activity (Ahmadian et al., 1997; Mittal et al., 1996), thus suggesting 
that the GAP acts by stabilising the transition state of the GTPase reaction. 
The realisation that GAPs exhibit conserved Arg residues (see for review Scheffzek 
et al., 1998) and the fact that a computational model of the interaction between p120GAP 
and Ras suggested that two invariant Arginine residues in the GAP protein were brought in 
close proximity of the nucleotide (Scheffzek et al., 1996) implied these Arg residues in the 
catalysis mechanism. 
This was confirmed with the solution structure of the complex between the GAP 
domain of p120GAP and H-Ras, which revealed that an Arginine side chain (R789 - the 
"Arginine Finger") protrudes into the active site of Ras and neutralises the charges 
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developing in the transition state by specific interactions with the p-phosphate of the guanine 
nucleotide (Scheffzek et al., 1997) (see figure I.6). In addition, the main chain carbonyl 
oxygen of this Arg residue forms an hydrogen bond with a side chain of Gln61 in Ras, thus 
stabilising this residue which is important in catalysis. A positively charged residue in a 
"secondary" loop (as opposed to the Arginine finger which is considered the primary loop) in 
the GAP stabilises the primary loop by side chain - main chain interactions (see figure I.6). 
The same interactions are found in the complex between the catalytic domain of 
p50RhoGAP and RhoA (Rittinger et al., 1997). Mutational analysis in RabGAPs in yeast 
(Albert et al., 1999) suggests that these proteins will also obey the "arginine finger" model. 
Ras/Rho 
T * * H V 
Ô- -v Gin 
Primary 
(finger arginine) 
Secondary 
GAP 
Figure 1.6 - Complementation of the active site of small GTPases by their GAPs: the 
"Arginine finger"mode", (reproduced from Scheffzek et al., 1998). 
Although GAPs for small GTPases are very divergent, a conserved core structure of 
seven a-helices was identified in RasGAP and RhoGAP (Bax, 1998; Rittinger et al., 1998). 
In both works the evolutionary implications of this finding is discussed, but for one it reflects 
convergent evolution of RasGAP and RhoGAP (Bax, 1998), while for the other it supports a 
shared ancestry between the two proteins (Rittinger et al., 1998). The recent solution 
structure of Gyp1, a yeast RabGAP reveals an protein with 16 a-helices, but there is no 
super-impositions of these and the a-helical core described above (Rak et al., 2000), thus 
limiting the scope of mentioned the evolutionary speculations to RasGAPs and RhoGAPs. 
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However, the Arginine finger model is not the only solution found in evolution for 
small GTPase activation. The solution structure of the complex between Arf1 and ArfGAP 
suggests that ArfGAP acts instead by inducing Switch II into a catalitically competent 
conformation (Goldberg, 1999). 
1.1.4.2. RabGAPs 
The complete yeast complement of RabGAPs has been identified (see table 1.2), but 
only a few mammalian RabGAPs have been described so far. 
Table 1.2 - RabGAPs 
RabGAP Rab Specificity Reference 
Gyp6 Ypt6, Ypt7 (Strom et al., 1993) 
Gyp7 Ypt7, Ypt31,Ypt32, Ypt1 (Vollmeretal., 1999) 
Gyp1 Ypt1, Sec4 (Du et al., 1998) 
Mdr1/Gyp2 Ypt6 and sec4 (Albert and Gallwitz, 1999) 
Msb3/Gyp3 Sec4, Ypt6, Ypt51, Ypt31, 
Ypt32, Ypt32 
(Albert and Gallwitz, 1999) 
Msb4p/Gyp4 Sec4, Ypt6, and Ypt7 (Albert and Gallwitz, 2000) 
Rab3-GAP Rab3 isoforms (Fukuietal., 1997) 
GAPCenA Rab6, 
Rab4, Rab2 
(Cuifetal., 1999) 
Tuberin Rab5 (Xiao et al., 1997) 
p120RasGAP Ras, Rab5 (LiuandLi, 1998) 
All known RabGAPs are cytosolic proteins. The yeast proteins share sequence 
similarity (Neuwald, 1997), but with the exception of GAPCenA, this does not happen in 
mammalian RabGAPs (Cuif et al., 1999). This divergence is particularly illustrated by the 
observation that Rab3-GAP is an heterodimeric protein, composed of a catalytic and a 
regulatory subunit (Nagano et al., 1998; Fukui et al., 1997), unlike all other RabGAPs which 
are monomeric proteins. 
The yeast RabGAPs are fully functional on non-prenylated Rabs (Albert and Gallwitz, 
2000; Albert and Gallwitz, 1999; Vollmer et al., 1999; Du et al., 1998; Strom et al., 1993), 
and so are tuberin and p120RasGAP (Liu and Li, 1998; Xiao et al., 1997). However 
GAPCenA exhibits a strict requirement for lipid modification (Cuif et al., 1999). Rab3-GEP 
was described as a a GAP specific for prenylated substrates (Fukui et al., 1997) but recently 
this requirement was questioned on the grounds that no difference in Rab3-GAP preference 
and activity between prenylated and non-prenylated substrates was detectable (Clabecq et 
al., 2000). 
RabGAPs are thought to activate GTP hydrolysis by the "Arginine finger" type 
mechanism described before. The active domains in Gyp1 and Gyp7 were identified by 
deletion analysis and by site directed mutagenesis one critical Arg residue in the active 
domain identified (Albert et al., 1999). Another supportive evidence for a conserved 
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mechanism of GAP action came from the solution structure of Gyp1 (Rak et al., 2000). 
Manually docking the crystal structures of Gyp1 and Ypt51 suggests that the best docking 
solution results in the alignment of the same arginine residue with Gln66 in Ypt51 (equivalent 
to Gln61 in p12 Ras) (Rak et al., 2000). Additional evidence for a conserved mechanism of 
GAP action came from the biochemical characterisation of the activation of GTP hydrolysis 
in Rab3 by Rab3-GAP. Mutation of conserved arginines in Rab3-GAP abolishes GAP 
activity, and the kinetics of interaction between Rab3-GAP and the different Rab3 mutants is 
consistent with a mechanism similar to that of RasGAP and RhoGAP (Clabecq et al., 2000). 
The sequence conservation between yeast RabGAPs surprisingly is also shared by 
spindle assembly checkpoint proteins in yeast (Neuwald, 1997). The biological significance 
of this finding is still unknown but may indicate that RabGAPs provide a link between 
vesicular transport and other cellular processes. Evidence towards this comes from the only 
mammalian RabGAP which shares homology with yeast RabGAPs, GAPCenA. This protein 
is mainly cytosolic, but a minor fraction associates with the centrosome (Cuif et al., 1999). As 
GAPCenA can form complexes with y-tubulin this may suggest that GAPCenA may provide 
a link between microtubule dynamics and vesicular transport (Cuif et al., 1999). 
1.1.5. Rab proteins in action 
1.1.5.1. What do thev do? 
Eukaryotic cells transport proteins between different compartments. This is 
accomplished by a complex series of events which is schematised in figure 1.7. Vesicles, in 
which the correct contents are sorted and packaged, bud and detach from one compartment 
(donor membrane), then move to its target membrane where fuse and release their contents 
into the lumen of the organelle ( for review see Zerial and McBride, 2001; Guo et al., 2000; 
Kamal and Goldstein, 2000; Hawes et al., 1999). 
Rab proteins were first implicated in vesicular trafficking in the late 1980ies with the 
identification of SEC4 as the gene mutated in a yeast mutant which displays blocked 
transport to the plasma membrane (Goud et al., 1988; Salminen and Novick, 1987). 
More than fifty Rab proteins have been identified to date in mammalian cells 
(Pereira-Leal and Seabra, 2000). Each Rab is believed to be localised to a specific 
subcellular compartment (see figure 1.8) and some show tissue-specific variation in 
expression level, reflecting the complexity and variety of trafficking events found in 
mammalian cells (for review see Zerial and McBride, 2001; Guo et al., 2000; Chavrier and 
Goud, 1999; Olkkonen and Stenmark, 1997). 
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Figure 1.7 - Simplified, schematic representation of the major steps that comprise a 
vesicular trafficking cycle. 
The sec4 mutant exhibits accumulation of vesicles which lead to the proposition that 
Rab proteins work at the docking or fusion stage. Evidence which supports this view has 
been produced for a variety of Rab proteins (see for review Zerial and McBride, 2001; 
Olkkonen and Stenmark, 1997). For example antibodies agains Rab5 inhibit in vitro 
homotypic fusion of endosomes, in cultured cells, over-expression of dominant negative 
Rab5 mutations inhibits early endosome fusion, and finally over-expression of dominant 
activated Rab5 mutations stimulates early endosome fusion (Stenmark et al., 1994; Bucci et 
al., 1992; Gorvel et al., 1991). All this indicates a role for Rab5 in endosome fusion. Another 
example is Yptlp. Antibodies against this protein inhibit ER to Golgi transport, resulting in 
the accumulation of vesicles, which indicates that vesicle formation is not affected (Baker et 
al., 1990). Furthermore, in recent work by Cao and Barlowe (Cao and Barlowe, 2000) it was 
observed that, in an in vitro system, vesicles prepared from yeast containing a mutant allele 
for Yptlp which causes blocking of transport in vivo, are able to fuse with vesicle prepared 
from wild type acceptor membranes, but wild type vesicles are not able to fuse with 
membranes prepared from mutant yeasts. This strongly indicates that Yptlp is required in 
the acceptor membrane and not in the donor membrane. 
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Additionally several effectors have been identified which support the widely accepted 
role of Rab proteins in the docking and fusion stage (see table 1.1). 
Figure 1.8 - Map of intracellular localization of Rab proteins, reproduced from (Zerial and 
McBride, 2001). (CCV, clathrin-coated vesicle; CCP, clathrin-coated pit; EC, epithelial 
cells; IC, ER-Golgi intermediate compartment; M, melanosomes; MTOC, microtubule-
organizing centre; SG, secretory granules; SV, synaptic vesicles; 7", T-cell granules; TGN, 
trans-Golgi nextwork.). 
However, some evidence as been advanced which is suggestive of Rabs also 
playing a role in budding of vesicles from the donor compartment. Studies in Sacharomyces 
cerevisiae have shown that inactivation of Ypt31 and Ypt32 results in the enlargement of the 
Golgi complex, but not in the accumulation of vesicles (Jedd et al., 1997; Benli et al., 1996). 
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This suggests an inability to bud vesicles from the Golgi (Jedd et al., 1997; Benli et al., 
1996). Also, clathrin coated pits can be formed in the absence of Rab5, but this protein is 
absolutely required for efficient cargo (transferin) sequestration (McLauchlan et al., 1998). 
This result came as a surprise at the light of the evidence described above which implicates 
Rab5 in endosome fusion. Rab5 thus seems to be a regulatory factor both for the early steps 
of vesicle formation and of vesicle fusion. Additionally, Nuoffer and co-workers (Nuoffer et 
al., 1994) observed that a dominant negative mutant Rabia inhibits the formation of vesicles 
from the ER, suggesting a role in vesicle budding. However, no effector protein has been 
identified which supports a role for Rabs in membrane budding. 
Another role for Rab proteins has been identified recently -mediating vesicle motility 
(see Deacon and Gelfand, 2001 and Kamal and Goldstein, 2000 for review). Echard and co-
workers using the two-hybrid system, identified a kinesin-like molecule which they named 
Rab kinesinõ, as a Rab6 interacting protein (Echard et al., 1998). This suggests a role for 
Rab6 in microtubule-dependent transport. More recently Rab5 was found to mediate 
attachment and mobility of endosomes along microtubules (Nielsen et al., 1999), and Rab27 
was found to regulate the peripheral localisation of melanosomes via interactions with 
myosinVa (Hume et al., 2001; Bahadoran et al., 2001; Wilson et al., 2000). Furhtermore, a 
genetic interaction has been described between Sec4 and the myosin heavy chain Myo2 
(Pruyne et al., 1998), thus establishing another link between Rab proteins and the actin 
cytoskeleton. 
Rab proteins can also regulate more than one transport step. For example mutant 
Ypt lp in Sacharomyces cerevisiae results in blockage both in ER to cis-Golgi transport and 
cis-Golgi to medial-Golgi transport (Jedd et al., 1997). 
In summary, different Rab proteins seem to act on different transport steps, 
regulating different events in vesicle budding, transport and fusion, via interactions with a 
diverse set of effector proteins. However some Rab proteins can regulate more than one 
transport step and/or regulate different events in vesicle budding, transport and fusion. To 
add even another layer of complexity to this problem, some evidence exists that questions if 
Rab proteins that are considered orthologs have indeed the same function in different 
organisms. For example, yeast Yptlp seems to be required exclusively in the acceptor 
membrane, indicating a role solely in docking or fusion (Cao and Barlowe, 2000) but in 
mammals, the putative Ypt lp ortholog Rab1 seems to be required for vesicle budding (Allan 
et al., 2000; Nuoffer et al., 1994). 
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Table 1.1 Effectors of Rab proteins (table expanded from the review (Zerial and McBride, 
2001)) 
Proposed 
Effector Rab Effector function References 
p115 Rab1 Tethering (Moyeretal., 2001; Allan 
Recruiting of SNAREs et al., 2000) 
Rabphilin-3 Rab3 Potentiates fusion (Burns et al., 1998) 
RIM1 Rab3 Membrane fusion (Wang et al., 2000) 
RIM2 Rab3 Membrane fusion (Wang et al., 2000) 
Calmodulin Rab3 Calcium sensibility (Coppola et al., 1999; 
Park et al., 1997) 
Noc2 Rab3 unclear (Haynesetal.,2001) 
Rabaptin-4 Rab4 Implicated in protein sorting (Nagelkerken étal., 
and recycling 2000) 
Rabip4 Rab4 Vesicle budding(?) (Cormontetal., 2001) 
Rabaptin-5 Rab4, Rab5 Activates Rab5 (Stenmarketal., 1995) 
Rabaptin-5p Stabilises Rabex-5 
recruitment 
EEA1 Rab5 Tethering (Christoforidis étal., 
Core fusion component 1999; McBride et al., 
1999) 
Rabenosyn-5 Rab5 Required for endosome 
fusion 
(Nielsen et al., 2000) 
p150 Rab5 Class III PI(3)K regulatory 
subunit 
(Simonsen et al., 1998) 
p110p Rab5 Class I PI(3)K catalytic 
subunit 
(Simonsenetal., 1998) 
Rabkinesin-6 Rab6 Vesicle motility 
Cytokenesis 
(Echardetal., 1998) 
RILP Rab7 Positioning of lysosomes 
(?) 
Stress activated protein 
(Cantalupoetal., 2001) 
Rab8IP Rab8 (Renetal. , 1996) 
kinase 
p40 Rab9 Stimulates fusion (Diaz et al., 1997) 
Tip47 Rab9 Cargo selection (Diaz and Pfeffer, 1998) 
Rab11BP Rab11 Vesicle recycling(?) (Mammoto et al., 2000; 
Mammotoetal., 1999) 
Rilp11 Rab11 Vesicle targeting(?) 
Ô-PDE Rab13 Extracts Rab13 from 
membranes 
(Marzescoetal., 1998) 
MyoV Rab27 Melanosome motility (Hume et al., 2001; 
Bahadoran et al., 2001; 
Wilson et al., 2000) 
Rab33BP Rab33 Probably regulates vesicle Cited in (Zerial and 
motility McBride, 2001) 
Usolp Ypt1 Tethering of vesicles (Caoetal. , 1998; 
Sapperstein et al., 1996) 
Yp1p-Yif1p Ypt1 Essential for docking and 
fusion 
(Matem et al., 2000) 
Sec15 Sec4 Tethering (Guoetal. , 1999; 
Bowser and Novick, 
1991) 
V a d p Ypt51p TGN-Golgi transport (Tall et al., 1999) 
Vamp2p/Vamp6p Ypt7p Tethering and GEF (Seals et al., 2000) 
complex Budding(?) 
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1.1.5.2. Is GTP hydrolysis really required? 
Rab proteins are traditionally viewed as "triggered" molecular switches, regulated by 
GAPs and GEFs, as their intrinsic exchange and hydrolysis rates are in general very slow. A 
variety of RabGEFs and RabGAPs has been identified in recent years (discussed above), 
which lend support to this view. However, the realisation of the diversity in the rates of 
hydrolysis has led to the suggestion that not all Rabs have the same requirement for GTP 
hydrolysis. 
Richardson and co-workers (Richardson et al., 1998) tested the importance of 
nucleotide hydrolysis in the function of one yeast Rab protein: Yptlp. Using a dominant 
activated mutation (and partially purified RabGAP activity), they observed that the cells could 
grow normally at 37°C and were not defective in the secretory pathway, as tested by 
secretase and CPY secretion. Rybin and co-workers, also observed a similar lack of 
requirement for GTP hydrolysis for Rab5 function in regulating endocytic membrane fusion 
(Rybin et al., 1996). This lack of requirement for GTP hydrolysis however questions the role 
of RabGAPs, particularly for Rab1 and Rab5 GAPs. Rybin and co-workers propose that 
Rab5 acts as a timer for fusion. According to this model, Rab5 undergoes futile cycles of 
activation-deactivation, but when required, Rab5 recruits Rabaptin-5 to the membrane and 
the binding to this effector secures GAP insensitivity, i.e., that Rab5 is maintained in the 
active conformation for the time required for fusion to occur, time that would be defined by 
the intrinsinc hydrolysis rate of Rab5 (Rybin et al., 1996). As Rab5 has an unusually high 
intrinsic hydrolysis rate (0.05 min"1) when compared to Ypt1 (0.006 min"1), it is difficult to 
generalise this mechanism to other Rabs . 
The role played by RabGAPs will need to be reassessed, particularly in the light of 
the finding that they are not essential genes in yeast (eg Strom et al., 1993). 
1.1.6. Rab: G DP binding proteins: General Regulators 
Two major types of proteins are defined as general regulators of Rab proteins: Rab 
Escort Proteins (REPs) and Rab GDP Dissociation Inhibitors (RabGDIs). These proteins are 
related at the primary sequence level and thought to have similar three dimensional fold 
(Schalk et al., 1996; Wu et al., 1996). A third unrelated protein, MSS4, has also been 
suggested to be a general regulator of Rab function. 
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1.1.6.1. Rab Escort Proteins 
Two independent groups originally reported the partial purification of an enzyme 
activity, distinct from other protein prenyl trasferases that catalysed double 
geranylgeranylation (Moores et al., 1991; Horiuchi et al., 1991), but all attempts to purify this 
activity to homogeneity failed as the enzyme lost its activity after a few steps of purification. 
This was then interpreted as being caused by enzyme instability. However, biochemical 
complementation experiments revealed that two distinct components, termed component A 
and B, separable under conventional chromatography, compose this new enzyme, termed 
Rab Geranylgeranyl Transferase (RGGT or GGT-II) (Seabra et al., 1992). Component B is 
related to the other Protein Prenyl Transferases (Armstrong et al., 1993; Seabra et al., 
1992), but component A coded for a novel protein with homology to RabGDI (Andres et al., 
1993; Seabra et al., 1992), a regulator of Rab function. The discovery that component A was 
not only required for prenylation of Rab proteins but that it remains in complex with 
prenylated Rabs and delivers them to cellular membranes led to its renaming to Rab Escort 
Protein (REP) (Alexandrov et al., 1994; Andres et al., 1993) 
Two REP proteins have been described in mammals, but only one is known in D. 
melanogaster, plants and unicellular eukaryotes. They function as essential activators of the 
prenylation reaction and differ only in the affinity for different Rab proteins (Anant et al., 
1998; Desnoyers et al., 1996). The role of REP in the prenylation of Rab proteins is 
discussed in section 1.2. More details will be given later on Part III of this thesis , which 
concerns the structural determinants of REP function. 
1.1.6.2. Rab GDP Dissociation Inhibitor 
RabGDI was originally identified by Takai and co-workers as a protein that interacts 
with the GDP-bound form of Rab3a, thereby inhibiting the dissociation of GDP from Rab3a, 
and thus it's binding to GTP (Sasaki et al., 1990). RabGDI was then observed to be active 
with other Rab proteins (Sasaki et al., 1990; Ueda et al., 1990). In addition to its properties 
as a negative regulator of the nucleotide cycling of Rabs, RabGDI was shown to inhibit 
association of GDP-bound Rabs with cellular membranes (Araki et al., 1990) and also to 
extract Rabs from membranes (Beranger et al., 1994; Garrett et al., 1993; Soldati et al., 
1993; Araki et al., 1990). Only lipid modified Rabs can associate with RabGDI (Araki et al., 
1991). In the light of these findings, RabGDI can be seen as a negative regulator of Rab 
function, both by inhibiting nucleotide cycling as well as Rab membrane association. 
Mutations in the brain specific RabGDI-a isoform cause non-specific mental 
retardation in humans (D'Adamo et al., 1998), indicating an essential function, at least for 
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this isoform in this tissue, and the deletion of the GDI gene in yeast is lethal, again indicating 
that this protein performs an essential role (Garrett et al., 1994). However the exact 
biological role of RabGDI has been a subject of contention. 
It has been proposed that RabGDI retrieves Rabs from acceptor membranes and 
recycles them back to donor membranes (Pfeffer et al., 1995). Supporting this model is the 
observation that a mutant Rablb which cannot bind RabGDI, accumulates in the 
membranes instead of partitioning between membranes and cytosol (Wilson et al., 1996), 
and mutations in RabGDI domain II result in accumulation of Rabs in the membrane fraction 
(Luan et al., 2000). Additionaly, it was observed that RabGDI can mediate in vitro delivery of 
Rab5, Rab4, Rab9 and Rab11b into specific cellular membranes (Ayad et al., 1997; Soldati 
et al., 1994; Ullrich et al., 1994; Peter et al., 1994). 
On the other hand, chimerical Sec4 and Ypt1, where the prenylation motif was 
substituted by a trans-membrane domain (thus rendering these proteins unavailable for 
RabGDI extraction), could rescue the loss of the corresponding wild-type protein (Ossig et 
al., 1995). This questions whether the dramatic effects that result from RabGDI deletion are 
indeed caused by lack of Rab recycling. 
Interestingly, it is possible that RabGDIs only act on a subset of Rab proteins. 
Marzesco and co-workers identified the rod cGMP phosphodiesterase delta subunit (ô-PDE) 
as a Rab13 binding protein (Marzesco et al., 1998). Surprisingly ô-PDE displays the ability to 
specifically dissociate Rab13 from cellular membranes, which RabGI does not. If this is due 
to the atypical ras-like CAAX box displayed by Rab13, as opposed to the characteristic 
double cysteine prenylation motif remains to be addressed. 
Another layer of complexity is added by the recent work of Erdman and Maltese 
(Erdman and Maltese, 2001), which observed that in human terato-carcinoma cells, different 
Rabs associate differentially with the two isoforms of RabGDI, independently of their relative 
abundance. 
1.1.6.3. MSS4, DSS4 and PRA1 
DSS4 and its mammalian counterpart MSS4 were originally described as exchange 
factors for members of the Rab family (Moya et al., 1993; Burton et al., 1993). However, 
several arguments can be raised to contest this classification. 
Unlike other exchange factors, MSS4 has a broad range of Rab specificity, acting at 
least on Rab1, Rab3, Rab8, Rab10, sec4 and Ypt1 (Burton et al., 1994). MSS4 is a week 
GEF when compared with other RabGEFS (Moya et al., 1993; Burton et al., 1993), and 
finally, DSS4 is not an essential gene nor does its deletion cause any remarkable effect 
which can be associated with the non-activation of any particular Rab protein (Nuoffer et al., 
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1997; Moya et al., 1993). This does not support a role as an exchange factor in vivo. Instead 
it was proposed that MSS4 and DSS4 represent a new class of general regulators of Rab 
proteins which bind and stabilise Rab proteins in the nucleotide free conformation, with a 1:1 
stoichiometry (Nuoffer et al., 1997). The observation that the binding of these proteins to 
Rabs is not prenylation dependent suggests they might interact with nascent unprenylated 
Rab proteins (Nuoffer et al., 1997). 
PRA1, standing for Prenylated Rab acceptor, was identified in a two hybrid screen as 
a Rab1 and Rab3 interacting protein, specific for prenylated Rab proteins and exhibiting two 
putative trans-membrane segments (Martincic et al., 1997). PRA1 can also bind RabGDU, 
albeit weakly, and inhibits the extraction of membrane-bound Rab3 by RabGDU (Hutt et al., 
2000). Recently another isoform of PRA1 was described and it was observed that the two 
isoforms display distinct sub-cellular localisations (one in the Golgi and the other in the ER) 
(Abdul-Ghani et al., 2001). The results above suggest that PRA1 may be a receptor for Rab 
proteins. However, in contradiction with the work of Martincic and co-workers (Martincic et 
al., 1997), PRA1 was recently shown to interact in vitro and in vivo also with prenylated 
members of the Ras and Rho families (Figueroa et al., 2001). In face of this, it is 
questionable if PRA1 can be indded a Rab receptor. Figueroa and co-workers suggest that 
PRA1 may act as an escort protein for small GTPases, by binding to the hydrophobic 
isoprenoid moieties of the small GTPases and facilitating their trafficking through the 
endomembrane system. An alternative possibility is that PRA1 is part of a protein complex 
that forms the Rab, Ras and Rho membrane receptors. PRA1 would provide for the prenyl 
protein specificity and the protein specificity would be decided by other components of this 
"receptor complex". In the Rab family, the soluble exchange factors could play this role, 
since, as discussed, they seem to be involved in membrane association of their target Rab 
protein (see 1.1.3.2). In this case, PRA1 can be seen as a general regulator of membrane 
association, instead of a specific Rab effector. 
I.2. Lipid modification of Rab proteins 
Expanded and adapted from Pereira-Leal, Hume and Seabra (2001) FEBS lett. In press 
Rab proteins, like other small GTPases, require association to cellular membranes 
for proper activity. This is accomplished by modification of the protein with lipid groups. Here 
a brief overview of the different types of lipid modifications is done, followed by a discussion 
on protein isoprenylation with particular emphasis on Rab isoprenylation. 
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1.2.1. Lipid modifications 
Lipid modification of proteins is an expression used to describe the co- or pos-
translational covalent attachment of a lipid group to a protein, in general to permit the 
association of hydrophilic proteins to the hydrophobic lipid bilayers of biological membranes. 
Four major types of lipids are known to be involved in lipid modification of proteins. 
These are fatty acids (myristic acid and palmitic acid), glycosyl-phosphatidylinositol, 
cholesterol and isoprenoids. Of particular relevance to this work is protein prenylation, which 
will be discussed in more detail. Here we will briefly mention the other major classes of lipid 
modification. 
Glycosyl-phosphatidylinositol (GPI) is involved in mediating anchorage to the plasma 
membrane of secreted proteins as diverse as CD55, acetylcholinesterase, alkaline 
phosphatase, CD48, urokinase receptor among others, via "GPI anchors". Synthesis of GPI 
precursors and the addition of GPI to a GPI-signal sequence containing protein occurs in the 
endoplasmic reticulum. GPI anchor-containing proteins are then transported to the external 
leaflet of the plasma membrane via the secretory pathway, and cluster in sphingolipid-sterol 
micro-domains (for review see Muniz and Riezman, 2000; Udenfriend and Kodukula, 1995)). 
Deficiency in GPI synthesis results in a human disease, paroxysmal nocturnal 
hemoglobinuria (reviewed in Kinoshita et al., 1996). 
Another type of lipid modification that seems to affect a family of secreted proteins is 
modification by cholesterol. It is a recent observation, and so far has only been observed in 
the fruit fly protein sonic hedgehog (Porter et al., 1996a; Porter et al., 1996b) and recently, in 
the human ortholog of this protein (Pepinsky et al., 1998). Interestingly, this modification is 
accomplished in the fly protein via an auto-catalytic process where after signal peptide 
cleavage, a precursor form of hedghog undergoes an autocatalytic cleavage that produces a 
lipid modified N-terminal fragment, the autocatalytic activity residing in the C-terminal portion 
of the precursor protein. The human form of this protein has also been reported to be 
acylated in the N-terminus by palmitate (Pepinsky et al., 1998). 
Modification of proteins by fatty acids is termed acylation. N-Myristoylation refers to 
the attachment of the C14:0 saturated fatty acid to an N-terminal glycine residue exposed 
after removal of the initiation methionine residue. It affects, among other proteins, members 
of the Arf family of small GTPases, proteins involved in the regulation of membrane transport 
(reviewed in Roth, 2000). Myristate is attached co-translationally to an N-terminal glycine 
residue, via an amide bond (Bhatnagar and Gordon, 1999) by one of at least two N-
myristoyltransferases (Giang and Cravatt, 1998). Acylation of Arts has been observed to be 
essential not only for membrane association but also for activation by exchange factors as 
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ARFs need to undergo a lipid mediated conformational switch before they can interact with 
GEFs (Donaldson and Jackson, 2000; Roth, 2000; Franco et al., 1996). 
Palmitoylation, another type of acylation (thyoacylation) will be further discussed in 
the context of the processing of CAAX small GTPases. 
1.2.2. Protein Prenylation 
Protein prenylation refers to the stable covalent addition of 15-carbon (famesyl) or 
20-carbon (geranylgeranyl) isoprenoids via thioether bonds to carboxyl terminal cysteine 
residues. This type of lipid modification was first reported in 1978 when peptide mating 
factors secreted by some fungi were observed to have a covalently attached farnesyl group 
(Kamiya et al., 1978). Protein prenylation was later found to also affect mammalian proteins. 
Mammalian epithelial cells incubated with radioactively labelled mevalonate, a precursor in 
the biosynthetic pathway of cholesterol (see figure 1.9), were shown to accumulate proteins 
labelled with mevalonate derivatives (Schmidt et al., 1984). 
The first prenylated mammalian protein identified was the nuclear envelope protein 
lamin B, which was shown to possess a farnesyl group covalently attached to a C-terminal 
cysteine via a thioether bond (Farnsworth et al., 1989; Wolda and Glomset, 1988). Since 
then, a wide range of proteins have been found to be prenylated, and prenylation has been 
recognised as a frequent post-translational modification in eukaryotic cells, estimated to 
affect about 0.5% of the cellular proteins (Epstein et al., 1991). 
Isoprenoids are produced by the mevalonate pathway, a metabolic pathway that 
produces a wide variety of compounds, namely cholesterol, dolichol and ubiquinone (Grunler 
etal., 1994) (see figure I.9). 
Protein prenylation is catalysed by a family of enzymes termed Protein Prenyl 
Transferases where all the enzymes are heterodimers consisting of an a and B-subunits 
(Casey and Seabra, 1996). 
Protein Farnesyl Transferase (PFT) and Protein Geranylgeranyl Transferase I 
(PGGTI), which share a common a-subunit, define the functional class of CAAX prenyl 
transferases. They recognise a CAAX tetrapeptide prenylation motif at the C-terminus of 
their substrates, where C represents a cysteine residue, A an aliphatic residue and X any 
amino acid. The identity of the residue at position X is sufficient to determine which enzyme 
will modify which protein. When X is a methionine or serine residue, as in Ras proteins, then 
the protein is famesylated by PFT. However, when X is a leucine residue, as in Rho 
proteins, then the protein is geranylgeranylated by PGGTI (Spence and Casey, 2001; 
Yokoyama and Gelb, 2001). CAAX prenylation motifs are also found in a variety of other 
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proteins such as y-subunits of heterotrimeric G-proteins, nuclear lamins, G-protein coupled 
receptor kinases, fungal mating pheromones and retinal cyclic GMP phosphodiesterase 
(Spence and Casey, 2001; Yokoyama and Gelb, 2001). 
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Figure 1.9 - (A) chemical structure of farnesyl pyrophosphate and genarylgeranyl 
pyrophosphate (B) Simplified scheme of the intermediates in the synthesis of cholesterol 
(adapted from (Goldstein and Brown, 1990) and (Grunler et al., 1994)). 
A second class of prenyl transferases is defined by RabGeranylgeranyl Transferase 
(RGGT or PGGTII), an enzyme that catalyses the addition of two geranlgeranylgroups to 
members of the Rab family. This enzyme will be discussed below. 
Until recently only isoprenoids in C15 and in C20 were thought to be involved in 
protein prenylation, but Parmyd and Dallner (Parmyd and Dallner, 1999) reported they 
observed protein modified by penta- and hexaprenyl groups in rats injected with labelled 
mevalonate. The nature of the putative Protein penta and hexa prenyl Transferases, and 
their substrates, remains to be elucidated. 
Geranylgeranyl-PP**-
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1.2.3. Prenylation ofRab proteins 
Rab Geranylgeranyl Transferase (RGGT) defines a second class of prenyl 
transferase which differs in many ways from the CAAX Prenyl Transferases. RGGT was 
originally identified as the enzyme that modified Rab proteins, and so far no other substrates 
are known (Seabra, 2000; Seabra et al., 1992). The structure of RGGT has been solved 
recently (Zhang et al., 2000). The B-subunit consists of an a-a barrel and forms the lipid-
binding site as shown for PFT (Seabra, 2000; Terry et al., 2001; Zhang et al., 2000). The a-
subunit is larger than those found in the CAAX prenyltransferases, consisting of a helical 
domain similar to PFT plus two other domains of unknown function: a leucine-rich repeat and 
an immunoglobulin-like domain (Zhang etal., 2000). 
Rab proteins, unlike other small GTPases, exhibit a variety of prenylation motifs at 
their C-termini, containing either one or, more frequently, two cysteine residues both of 
which are modified by geranylgeranyl groups (Farnsworth et al., 1994). Also, the prenylation 
motif in Rab proteins is insufficient by itself for substrate recognition by RGGT. Biochemical 
evidence indicate that unprenylated Rab must first bind to a 95kDa protein termed Rab 
Escort Protein (REP, originally termed component A of RGGT) in order to be recognised as 
a substrate for RGGT (Seabra, 2000; Anant et al., 1998). The role of REP in prenylation is 
supported by the finding that deficiency of REP results in hypoprenylation of Rab proteins in 
vivo (Bialek-Wyrzykowska et al., 2000; Seabra et al., 1995). Together these observations 
suggest that the REP:Rab complex is the true substrate of RGGT (Seabra, 2000; Anant et 
al., 1998). 
Figure 1.10 - The Rab prenylation cycle 
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Two REP proteins are found in mammals (Desnoyers et al., 1996). Both REP1 and 
REP2 are ubiquitously expressed and are structurally related to RabGDI (Seabra, 2000; Wu 
et al., 1996). Recent results suggest that REPs and GDIs interact with Rab proteins in a 
conserved way, using amino acid residues in the conserved "Rab-binding platform" (Alory 
and Balch, 2000). Part III will deal with these issues. 
Rab prenylation occurs in several steps (see figure 1.10). Newly synthesised Rabs 
bind to one of the two REP proteins and this complex then associates with RGGT. This 
enzyme contains one GGPP binding site and recent studies indicate that GGPP binding 
increases the affinity of RGGT for the REP:Rab complex suggesting that the enzyme may 
already be bound to a single GGPP group at this stage (Thoma et al., 2000; Desnoyers and 
Seabra, 1998). Geranylgeranylation of the most N-terminal cysteine follows (Shen and 
Seabra, 1996). In the case of some Rabs e.g. Rab8 or Rab13, which contain a lone cysteine 
residue available for prenylation, dissociation of the enzyme is thought to occur at this point. 
However, a second cysteine residue is available in most cases and RGGT catalyses another 
round of lipid binding and transfer. In this case, it is unclear whether RGGT dissociates from 
the monoprenylated REP:Rab-GG complex, due to the reduction in the affinity of RGGT for 
the mono-prenylated complex in the absence of GGPP, or whether it can recruit a second 
geranylgeranyl group while bound to the REP:Rab-GG complex. Finally, after the second 
GG group is transferred, binding of an additional lipid group to the B-subunit destabilises the 
complex and the enzyme dissociates from the di-prenylated REP:Rab complex. (Thoma et 
al., 2000). REP may then deliver the geranylgeranylated-Rab to cellular membranes (Wilson 
et al., 1996; Alexandrov et al., 1994) where it can interact with specific effectors and perform 
its biological role. 
1.2.4. Post-prenylation processing 
1.2.4.1. Post-prenylation processing of CAAXproteins 
CAAX proteins, after prenylation, see the proteolytical removal of the most C-terminal 
three amino-acids (see figure 1.11). This reaction is catalysed by a isoprenylprotein 
endoprotease and is followed by carboxyl methylation of the prenylated cysteine, in a 
reaction catalysed by a prenylcysteine carboxyl methyltransferase. Some CAAX proteins, 
like N- or H-Ras can be also S-acylated in cysteine residues close to the prenylated cysteine 
residue. 
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Isoprenylprotein endoproteases were originaly cloned in Saccharomyces cerevisiae, 
in a genetic screen for sterile mutants that could not process the a mating factor (Boyartchuk 
et al., 1997). Two genes were identified, RCE1 and STE24, which were required for the 
processing of the a-mating factor and at least another protein, Ras2p. STE24, also known as 
AFC1 (a-factor convertase 1) is a zinc metallo-protease that participates in the 
endoproteolytical processing of a-factor, whereas RCE1, which stands for "Ras and a-factor 
converting enzyme" participates in the processing of both Ras and a-factor. The mammalian 
counterpart of RCE1 was cloned based on sequence similarity to the yeast protein (Otto et 
al., 1999). Further work by the same group revealed that inactivation of this protease by 
gene targeting results in complete loss of Ras proteolytical processing, suggesting that in 
mammals this protease is the sole protease involved in Ras post-prenylation removal of the 
C-terminal tripeptide (Kim et al., 1999). Interestingly, Ras proteins were found to be mainly 
cytosolic in RCE1 -I- cells, in contrast with the normal plasma membrane association found 
in RCE1 +/+ cells, suggesting an important role of post-prenylation processing in membrane 
association and/or targeting of Ras (Kim et al., 1999). 
After endoproteolysis of the tripeptide AAX, the prenylated cysteine will then be 
methylated by a prenylcysteine Carboxyl Methyltransferase (pcCMT) (see figure 1.11). The 
identification of the yeast pcCMT was made also from sterile mutants that could not process 
a mating factor. The mutant Ste14 was found to lack any pcCMT activity towards a Ras 
derived peptide (Hrycyna and Clarke, 1990) which suggested that the same pcCMT was 
responsible for processing of both a-factor and Ras proteins. Later, the same group cloned 
the STE14 gene and found that the Ste14 mutant completely lacked the ability to process 
Ras, thus showing that Ste14 is the pcCMT that methylates Ras proteins (Hrycyna et al., 
1991). Lack of prenylcysteine carboxyl methylation, surprisingly, did not affect Ras function 
(Hrycyna et al., 1991). It did however have an effect in Ras levels and in its membrane 
association, resulting in reduction in total levels of Ras and reduction in the membrane 
fraction (Hrycyna et al., 1991). 
The mammalian prenylcysteine Carboxyl Methyltransferase (pcCMT) was cloned 
recently by Dai and co-workers (Dai et al., 1998) which searched the EST databases for 
sequences homologous to Ste14. The pcCMT gene was able to complement an Ste14 
mutant and is predicted to be a multiple membrane-spanning 33 KDa protein. This enzyme, 
like its yeast counterpart (Romano et al., 1998) was localised, by immuno-fluorescence 
microscopy to the ER (Dai et al., 1998). For a comprehensive review on proteolysis and 
carboxyl methylation of CAAX proteins see (Young et al., 2000). 
All CAAX small GTPases are believed to undergo post-prenylation proteolysis and 
carboxyl methylation, but for some, like N- and H-Ras and RhoB and TC10, further 
processing is required (see figure 1.11). These proteins display cysteine residues close to the 
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prenylated cysteine that can be modified by a saturated Ci6:0 fatty acid via thioester bond. 
This type of lipid modification is called palmitoylation, or more correctly, protein thioacylation 
(see (Linder, 2001) for review) 
Palmitoylated proteins include several families of small GTPases, heterotrimeric G 
proteins, rhodopsin, phospholipase D, the HIV-1 envelope glycoprotein, among others 
(Linder, 2001). Palmitoylation occurs frequently in conjunction with other lipid modifications, 
like prenylation in Ras, cholesterol modification in hedgehog and N-myristoylation of cc-
subunits of heterotrimeric G proteins. The most striking difference between thioacylation and 
other forms of lipid modification resides in its dynamic, reversible character. Several protein 
acyltransferases have been purified (for example (Das et al., 1997; Liu et al., 1996)), but it is 
still unclear if they perform this function in vivo, particularly in the light of the observed 
spontaneous and efficient transfer of fatty acid from acetyl-CoA to proteins (for example 
(Bizzozero et al., 1987)). Removal of acylgroups is better understood, with two enzymes 
responsible for this reaction already described and characterised (Duncan and Gilman, 
1998; Camp et al., 1994). Mutations in one palmitoyl thioesterase (PPT1) cause infantile 
neuronal ceroid lipofuscinosis, a severe neurodegenerative disorder (see (Linder, 2001) for 
review). 
Recent work by the groups of Mark Philips and John Hancock (Apolloni et al., 2000; Choy et 
al., 1999) revealed that the pos-prenylation modifications are part of a hierarchy of signals 
that determine the trafficking and targeting of Ras proteins to the plasma membrane. 
Prenyltransferases are believed to be solube enzymes (Casey and Seabra, 1996), but both 
the protease and the pcCMT localise to the ER membrane. Choy and co-workers (Choy et 
al., 1999) showed that prenylated Ras associates with the ER before reaching the plasma 
membrane, and that the targeting to the ER is determined solely by the CAAX motif. 
Trafficking from the ER to the plasma membrane for N- and H-Ras, happens through the 
exocytic pathway, but is dependent on a second signal, the cysteine residue which is 
modified by palmitoylation (Apolloni et al., 2000). In contrast, K-Ras, which does not posses 
a palmitoylatable cysteine residue, but instead has a polybasic stretch near the C-terminus, 
was found to undergo initial targeting to the ER, but traffics to the plasma membrane by an 
unknown route. Some evidence is presented which suggests that it might be a microtubule-
dependent pathway (Apolloni et al., 2000). Together these two studies suggest that the 
CAAX motif targets the GTPase to the prenyltransferase, that the prenylated CAAX motif 
then targets the protein to the ER for proteolysis and carboxyl methylation, and that the 
presence of a palmitoylation motif directs trafficking of the protein, via the exocytic pathway 
to the plasma membrane, but that the absence of this second signal and/or the presence of 
a poly-basic signal directs trafficking to the plasma membrane via different route. 
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Figure 1.11 - Model of Ras post-prenylation processing and trafficking, reproduced from 
(Apolloni et al., 2000). After the common processing steps of farnesylation, AAX proteolysis, 
and methylation which are completed on the cytosolic surface of the ER, the trafficking 
routes of the different Ras proteins diverge. K-ras, by virtue of its C-terminal polybasic 
domain, is sorted out of the conventional exocytic pathway and takes an undefined pathway 
to the cell surface that bypasses the Golgi. H- and N-ras are palmitoylated by an ER-
localized palmitoyltransferase and enter the exocytic pathway; they traffic to the cell surface 
via the Golgi. OMe, carboxymethyl; PalmCoA, palmitoyl coenzyme A; SAM, S-adenosyl 
methionine; PalmTase, palmitoyltransferase; MethTase, methyltransferase; FPTase, 
farnesyl protein transferase; Farnesyl-PP, farnesyl pyrophosphate. 
Recent work suggests that this simple model does not apply to members of the Rho 
family, where the existence of general regulators like RhoGDIs and possibly of other 
targeting signals play a role both in trafficking and targeting of members of this family 
(Michaelson et al., 2001). 
1.2.4.2. Post-prenylation processing of Rab proteins 
The only post-prenylation processing of Rab proteins that has been described so far 
is carboxyl methylation of the C-terminal prenylated cysteine residue in the contex of a CXC 
prenylation motif, but not in CC motifs (Smeland et al., 1994). The enzyme that catalyses 
this reaction is the same pcCMT that carboxyl methylates CAAX proteins (Bergo et al., 
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2001), but unlike CAAX proteins, doubly-geranylgeranylated CXC proteins do not seem to 
require carboxyl methylation for efficient membrane association (Bergo et al., 2001 ; Smeland 
et al., 1994), nor does it seem to play a role in the trafficking or targeting (Bergo et al., 
2001). 
As mentioned before, some Rab proteins exhibit a single C-terminal cysteine residue, 
in the context of a CAAX or CAAX like prenylation motif. It has not been addressed, to our 
knowledge, if these Rab proteins will undergo the same type of post-prenylation processing 
that was described above. We have noticed though that some recent additions to the Rab 
family (see Part II of this thesis) display C-terminal sequences that resemble the 
palmitoylation signals in N- and H-Ras or the poly-basic signals in K-Ras. It is tempting to 
speculate that although members of the Rab family have evolved a different strategy for 
membrane association, which involves double geranylgeranylation by RGGT, some of the 
components of the Ras signals could have been re-utilized in this family. 
1.2.5. Deficient Rab prenylation and human disease 
Choroideremia (CHM) is an X-linked chorioretinal degeneration characterised by 
progressive night blindness and loss of peripheral vision starting in the second or third 
decade of life which invariably results in complete blindness within two or three decades of 
the initial manifestation of symptoms (van den Hurk et al., 1997; Seabra, 1996). The gene 
mutated in this disease was identified by Cremers and co-workers (Cremers et al., 1990) 
and named CHM. All known CHM mutations are predicted to result in loss of CHM protein 
function due to the production of truncated, non-functional or unstable polypeptide (van den 
Hurk et al., 1997). 
A function of CHM became apparent when REP1 was purified and cloned, and 
observed to correspond to the CHM gene product (Seabra, 1996; Seabra et al., 1993). This 
suggested that CHM was caused by improper Rab prenylation, but it remained unclear how 
loss of a function essential for every cell type resulted in an eye-specific phenotype. The 
observation that lymphoblasts from CHM patients still contained RGGT activity led to the 
identification of a second REP protein, REP2 and to the hypothesis that REP2 incompletely 
compensates the loss of REP1 in CHM patients thus leaving a subset of Rab proteins 
unprenylated (Cremers et al., 1994). Consistent with this hypothesis, one Rab protein was 
observed to be selectively unprenylated in CHM lymphoblasts (Seabra et al., 1995). This 
Rab was subsequently identified as Rab27a and shown to be highly expressed in the same 
layers of the rat eye that are observed to degenerate in CHM patients, the retinal pigment 
epithelium (RPE) and the choroid (Seabra et al., 1995). 
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Rab27a, one of two isoforms of the Rab27 subfamily, was recently shown to localise 
to melanosomes, melanin containing granules present in melanocytes, and to be involved in 
the transport of these organelles to the periphery of melanocytes (Hume et al., 2001; 
Bahadoran et al., 2001; Wilson et al., 2000). Therefore, one possibility is that retinal 
degeneration in CHM patients might be triggered by defects in transport of melanosomes in 
RPE and choroidal melanocytes. However, recent data call into question the relationship 
between Rab27a hypoprenylation and chorioretinal cell death. First, Rab27a is highly 
expressed in a number of other tissues which are apparently unaffected in CHM patients 
(Hume et al., 2001; Ramalho et al., 2001; Chen et al., 1997). Second, loss-of-function 
mutations in the human and murine RAB27A genes result in Griscelli syndrome (GS) and 
the ashen (ash) mutant mouse, respectively. GS is characterised by partial cutaneous 
albinism and immunodeficiency, neither of which is reported as affecting CHM patients 
(Menasche et al., 2000; Wilson et al., 2000). In both GS patients and the ash mouse, the 
absence of Rab27a protein results in immunodeficiency due to failure of cytotoxic T 
lymphocytes to secrete the contents of their lytic granules (Stinchcombe et al., 2001; 
Haddad et al., 2001; Menasche et al., 2000), and albinism due to defects in melanosome 
transport (Hume et al., 2001; Bahadoran et al., 2001; Wilson et al., 2000). 
In spite of these observation the involvement of Rab27a in the pathogenesis of CHM 
cannot be discounted at present as the ash mutant examined in the above studies is 
maintained in the inbred laboratory mouse strain (C3H) which is homozygous for the rd 
mutation (Pittler and Baehr, 1991). This mutation of the p-subunit of cyclic GMP 
phosphodiesterase causes complete degeneration of photoreceptors shortly after birth. The 
absence of observed retinal degeneration in GS is understandable as their mean life 
expectancy is 5 years in the absence of early bone marrow transplantation (Klein et al., 
1994) and to our knowledge no reports of long term health of transplanted patients are 
published. In our view, it is still likely that dysfunction of Rab27a contributes to CHM 
pathogenesis perhaps in combination with other retinal Rabs similarly hypoprenylated and 
partially dysfunctional. Another possibility is that REP-1 may have other functions yet 
undiscovered required for survival of retinal cells. 
Hermansky-Pudlak syndrome (HPS) is a group of recessively inherited disorders 
caused by mutation in multiple genes whose products are involved in the biogenesis and 
function of three related organelles; melanosomes in melanocytes, platelet dense granules 
and lysosomes. The disease manifests as hypopigmentation (partial albinism), prolonged 
bleeding and ceroid deposition in lysosomes (Huizing et al., 2000; Swank et al., 1998). 
The gunmetal (gm) mutant is one of 14 murine models of HPS. In addition to the 
above defects, the gm mutant exhibits other abnormalities relative to wild-type animals; they 
have fewer, larger platelets, reduced platelet alpha granule content, and reduction in killing 
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capacity of cytotoxic T cells (Stinchcombe et al., 2001 ; Swank et al., 1993). Recently, the gm 
mutation was identified as a G to A substitution in a splice acceptor site in the gene encoding 
the murine RGGT a-subunit (Detter et al., 2000). As a consequence, the major RGGT 
transcript in the gm mutant lacks a start codon and is nonfunctional. However, the gm 
mutant contains a reduced level of RGGT activity due to the low frequency activation of a 
cryptic splice acceptor site within RGGT- a RNA which results in the production of a 
transcript containing a start codon. 
Choroideremia Gunmetal IH ermansky-Pudlak 
Figure 1.12 - Rab prenylation and disease of mice and man. Newly synthesised Rabs 
bind to one of two REP proteins. Mutations in REP1 cause Choroideremia, an X-linked 
retinal degeneration. Histological sections of retina reveal early pathological changes in a 
female carrier of the CHM mutation (A), and the fundus of the eye of an affected male show 
marked peripheral retinal degeneration (B). The REP:Rab complex is the substrate for the 
enzyme RGGT which catalyses geranylgeranylation of the Rab protein. Mutations in the ct-
subunit of RGGT result in hypopigmentation as observed in the gunmetal mouse model of 
Hermansky-Pudlak syndrome (C) and platelet dysfunction characterised by 
macrothrombocytopenia and reduced number of a- and dense-granules (D). Mutations in 
one Rab protein, Rab27a result in hypopigmentation as observed in the ashen mouse model 
of Griscelli syndrome (E), due to clustering of melanosomes in the perinuclear region of 
melanocytes (F). Inset in panel F shows normal distribution of melanosomes in wild-type 
melanocytes. 
This observation suggested that deficiency of Rab(s) prenylation results in the HPS 
phenotype, a hypothesis remarkably similar to the one proposed for CHM. Consistent with 
this possibility, a subset of Rabs accumulate unprenylated in the gm cytosol, including 
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Rab27a (Stinchcombe et al., 2001; Detter et al., 2000; Swank et al., 1993). Interestingly, 
Rab27 isoforms are highly expressed in the tissues affected in the gm mouse suggesting 
that the gm phenotype is at least in part a result of reduced Rab27 function. However, a 
number of observations indicate that hypoprenylation-induced defects in the function of other 
unknown Rabs contribute significantly towards more general disruption of membrane 
transport which triggers the pathological changes observed in this mutant. The most obvious 
of these is that although both the gm and ash mutants exhibit hypopigmentation and 
immunodeficiency, the fundamental cell biological defects underlying these phenotype differ. 
In gm, immunodeficiency appears to result from defects in T cell cytotoxic granule 
polarisation rather than in secretion of granule contents as observed in ash (Stinchcombe et 
al., 2001). Our preliminary observations of melanosome distribution in melanocytes derived 
from gm neonates indicate that hypopigmentation in this mutant does not result from failure 
to transport melanosomes to the peripheral cytoplasm (E Sviderskaya, AN Hume, DC 
Bennet and MC Seabra, personal communication) as is observed in ash (Wilson et al., 
2000). Identification and characterisation of the other Rabs which accumulate unprenylated 
in the cytosol of gunmetal mutant should provide further insight into Rab prenylation and 
function, the pathogenesis of HPS and other human lysosomal storage disorders. 
In conclusion, deficiencies in the Rab prenylation machinery can lead to 
different diseases (Figure 1.12). Hypoprenylation of one or more Rab proteins seems 
to be the cause of the different diseases, although it is impossible to rule out at this 
point other molecular mechanisms. It is intriguing that while prenylation is required 
for the function of most Rab proteins, deficiencies in the prenylation machinery only 
affects certain tissues. A possible explanation is that these restricted pathologies 
result from members of the Rab family having a range of affinities for REP1, REP2 
and/or RGGT, together with a differential tissue requirement. 
Rab27 appears to be a common denominator in CHM and gunmetal, suggesting that 
it is not a good substrate for prenylation. As we cannot detect significant differences in 
binding of REP1 and REP2 to Rab27 in vitro (B Larijani and MC Seabra, personal 
communication), other yet undescribed factors may regulate Rab prenylation in vivo. If this is 
the case, elucidation the nature of these factors will bring further insight to the understanding 
of Rab prenylation and these pathologies. 
1.3. The questions this work attempts to address 
For almost a decade Miguel Seabra's lab has been interested in the lipid modification 
of small GTPases of the Rab family. A significant amount of work has been done on the 
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biochemistry of lipid modification of Rab proteins, but a number of questions dealing with the 
early steps of prenylation remain unanswered. The formation of the REP:Rab complex, the 
substrate of the enzyme RGGT, in particular hasn't been properly characterised. What are 
the structural determinants of REP:Rab binding? 
This work tries to address this question, by dividing it into smaller questions: 
• What defines a Rab protein?? What do they all have in common that could be 
recognised by 2 REPs 
• What defines a REP protein? What do they have in common that different 
structures serve the same role in different organisms 
• How do Reps and Rabs interact? 
• Are there additional factors that regulate association of REP and Rab? 
Several observations made in the course of this work prompted us to also pursue 
structural determinants of events after the prenylation reaction as natural consequences of 
our work, and to look into the proteins here studied from an evolutionary perspective in order 
to gain insights into the conserved and divergent features of these proteins. 
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Part II - Rab Proteins 
11.1. The Mammalian Rab Family of Small GTPases: 
Definition of Family and Subfamily Sequence Motifs Suggests a Mechanism for 
Functional Specificity in the Ras Superfamily 
Reproduced from: Pereira-Leal and Seabra (2000) J.Mol.Biol. 301: 1077-1087 
II. 1.1. Introduction 
The Ras superfamily of GTPases encompasses a large group of proteins that bind 
GTP and GDP and serve as molecular switches to regulate important cellular processes 
such as growth, motility and protein trafficking (Barbacid, 1987; Bourne et al., 1990). General 
guidelines for nomenclature on Ras-like GTPases were set in 1992, following a FASEB 
Summer Conference (Kahn et al., 1992). The proposal that there are five different families 
within the superfamily (Ras, Rho/Rac, Rab, Arf, Ran) is now widely accepted. 
The largest branch of this superfamily is formed by the Rab/Ypt/Sec4 family, proteins 
that act as essential regulators of vesicular transport pathways (Lazar et al., 1997; Novick 
and Zerial, 1997; Olkkonen and Stenmark, 1997; Schimmoller et al., 1998; Chavrier and 
Goud, 1999; Brennwald, 2000; Rodman and Wandinger-Ness, 2000). Rabs have been 
traditionally numbered in order of discovery, Rab1, Rab2, Rab3, through to Rab37 at 
present. The number of Rab-like sequences has been growing steadily over the last decade 
and we noted that a significant number of Rabs have been deposited in the databases under 
different names. The problem is that there is no comprehensive definition of what 
distinguishes a Rab from other small GTPases. Simple criteria such as the presence of a 
double-cysteine prenylation motif at the C-terminus is insufficient as some bona fide Rabs 
such as Rab8 or Rab13 contain only a single cysteine residue (Casey and Seabra, 1996). 
In this study, we attempt to identify mammalian Rab-specific regions that serve as 
diagnostic Rab sequences in order to define a Rab protein on the basis of its primary 
structure. We found five Rab-specific regions that we termed Rab family (RabF) motifs. 
Using the RabF motifs, we were able to identify new Rabs from the databases as well as find 
all the known Rabs, thus validating these motifs. We also analysed Rab subfamily sequence 
motifs (RabSF) and propose a new nomenclature for the family. These new findings suggest 
general mechanisms by which Rabs and possibly other families of Ras-like GTPases are 
able to bind such a myriad of regulators and effectors. 
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11.1.2. Materials and Methods 
We selected a mammalian representative of each Rab sequence from the 
databases. Where more than one sequence was available, we chose the following arbitrary 
priority of species: human, rat, mouse, canine, bovine and rabbit. We performed alignments 
of the sequences retrieved from Genbank using the Clustal W 1.80 algorithm (Thompson et 
al., 1997) and the multiple sequence alignment with hierarchical clustering algorithm (Corpet, 
1988). The complete sequence alignment data can be viewed at 
http://www.med.ic.ac.uk/db/dbbm/ rab_family.html. The software package HMMER 2.0 
(available at http://hmmer.wustl.edu/) was used to calculate profile HMM and generate 
model sequences for each family. The alignment of model sequences was manually 
adjusted to accommodate structural considerations. 
The search for new mammalian Rab sequences was performed by ^-BLAST 
(Altschul et al., 1997) of known Rab sequences, or by searching the databases with 
combinations of the Rab family specific motifs (RabF) defined in this work, using the 
PatternFind Server at http://www.isrec.isb-sib.ch/software/PATFND_form.html. 
The final alignments were used to calculate phylogenetic trees using the Neighbour-
Joining method excluding positions with gaps. Bootsraping (Felsenstein, 1985) involved 
1000 trials. Trees were calculated using the program ClustalX 1.80 (Thompson et al., 1997) 
and plotted using the program Njplot (Perrière and Gouy, 1996). PDB files were retrieved 
from the Protein Data Bank and the mapping of the different regions identified in this work 
done using the Swiss-PDBviewer v3.51 program available on 
http://www.expasy.ch/spdbv/mainpage.htm (Guex and Peitsch, 1997). 
11.1.3. Results 
11.1.3.1. Rab-specific sequences (RabF1 to RabF5) 
Many previous studies have highlighted conserved regions in all members of the Ras 
superfamily that are involved in guanine and phosphate/Mg2+ binding (Barbacid, 1987; 
Bourne et al., 1990). These have been referred to as G for guanine (G1-G3) and PM for 
phosphate/Mg2+ (PM1-PM3) (Valencia et al., 1991). We first analysed these sequences. As 
predicted, we found that these GTP-binding regions are not useful to distinguish Rabs 
because they are extremely conserved between all Ras-like proteins. Also, the variations are 
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not typical of one family. For example, the Rab9 PM1 motif GDGGVGKT is much closer to 
Rho protein PM1 sequences than Rab. This principle applies to the other PM/G motifs. 
Rab27 insert Rab20 and Rab36 insert Rab39 insert 
0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 
position 
Figure 11.1.1 - (Panel A) Number of mammalian Rab sequences that align at a given 
position, highlighting the existence of some insert regions in specific Rabs. (Panel B) 
Frequency of the most common amino acid in the Rab family alignment. Green and red 
boxes indicate, respectively, the conserved GTP binding motifs and the RabF regions. 
Rabs have been shown to be substrates for prenylation by the enzyme Rab 
Geranylgeranyl Transferase (Seabra et al., 1992). They present prenylation motifs distinct 
from the motifs found in Ras and Rho, substrates for the CAAX prenyltransferases, Protein 
Famesyl Transferase or Protein Geranylgeranyl Transferase-I. The Rab prenylation motifs 
consist of two C-terminal cysteines, found in one of the following combinations: XXXCC, 
XXCCX, XCCXX, CCXXX or XXCXC. The presence of the double-cysteine motif in the C-
terminus is in general a very good diagnostic of a Rab protein. However, some Rabs present 
a CXXX box, where only one cysteine is available for prenylation. Therefore, the double-
cysteine prenylation motif may confirm that a given small GTPase is a Rab but its absence 
should not be used to prove otherwise. 
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Figure 11.1.2 - Alignment of profile HMM model sequences (manually adjusted to 
accommodate structural considerations). The uppercase/lower case coding represents the 
results of the profile HMM method, in which uppercase characters were found at p>0.5. 
Residues found to be Rab specific are highlighted in red. When a position is conserved in 
other families, the corresponding position is also highlighted in red. Green characters denote 
the conserved nucleotide binding (PM/G) motifs. 
To address the existence of Rab-specific sequences, we first aligned all the known 
mammalian Rabs using the ClustalW 1.80 algorithm. The alignment of the complete 
mammalian Rab family (gap opening and extension penalties, respectively 10.00 and 0.20) 
can be found at http://www.med.ic.ac.uk/db/dbbm/rab_family.html. 
Based on this alignment we followed two complementary approaches to describe a 
"model Rab" sequence. The first approach consisted in manually plotting the frequency of 
the most abundant amino acid for any given position in the alignment (Figure 11.1.1). We 
observed the existence of regions of high amino acid identity, some corresponding to the 
conserved GTP-binding motifs, and some corresponding to other regions. In order to identify 
the Rab-specific regions, we defined variable length windows around the most promising 
areas, calculated the average amino acid identity for all the windows and compared it with 
the identity calculated, for the same window, for the entire Ras superfamily. We found five 
regions that appeared to be Rab specific (Figure 11.1.1, red squares). 
The second approach was based on profile Hidden Markov Models (HMM) (Eddy, 
1996). A statistical model of each family consensus was calculated using the software 
package HMMER 2.0. The aligned model sequences revealed positions conserved 
throughout the superfamily as well as candidate family-specific regions. Figure 11.1.2 
summarises the results of the two strategies. The uppercase/lowercase code represents the 
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results of the profile HMM, in which uppercase amino acids were found at p>0.5. This 
analysis confirmed the existence of five conserved short stretches of residues that seem to 
be diagnostic for the Rab-family (RabF) that we numbered RabF1 to RabF5 (Figure 11.1.2). 
The RabF motifs include mostly Rab-specific positions but in some cases residues that are 
also highly conserved in other small GTPase families. These residues are also helpful in that 
they help rule out specific families, for example the G residue in RabF1 helps rule out Ras 
and Rho. 
RabF1 localises to the so-called effector domain (loop 2 - |32), in the putative switch I 
region. The prototypical sequence is IGVDF (Figure 11.1.2). Olkkonen & Stenmark (Olkkonen 
and Stenmark, 1997) previously suggested that this region was Rab-specific, but by itself 
this sequence is not large or specific enough to serve as the sole criteria to identify a Rab 
protein. The G position is almost absolutely conserved in Rabs, Arts and Ran, and 
represents an insertion relatively to Ras and Rho proteins. The solution structure of Rab3a-
GTP revealed that this residue plays an essential role in forcing the main chain in the 
putative switch I region to bulge in the direction of the helix a2, promoting a closer interaction 
with the putative switch II region. This results in a more rigid conformation in the putative 
switch regions, apparently characteristic of the Rab family (Dumas et al., 1999). While we 
have been referring to "switch" regions in Rabs, it is important to note that there is only one 
known crystal structure form of Rab to date. In the absence of a Rab-GDP structure, we 
have no information on the conformational changes between the two nucleotide-bound 
configurations in Rabs. Whilst it is almost certain that Rab switch regions exist, their precise 
boundaries as compared to those well defined in Ras are difficult to predict at present (Pai et 
al., 1989; Tong et al., 1991), and hence it is more prudent to refer to "putative" switch 
regions. 
All the other RabF regions cluster in and around the putative switch II region. The 
RabF2 prototypical sequence is KLQIW ((33) (Figure 11.1.2). The W position is not Rab-
specific as it is conserved in all small GTPases except Ras. The RabF3 prototypical 
sequence is RFrsiT (loop 4) (Figure 11.1.2). In the Rab3a crystal structure, the hydrophobic 
residues in this motif and the adjacent hydrophobic T residue (corresponding to oc2) reinforce 
the effect of the bulge in (32, contributing to the higher rigidity of the switch l/switch II 
interface (Dumas et al., 1999). The RabF4 prototypical sequence YYRGA (a2 - loop 5) is 
almost adjacent to RabF3 (Figure 11.1.2) followed closely by the RabF5 motif, LVYDIT ((34 -
loop 6). Therefore, RabF2 to RabF5 cluster between sheets (33 and [34 in a region that 
includes the putative switch II region. 
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11.1.2.2. New Rabs 
Based on the criteria described, we found 52 sequences in Genbank that we 
consider Rabs. The submissions have been numbered in order of discovery, starting with 
Rabia through Rab40. The gaps in the numbering are Rab16, which is Rab3d, and Rab31, 
which is Rab22b. 
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Figure 11.1.3 - Alignment of RabF regions for novel and selected Rab proteins, and the 
corresponding regions in other representative small GTPases. Conserved residues are 
highlighted in red. The prototypical sequence for each of the RabF motifs is indicated on the 
top of the alignment, in italics. An asterisk indicates that the position is frequently occupied 
by a conservative substitution and the second most common occurrence is also highlighted 
in the alignment. 
The newly identified Rabs are shown in Figure 11.1.3. Two "old" entries, called Rah 
(accession AAC83182) and Ray (accession AAD25874) are clearly Rabs. Both possess all 
the RabF motifs, either with the prototypical sequence or in variations that are recognisable 
as Rab specific, possess the unique double cysteine prenylation motif and have overall 
average identities to other Rabs of respectively 23.9% and 36.3%. We propose that they 
should be renamed Rab34 (rah) and Rab35 (ray) and on our recommendation, the latter has 
already been renamed Rab35. 
Our analysis suggests that a recent entry called Rab36 is indeed a Rab despite being 
peculiar. Rab36 presents a 125-residue long N-terminal extension (counted from the 
conserved K residue on position 13 in hRabla) (Mori et al., 1999). Interestingly, one yeast 
protein known as Ypt11p or Ybj9 (Garcia-Ranea and Valencia, 1998; Lazar et al., 1997) also 
possesses a large N-terminal extension. It is not clear whether this protein is the Rab36 
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ortholog as both proteins share only 10% identity to each other. No functional information is 
available on either protein other than the deletion of the yeast gene produces no phenotype. 
Two "Rab-related" sequences are found in the databases, with accession numbers 
AAA42000 and X99962 (Stankovic et al., 1997). We propose to rename Rab38 the first 
protein. The second protein we propose to be renamed Rab39. Its closest mammalian 
relative is hRab2 which is 41% identical.. 
Several proteins have been named "Rab-like". The human protein Rab7L1 
(accession number NP_003920) (Shimizu et al., 1997) is 94% identical to the protein Rab29 
from rat, suggesting that Rab7L1 is the human ortholog of rat Rab29 and should be renamed 
accordingly. The proteins with accession numbers NP_009012 and NP009013 (RabL2B 
and Rabl_2A) (Wong et al., 1999) do not present any prenylatable cysteine in the C-
terminus, have low overall identity to the rest of the family (average identity respectively 21% 
and 23%) and have sequences that do not conform to the RabF motifs described above. 
They are clearly not Rab proteins but they are also not obvious members of another family. It 
is possible that RabL2 may represent a new family of small GTPases. 
Using ^-BLAST of different Rabs, and searching the databases using combinations 
of the RabF motifs described above, we found two more mammalian sequences that we 
consider Rabs. The two related proteins CAB09136 and AAA17031 (originally called Rar) 
are more related to Rabs (27.5% average identity to the Rab family) than to any other small 
GTPase family. Both possess recognisable RabF motifs and none of the sequences 
presents structural motifs that suggest they belong to any of the other small GTPase 
families. We propose that they should be renamed Rab40a and Rab40b, due to their high 
identity to each other. Both protein present unusual substitutions at the conserved PM2 
position. This residue, typically a threonine is replaced by proline or alanine. The role of the 
threonine residue has been extensively studied and shown to be involved in coordination of 
the Mg2+ ion and in stabilisation of the y-phosphate (Valencia et al., 1991). Its absence in the 
Rab40 subfamily may imply that these proteins do not cycle between two conformations, but 
are permanently locked in an inactive state. A precedent for a Rab that appears not to cycle 
efficiently between two conformations was set by Rab24. Rab24 appears to be locked in the 
GTP bound conformation due to variations in two PM/G motifs (Erdman et al., 2000). 
11.1.2.3. Rabs subfamilies and subfamily-specific sequences (RabSF) 
Phylogenetic analysis of the complete mammalian Rab family using the Neighbour 
Joining algorithm (disregarding the gaps in the alignment caused by some Rabs having 
specific "insert regions"), revealed several clusters of "related" Rabs (Figure 11.1.4). Within 
these clusters there are Rabs that show unusually high homology and are termed isoforms, 
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defining Rab subfamilies. The problem is where to draw the line between isoforms (named 
Rabia and Rablb, for example) and simply "related" Rabs. Since isoforms are believed to 
be functionally related and are thought to interact with the same type of effectors (Lazar et 
al., 1997; Novick and Zerial, 1997; Olkkonen and Stenmark, 1997; Schimmoller et al., 1998; 
Chavrier and Goud, 1999; Brennwald, 2000; Rodman and Wandinger-Ness, 2000), it is 
plausible that this functional conservation reflects conservation in specific regions, as 
opposed to complete sequence conservation. If such regions exist they are the best criteria 
to decide if two or more Rabs are isoforms. 
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Figure 11.1.4 - Phylogenetic tree of the 52 members of the mammalian Rab family, 
calculated using the Neighbour-Joining method and excluding the gaps. Bootstraping 
involved 1000 trials and is represented as percentage in the figure. 
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Table 11.1.1 - Amino-acid identity within the different Rab Sub-Family Specific regions 
(RabSF). 
Complete 
sequence RabSFI RabSF2 RabSF3 RabSF4 
Rab family 
Average 32.7% 34.2% 28.6% 23% 14.4% 
identity 
78.3% 92.3% 90.1% 87.5% 58.4% 
Subfamilies 
1 91% 100% 100% 96% 84% 
3 73%-82% 100% 83%-100% 88%-96% 46%-76% 
4 82% 100% 88% 76% 84% 
5 81%-86% 85-100% 94%-100% 88%-96% 69%-76% 
6 90% 100% 100% 95% 53% 
8 82% 100% 88% 88% 30% 
11 90% 100% 100% 100% 84% 
22 70% 85% 72% 76% 23% 
27 71% 100% 72% 84% 76% 
40 88% 100% 72% 86% 54% 
Moore and co-workers (Moore et al., 1995) observed that there was high amino acid 
conservation within subfamilies in three regions designated here RabSF2, RabSF3 and 
RabSF4 and corresponding, respectively, to cc1/loop2, a3/loop7 and oc5 (Figure 11.1.2). We 
verified the corresponding regions in all our mammalian Rab sequences and in general we 
confirmed that these regions show higher identity within the sub-families than the overall 
sequence (Table 11.1.1). This is particularly remarkable with RabSF4, which is located in the 
so-called hypervariable domain, a region characterised by its sequence divergence: the 
average identity of this region among Rabs is 14.4% while subfamilies show an average of 
58.4%. 
Recently, the 3D structure of Rab3a in complex with its effector Rabphilin-3A 
revealed that three regions in Rab3a contribute to form a "pocket" that mediates binding to 
this and possibly other effectors (Ostermeier and Brunger, 1999). These three regions were 
named RabCDRs (Rab complementary-determining region) and we refer to them as 
RabCDRI to RabCDRIII, counting from the N-terminus of the protein. Interestingly, these 
regions correspond to subfamily specific sequences: RabCDRII and RabCDRIII correspond 
to RabSF3 and RabSF4. RabCDRI includes the N-terminal sequence upstream of PM1 
(YXYLFK) previously proposed to be diagnostic of the Rab family (Sanford et al., 1995). 
However, the overall identity within the region is only 34% and one residue (K13 in hRabla) 
is highly conserved throughout the superfamily. We propose instead that this sequence is a 
good indicator of Rab subfamily and termed it RabSFI (Figure 11.1.2). 
We mapped both the RabF and RabSF regions into the crystal structure of Rab3a 
(Figure 11.1.5). We observed that Rabs present two subfamily-specific surfaces: RabSFI, 
RabSF3 and RabSF4 form a surface that mediates specific interactions between Rab3a and 
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Rabphtlin (Ostermeier and Brunger, 1999). Almost on the opposite side of this surface 
RabSF2 forms a second subfamily-specific surface near or within the switch I region that 
could mediate interaction with other effectors. The existence of these two distinct subfamily-
specific surfaces suggests that different effectors will bind different RabSF regions. Taken 
together, this analysis is consistent with the hypothesis that isoforms will interact with the 
same type of effectors/auxiliary molecules via subfamily specific regions. 
Criteria in addition to sequence homology at the RabSF regions need to be taken in 
consideration when defining a Rab subfamily. These include specific variants of PM, G or 
RabF motifs and small characteristic diversions from the consensus. For example, only 
Rab27 isoforms present the RabF4 variant FFRDA and have a 10-residue insertion in loop3, 
supporting the definition of the Rab27 subfamily. These new criteria allowed the definition of 
one more subfamily, Rab40a and Rab40b (Table 11.1.1). The overall sequence identity is 
88%. Both sequences present a high identity within all the RabSF regions as well as all the 
PM/G and RabF motifs, and both present a long C-terminal insertion. 
Rab 12 
KaJbSFi 
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RabSF3 !► 
RabF4 
R«bF3 
RakFS 
<< Rab SF2 
RahFl 
Figure 11.1.5 - Cartoon representing the Rab3a-GTP 3D structure (PDB code 3RABA). 
RabF regions are depicted in red, RabSF regions in yellow, and the conserved nucleotide 
binding (PM/G) motifs in green. The nucleotide and the Mg2* atom are both represented in 
blue. 
A number of related Rabs present a problem of classification, in that they are clearly 
related but should they be considered isoforms? These related Rabs include Rab4a/b and 
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Rab14, Rab8a/b and Rab10, Rab11a/b and Rab25, Rab32 and Rab38, Rab33a and Rab33b 
(Figure 11.1.4). Considering that in all cases the overall identity is lower than 70% and that 
there is no consistent conservation in more than two out of the four RabSF motifs, we 
suggest that they should not be considered isoforms (Table 11.1.1). 
11.1.3. Discussion 
In this study, we identified five Rab specific motifs, named RabF1 to RabF5, that in 
conjunction with the conserved PM/G motifs and a double-cysteine C-terminal prenylation 
motif allow the definition of a Rab GTPase. As of June 2000, we found 52 sequences in the 
database that fit our criteria. Unfortunately, it is impossible to use the information in the EST 
database to predict whether this number is close to the real number of genes in a 
mammalian genome as only full length (or near full length) sequences are useful in this 
regard. Despite this problem, it is clear that the mammalian Rab family is much larger than 
the eleven-member orthologous gene family in S. cerevisiae (Garcia-Ranea and Valencia, 
1998; Lazar et al., 1997), possibly reflecting the higher intracellular specialisation of 
mammalian cells. In order to classify a Rab as an isoform, we propose that the sequences 
must be at least 70% identical and this value should be supported by conservation at the 
RabSF and RabF motifs as well as unique characteristics. Currently, we recognise ten Rab 
subfamilies (Rab1, 3, 4, 5, 6, 8, 11, 22, 27, 40). 
When we mapped these regions into the crystal structure of Rab3a, we noted 
surprisingly that all RabF motifs localise in and around the switch I and switch II regions. The 
switch regions change conformation significantly upon GTP binding and hydrolysis and 
therefore mediate interaction with effectors and regulators. If the switch regions are 
conserved among all Rabs, how are Rabs able to bind specific effectors and regulators, 
given that these proteins must discriminate between the two nucleotide-bound states of 
Rabs? 
One possibility is that effectors and regulators will bind both RabF regions to 
discriminate between active/inactive conformations and RabSF regions for specificity. The 
existence of two distinct subfamily-specific surfaces further suggests that different 
effectors/regulators bind to different combinations of RabSF regions. Different lines of 
evidence support this model. First and foremost, the recent solution structure of the Rab3a-
Rabphilin complex (Ostermeier & Brunger, 1999) revealed that the binding surface of this 
complex involves both switch regions and a Rab-subfamily specific surface composed by the 
regions we defined herein as RabSFI, RabSF3 and RabSF4. Second, both switch regions 
and the region corresponding to helix a3/loop 7 (RabSF3) have been shown by site directed 
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mutagenesis to be involved in interaction with regulators such as GEFs and GAPs (Becker 
et al., 1991; Burstein et al., 1992; Brondyk et al., 1993; Day et al., 1998; McKiernan et al., 
1993). Third, helix a3/loop 7 (RabSF3), the effector domain (RabF1) and the hypervariable 
domain (including RabSF4) are key regions in determining both localisation and function of 
ypt1/sec4 chimeras (Brennwalt & Novick, 1993; Dunn ef a/., 1993), Rab2/Rab5/Rab7 
chimeras (Chavrier et al., 1991) and Rab5/Rab6 chimeras (Stenmark et al., 1994). Fourth, 
the N-terminus (RabSFI) and helix oc2/loop5 (RabF4) have also been shown to be essential 
in producing functional Rab5/Rab6 chimeras (Stenmark et al., 1994). 
Another prediction of this model is that the binding of general regulators such as Rab 
Escort Protein (REP) and Rab GDP Dissociation Inhibitor (RabGDI) is nucleotide sensitive 
and occurs via the newly identified RabF regions. There is some evidence to support this 
hypothesis (Beranger et al., 1994; Burstein et al., 1992; Overmeyer et al., 1998; Wilson and 
Maltese, 1993; Wilson et al., 1996). It is also likely that binding of general regulators and 
specific regulators/effectors is mutually exclusive since both are able to sense the two 
alternative nucleotide-bound conformations and thus must interact with the switch regions. 
We questioned if this could be a general model that applies to other Ras-like 
GTPases. The answer is generally yes but not in all cases. The most notorious exception is 
with Ras proteins. In Ras, the switch regions are also quite conserved (Figure 11.1.2) but they 
appear to be the only contact point in some interactions such as with RalGDS (Vetter et al., 
1999b) and the Ras binding domain of Raf1 (Nassar et al., 1995). The strategy to determine 
specificity seems to be that distinct Ras effectors bind different subsets of residues within the 
switch regions. This is particularly well characterised for the switch I region (also called 
effector loop) (White et al., 1995). In other cases, helix oc3 (corresponding roughly to 
RabSF3) is also involved in defining the binding surface, as with the exchange factor SOS 
(Boriack-Sjodin et al., 1998) and p120GAP (Scheffzek et al., 1997). Similar conclusions may 
be drawn from the limited data available for the Arf family, where interaction with effectors 
and regulators appear in most cases to be restricted to the switch regions and helix a3 
(Beraud-Dufour et al., 1998; Goldberg, 1998; Mossessova etal., 1998). 
The picture is more complex in the Rho family probably because of the existence of a 
staggering number of Rho regulators/effectors. The switch regions are involved in binding 
regulators/effectors in every case we found, but other regions have been shown to be 
involved. RhoA and Cdc42 use switch I and/or switch II in combination with helix a5 
(reminiscent of RabSF4) to bind the effector domain of PKN/PRK1 (Maesaki et al., 1999), 
Wiskott-Aldrich syndrome protein (WASP) (Abdul-Manan et al., 1999) and ACK (Mott et al., 
1999). On the other hand, the binding of Cdc42 to Cdc42GAP appears to involve mainly 
residues in the switch regions (Nassar et al., 1998). As in Ras, different residues in the 
switch regions appear to confer specificity to the interaction in some cases. Examples for 
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this type of interaction are RhoA/Cdc42 to Lbc/Cdc24 (Li and Zheng, 1997) and RhoA/Cdc42 
to PLD (Bae et al., 1998). In other cases, it seems that the interaction requires both the 
switch regions (possibly RhoF regions) and other regions (possibly RhoSF regions) such as 
helix a3 (Zhong et al., 1999), helix a5 (Abdul-Manan et al., 1999; Maesaki et al., 1999; Mott 
et al., 1999), and the specific Rho insert region (Freeman et al., 1996). 
As for Ran, structural and biochemical data also implicate the switch regions and the 
helix oc3 in binding effectors, such as binding to RCC1 and NTF2 (Azuma et al., 1999; 
Stewart et al., 1998) but other regions also contribute to binding, such as the a4/p6/oc5 
region with Importin (3 and the C-terminal helix oc6 with RanBDI (Vetter et al., 1999a; Vetter 
etal., 1999). 
Overall, the available data suggest the interesting possibility that primitive 
interactions between Ras-like GTPases and effectors/regulators depended upon the switch 
regions. As the range and complexity of cellular mechanisms controlled by these GTPases 
grew, so did the interaction surfaces between them and the increasing number of specific 
effectors/regulators. The future analysis of the Ras, Rho and Arf families as presented here 
for the Rab family may help clarify this hypothesis. 
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11.2. Evolution of the Rab family of small GTP binding 
proteins 
Reproduced from Pereira-Leal and Seabra (2001) submitted. 
11.2.1. Introduction 
The recent availability of substantially completed genome sequences for several 
eukaryotic organisms creates new opportunities for the study of protein evolution and 
function. At present, the nematode (C. elegans), fruit fly (D. melanogaster), the budding 
yeast (S. cerevisiae) and the fission yeast (S. pombe) have had their genome sequenced, 
and recently the first drafts of the complete genome of H. sapiens and A. thaliana were 
released. With six complete or near complete genomes of evolutionary distant organisms, it 
is now possible to start addressing the evolution of primary structure and function in the Rab 
protein family. 
Rab proteins form the largest family of the Ras-like superfamily of small GTP-binding 
proteins and regulate intracellular trafficking pathways. More than fifty Rab proteins have 
been described in mammalian cells, each with a specific subcellular localisation and many 
with specific patterns of tissue distribution (Chavrier and Goud, 1999; Zerial and McBride, 
2001; Stenmark and Olkkonen, 2001). Rabs behave as membrane-associated molecular 
switches to regulate budding, transport and fusion reactions in vesicular transport. 
In a previous study, we analysed sequence conservation in the mammalian Rab 
family (Pereira-Leal and Seabra, 2000) and observed the existence of mammalian Rab-
specific motifs (RabF motifs) that clustered in and around the switch regions. This allowed us 
to propose criteria for Rab family classification, and to identify novel Rab sequences from the 
databases. We also suggested that Rab proteins use the switch regions (Merithew et al., 
2001; Dumas et al., 1999) in addition to other regions to determine specificity of binding to 
protein partners, unlike Ras proteins where specificity of binding is determined mainly by the 
switch regions (White et al., 1995; Vetter et al., 1999; Nassar et al., 1995). These specificity-
determining regions were named RabSF regions (for Rab subfamily) (Pereira-Leal and 
Seabra, 2000; Moore et al., 1995; Ostermeier and Brunger, 1999). 
In the present study, we identify and annotate the complete Rab family in H. sapiens, 
D. melanogaster, C. elegans and A. thaliana, and use this dataset, complemented with the 
complete Rab families in S. pombe and S. cerevisiae to study their evolution. We test the 
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hypothesis that there is a conserved mechanism of Rab interaction with regulators and 
effectors across evolution and we attempt to reconstruct the multiplication of Rab proteins. 
This analysis suggested the existence of a higher-order hierarchy in the Rab family with 
implications for the function and evolution of these proteins. 
11.2.2. Methods 
We retrieved protein sequences of known Rab families from GenBank. To identify the 
complete Rab families in H. sapiens, D. melanogaster, C. elegans and A. thaliana, we 
downloaded the latest releases of the calculated open reading frames of each organisms 
from the public databases. We then used a profile Hidden Markov Model (pHMM) calculated 
from the alignment of the mammalian Rab sequences presented previously (Pereira-Leal 
and Seabra, 2000) to query each database using the software HMMER 2.1.1 found at 
hmmer.wustl.edu (Eddy, 1998). 
All the positive hits were then visually inspected, compared to pHMMs representing 
other small GTPase families and individually BLASTed against the non-redundant database 
in GenBank to assert if they were indeed Rab proteins, and to insure that no sequence was 
missed from our analysis due to a possible bias created by the query sequences. 
Protein sequences were aligned using the Clustal W 1.80 (Thompson et al., 1994) 
multiple sequence alignment program with default parameters. Phylogenetic trees were 
reconstructed by the distance methods of Neighbour-Joining (Saitou and Nei, 1987) scoring 
for observed amino acid difference and were always bootstrapped with 1000 replicates 
(Felsenstein, 1985), using the software Phylo_Win (Galtier et al., 1996). Genomic structures 
were obtained from GenBank, via the interface MapView. 
11.2.3. Results and Discussion 
11.2.3.1. Identification and annotation of complete Rab families 
Previous studies have identified the Rab families in the budding and fission yeasts 
(Armstrong, 2000; Lazar et al., 1997; Armstrong, 2000) (shown in tables S1 and S2 of 
supplementary material). We first attempted to identify the complete Rab families in the 
human, nematode, fly, and Arabidopsis genomes. We searched the public databases with 
pHMM described in a previous study (Pereira-Leal and Seabra, 2000). This criteria 
considers conservation of GTP-binding motifs, presence of doubie-cysteine prenylation 
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motifs, and conservation of the RabF motifs. The fact that all the budding yeast Rab 
(Ypt/Sec4) proteins were correctly identified validated our method. 
In the C. elegans genome, we identified 29 independent open reading frames which 
conform to our criteria (tables 11.2.1, S3 and figure 11.2.1) (Pereira-Leal and Seabra, 2000). 
Comparison of each sequence with pHMM describing other small GTPase families indicated 
that they were clearly not members of any other Ras-like small GTPase family. Using the 
same criteria, we identified 29 independent open reading frames in the D. melanogaster 
genome that we consider Rabs (tables 11.2.1, S4 and figure 11.2.1). Our strategy led to 
identification of more Rab sequences than two previous attempts (Bock et al., 2001; 
Armstrong, 2000), suggesting our analysis was more thorough and/or a recent improvement 
in the databases. 
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Figure 11.2.1 - Neighbour-Joining tree of the C. elegans and D. melanogaster Rab families, 
rooted with H-Ras (not shown), scoring for amino acid difference. The numbers on the 
branches represent the percentage of 1000 bootstrap pseudo-samples supporting that 
branch; only values £ 40% are shown. For clarity, subfamilies are represented in blue or red. 
In A. thaliana, we identified 56 proteins that we consider bona fide Rabs (tables 
11.2.1, S5 and figure II.2.2). One additional protein, named Ara6 (accession BAB32953), 
exhibits some peculiar features. It possesses putative N-terminal myristoylation and 
palmitoylation motifs, but not a C-terminal prenylation motif. Although this type of lipid 
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modification has not been described in the Rab family before, the presence of consensus 
sequences in the RabF motifs suggests that this is likely a Rab protein, albeit an unusual 
one. 
Table 11.2.1 - Rab families in six different organisms, represented in relation to the human 
Rab family. Presence on the same row indicates that proteins are putative orthologues or 
are the closest homologs. Below the doted line are represented Rabs for which no clear 
homologues are found in the human Rab family, except for A. thaliana for which the family 
members are respesented according to their homology group". Accession numbers for all 
these proteins can be found in the supplementary material 
H.sapiens D.melanogaster C.elegans S.cerevisiae S.pombe A.thaliana 
Rab1A,B DmRabl CeRabl Ypt1 Ypt1 AtRabD1-D3b 
Rab2A,B DmRab2 CeRab2 AtRabB1a-B1c 
Rab3A,B,C,D DmRab3 CeRab3 
Rab4A,B DmRab4 
Rab5A,B,C DmRabõ CeRab5 Ypt5152,53 Ypt5 AtRabF1a-F2b 
Rab6A,B,C DmRab6 CeRab6A,B Ypt6 Ryh1 AtRabH1a-H1e 
Rab7 DmRab7 CeRab7 Ypt7 Ypt7 AtRabG1a-G3f 
Rab8A,B DmRab8 CeRab8 Ypt2 AtRabE1a-E1e 
Rab9A,B DmRab9 
Rab10 DmRablO CeRab10A,B 
Rab11A,B DmRabl 1 CeRabl 1A,B Ypt31,32 Ypt3 AtRabA1a-A6b 
Rab12 
Rab13 
Rab14 DmRab14 CeRab14 
Rab15 
Rab17 
Rab18 DmRab18 CeRabl8 AtRabC1-C3 
Rab19 DmRab19 CeRab19 
Rab20 
Rab21 DmRab21 CeRab21 
Rab22A,BC 
Rab23 DmRab23 
Rab24 
Rab25 
Rab26 DmRab26 
Rab27A, B DmRab27 CeRab27 
Rab28 CeRab28 
Rab29 
Rab30 DmRab30 CeRab30 
Rab32 DmRab32 
Rab33A,B CeRab33 
Rab34 
Rab35 DmRab35 CeRab35 
Rab36 
Rab37 CeRab37 
Rab38 
Rab39A,B DmRab39 CeRab39 
Rab40A,B,C DmRab40 
Rab41 
Chrowded/ CeRabYl Sec4 Ypt4 
DmRabXI 
DmRabX2 CeRabY2 Ypt10 
DmRabX3 CeRabY3 Yp11 
DmRabX4 CeRabY4 
DmRabX5 CeRabY5 
DmRabX6 CeRabY6 
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AlRahAlh 
AlRahAli 
AlKabAII 
AtRahAlg 
AlRabAle 
AlRahAIn 
AlRubAlb 
•\lRabBlb 
AtRabBIc 
AtRabCI 
AlRabCJ 
Figure 11.2. 2 - Neighbour-Joining tree of the A. thaliana Rab family, rooted with H-Ras (not 
shown), scoring for amino acid difference. The numbers on the branches represent the 
percentage of 1000 bootstrap pseudo-samples supporting that branch; only values z 40% 
are shown. For clarity, putative subfamilies are represented in blue or red. 
Finally, we identified 60 independent open reading frames encoding Rab proteins in 
the H. sapiens genome (tables 11.2.1, S6 and figure II.2.3). We caution that this analysis 
represents our best guess as of May 2001 and it is likely that the present list needs to be 
updated as the quality of the sequences in the databases improves. Surprisingly, our 
analysis differs considerably from a previous report published in early 2001 (Bock et al., 
2001). First, we identify human proteins not previously reported, namely Rab24 and Rab33b. 
Secondly, we chose to discard sequences that differ from established Rab sequences only 
by the presence of insertions (for example, IGI_M1ctg4256_3 from Rab4a) or are virtually 
identical (for example, GI7705963 and Rab9), as these are suggestive of putative splice 
variants, misidentification of splice sites or pseudogenes. Thirdly, we renamed a few Rabs to 
fit our nomenclature criteria (Pereira-Leal and Seabra, 2000). A direct comparison between 
I I - 19 
Part II - Rab Proteins 
the present study and the Bock et al., study (Bock et al., 2001) is shown in table S6 of 
supplementary material. 
We detect inconsistencies not just between these two studies on the human genome 
but also with annotation in Genbank. For example, the protein NPJ303920 is annotated in 
GenBank as Rab7 like 1, renamed Rab42 by Bock et al., (Bock et al., 2001 ) but we find it to 
be 93% identical to rat Rab29 (BAA65444), indicating that it represents the human homolog 
of Rab29. Another example is the protein AF322067, which is clearly the human Rab34 
protein but is annotated in GenBank as Rab39 (direct submission). This is particularly 
problematic in the Rab family as the numbering of the different family members is taken 
frequently as indicative of function. 
i 0.05 
Xi 
"Rab36  
Rab34 
-Q 
57~t 
iog_ 
- Rahtt ' 
- Rah5A 
-RahhB  
RabM-
" R a h ' / B 
- R a b 2 7 A 
Rlb3C 
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Kahi l i 
Rab3A 
-Rab.17 
-Rah26 
—Rab18 
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-RuMOC 
- Rab40B 
— Rab40A 
- R a h 13 
"Rab 10 
- KahXH 
— RabBA 
- Rata l 
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-RahIA 
-Rab39B 
— Rah39A 
"RabMB 
-Rab33A 
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-Rab2B 
Rah'A 
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Figure 11.2.3 - Neighbour-Joining tree of the H. sapiens Rab family, rooted with H-Ras (not 
shown), scoring for amino acid difference. The numbers on the branches represent the 
percentage of 1000 bootstrap pseudo-samples supporting that branch; only values è 40% 
are shown. For clarity, subfamilies are represented in blue or red. 
We observed that in phylogenetic trees of Rab proteins of different species, known 
orthologues always co-segregated, e.g., human Rab1 and yeast Yptlp. This observation 
suggests that the strict phylogeny of function in the Ras superfamily previously observed by 
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Valencia and co-workers (Valencia et al., 1991) also applies within the Rab family (figure 
II.2.4). We thus propose that co-segregation in phylogenetic trees, together with specific 
conservation in the RabSF regions be used as the criteria to assign putative orthologues 
(Pereira-Leal and Seabra, 2000; Ostermeier and Brunger, 1999; Moore et al., 1995). The 
results of our analysis, including the proposed names for all members of the Rab families, 
are summarised in table 11.2.1, and can be found cross-referenced with the respective 
accession numbers in tables S3 to S.6 of supplementary material. 
Figure 11.2.4 - Neighbour-Joining dendogram of the human, nematode, fly and fission yeast 
Rab families. For clarity, human Rabs are not preceded by the species initials. The romanic 
numerals (I - VIII) and the coloured branches represent Rab functional groups (see text for 
further details). 
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Several proteins defied our annotation attempts. The nematode protein AAB04568, 
for example, has no clear homolog, presenting only vague homology to human Rab8. 
Protein AAB52431 is the clear ortholog of mammalian Rab2, however two other proteins 
(CAB07356 and CAB07357) are also most similar to mammalian Rab2, but all three are not 
similar enough between them (i.e., < 70% identity) to be considered isoforms. In these 
difficult cases, we decided to assign letters, rather than the usual numbering system to avoid 
confusions. For example, we propose AAB04568 to be named CeRabYL 
The Rab family of A. thaliana contains large putative subfamilies (up to 9 isoforms in 
each subfamily), and in several cases the similarities to proteins of known function are not 
sufficiently high to allow us to ascribe putative orthologies. Unfortunately, some of the 
proteins have already been named, based on weak similarities, order of discovery or other 
undefined criteria. We now propose different criteria for annotation of plant Rab families. 
Inspection of the tree in figure II.2.2 reveals that there are 8 major groups of Rab proteins in 
A. thaliana genome which can be broadly related to mammalian Rabs by homology (Ian 
Moore, personal communication). Each of these groups should be labelled with capital 
letters, from A to H. Within these groups, there are subfamilies which can be defined based 
on co-segregation and conservation in the RabSF regions. Subfamilies should be defined by 
a number after homology group letter, which in turn is followed by a letter when there is more 
than one isoform (figure II.2.2). As Rabs should be preceded by the species initials (e.g. 
AtRab), protein BAB09078 for example should be called AtRabA6a, which should be read as 
Arabidopsis thaliana Rab, group A, subtype 6, isoform a. 
11.2.3.2. Rab familes across evolution 
Of all available Rab families, the fission yeast (S. pombe) presents the smallest 
number of Rab proteins (table 11.2.2). In this organism, all the Rabs produce a detectable 
phenotype when the corresponding gene is disrupted, ranging from lethality (Yptlp, Ypt2p, 
Ypt3p), temperature sensitive growth (Rhylp), fragmentation, size increase or reduction in 
number of vacuoles (Ypt7p andYpt4p, respectively) and vesicle accumulation (Ypt5p) (Lazar 
et al., 1997; Olkkonen and Stenmark, 1997). Furthermore, all S. pombe Rabs, with the 
exception of Ypt4p, are conserved in all other organisms. 
The evolutionary divergent budding yeast (S. cerevisiae) on the other hand, displays 
an increased number of Rab genes, many of which produce no phenotype when they are 
disrupted (Ypt31, Ypt32, Ypt51, Ypt52, Ypt53, Ypt10, Ypt11). This increased number is in 
part due to the appearance of subfamilies, i.e., functionally redundant isoforms (Ypt51, 
Ypt52,Ypt53 and Ypt31, Ypt32), but also due to the appearance of Rab proteins without 
clear functional or sequence homology to known Rab proteins in other organisms (Ypt10, 
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Ypt11, and Sec4). The genome of the budding yeast contains several duplicated 
chromosomal regions that could underlie the appearance of subfamilies, which is consistent 
with the non-essentiality of the members of the different isoforms (Seoighe and Wolfe, 1998; 
Wolfe and Shields, 1997; Achaz et al., 2000). 
Table 11.2.2 - Structure of the Rab family in six organisms. The listing of the family members 
and their accession numbers can be found as supplementary material. 
Species Cell # *ab# Sub-families 
7 0 
11 2 
29 3 
29 0 
>60 11 
>57 11 
S. pombe 
S. cerevisiae 
C. elegans 
D. melanogaster 
H. sapiens 
A. thaliana 
1 
1 
~1x103 
-3x109 
-1x10 13 
The human Rab family is the largest of all Rab families studied here and 
reflects the increased family size that accompanies multicellularity. Many of the Rab proteins 
have close homologues and form subfamilies. If we consider, in a simplistic view, that each 
subfamily corresponds to one function, then 39 functions are required in mammals. A 
significant number of these functions may involve specialised, tissue-specific trafficking 
pathways, as many Rabs are not ubiquitously expressed. 
The nematode and the fly Rab families contain an intermediate number of Rabs 
between the yeasts and the mammals. Interestingly, we observe the existence of subfamilies 
in the nematode, but not in the fly Rab family, consistent with the recent genomic 
duplications observed in the nematode (Friedman and Hughes, 2001). Analysis of these 
genomes suggests that there is not a linear increase in the number of Rab proteins with the 
number of cells as the nematode is made of less than a thousand cells and the fruit fly 
contains more than three billion, and both organism have a similar number of Rab proteins. 
This is true even if we discard "redundant" Rabs (i.e. Rabs forming subfamilies), assuming 
they represent a single function (26 Rab functions in C. elegans compared with 29 in D. 
melanogaster). 
The Rab family of /\. thaliana is quite different from the other Rab families considered 
here. It exhibits large subfamilies, which can be grouped in terms of homology to a small set 
of animal Rabs: Rab1, Rab2, Rab5, Rab6, Rab7, Rab8, Rab11 and Rab18. Surprisingly, the 
Rab11-like group in A. thaliana contains 26 proteins, but the significance of this fact is 
unclear. This Rab family organisation seems to be found also in other plant Rab families (Ian 
Moore, personal communication). It seems obvious to suggest that Rab proteins in plants 
followed a different evolutionary pathway than animals or fungi. The rationalisation of this 
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observations however will have to wait for more functional information on the different plant 
Rab proteins, as very little is known at present. 
So what is the minimum number of Rab proteins required in a eukaryotic cell? One 
possibility is seven, as this is the number of Rabs found in the fission yeast (Lazar et al., 
1997). Multicellular^ and cellular specialisation may require more Rab proteins, possibly 
those corresponding to the conserved Rab proteins between the animal genomes 
considered here (table 11.2.1). Such candidate Rabs include Rab3 and Rab27, two examples 
of tissue-restricted with specialised functions. The future availability of more sequenced 
genomes will allow a more accurate definition of the basic vesicular transport steps required 
in a multicellular organism. 
11.2.3.3. Conserved interactions with general regulators and effectors 
We recently proposed in mammalian Rabs that the RabF motifs, clustering in and 
around the putative switch regions, determine the interaction with Rab-specific general 
regulators such as Rab Escort Proteins (REP) and GDP Dissociation Inhibitors (RabGDI). 
We sought to determine whether this mode of interaction with general regulators is 
conserved across evolution. To do so, we asked if the same regions are conserved in the 
different Rab familes considered in this study. We calculated pHMMs for each organism Rab 
family and generated model sequences for each organism. Upon alignment we observed 
that the same regions are conserved in all organisms and that there is no organism-specific 
consensus (figure 11.2.5). Thus, the RabF motifs seem to be a feature conserved in evolution 
and may indicate a conserved mode of interaction between Rabs and general regulators. 
Recent work showing that similar positions in yeast REP and RabGDI mediate interactions 
with Rabs further supports this possibility (Alory and Balch, 2000). 
We worried that this observation could have been biased by the Rab identification 
strategy followed, as the presence of RabF motifs was one of the criteria used. However, 
this was by no means the only criteria. We BLASTed each individual "putative" Rab 
sequence against the non-redundant and organism-specific databases to confirm the 
similarity with other Rabs, and to look for further members of the Rab family. Also, we 
checked every sequence against pHMM of other small GTPase families (Ras, Rho, Arf, Ran, 
Gem). 
We proposed previously the existence of Rab subfamily (RabSF) regions in 
mammalian Rabs, possibly involved in determining binding specificity to effectors. These 
RabSF regions are conserved across species(Moore et al., 1995). Consistently, Rabs from 
evolutionary distant organisms exhibit functional complementation. For example, yeast Ypt1 
deletions or temperature sensitive mutations can be complemented by small GTPases from 
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Volvox carteri, Chlamidomonas reinhardtii (Fabry et al., 1995), Brassica napus (Park et al., 
1994) and Mus musculus (Haubruck et al., 1989), and ypt6 null mutants can be 
complemented by a small GTPase from Arabidopsis thaliana (Bednarek et al., 1994). 
H. sapiens 
C.elegans 
D.melanogas t e r 
A. thaliana. 
S. pombe 
S.cerevisiae 
H. sapiens 
C.elegans 
D.melanogaster 
A.thaliana 
S.pombe 
S.cerevisiae 
H. sapiens 
C.elegans 
D.melanogaBter 
A.thaliana 
S.pombe 
S.cerevisiae 
RabSFI PM1 RabSF2 PM2 G1RabF1 
dydylFKllliGDBgVGKTSLllRFtddtFdp8yi»T« 
pkBisaaeelrmamad<ipstnydylFKlvliGDsGVGKTsLI.lRFtdBaFtnqf Í S T H 
-maaggaepetLqlsgmaaaeydylFKllliGDsGVGKTBLLlRFtdgrFtetyisTM 
MasyradeoydylfKWLIGDSGVGKS»LLlRFtrne> s l « s k a IGV 
Maskk--svydyLfKlVLlGasGVGKSsLllRFvkdqFddsyksTBT 
Msde-gydydllf KiVLLGDSGVGKSSIiVlRFv«DkFn«sye«LT J a 
RabF2 PM3 RabF3 RabF4 RabF5 
t tKtvevdgkk vMMBDTAGQEMrsi t ra l | HqGaiLVYDITnreSFaa 
t iKtve lddkkr - tV^^HDTA! RFRSI t a l E ldGa lRyDITnreSFB 
c t k t i e l d g k r v^^HDTAGQE^HsiBpsferROAhGa] LVY1 H a r k S F H 
F a t r t l e i d g K t v i HDTAGQE^Hal|SaH BvGAILVYDVTrretrB 
r i t r t io lddnkr - -vB^HDTAGQEHfcl t saHRQAsyrf i lVYDVTnqkSFsavk 
l tKtv t idgnkeKtIK QIW RF SL pmtíí (gfxffAl^rtD T1i«sSFen 
RabSF3 G2 G3 
nWlkelrehaspenwivLVGNKcDLodk ReVtreeaeefAeeng-lpffETSAKtn 
nWlkeikehagsenwimLVGNKcDLodk RaVsteeaealAeelg-lpFmETSAktg 
sWlrEireyasp-nviivLVGNKcDLKDQ RvVsreeaoqfArong-lpFfETSAKeg 
rWleElrahadp-nwimLVGNKaDLedk RaVatEegkafAeeoG-lfFmETSAkea 
BWlkelraqA-potivivLvGNKtDLadk RgVakeeAaafAaElgiilflETSAKta 
hWveELknenadddviilLVGNKsDLedeEkvRaVatoeakelAkelg-UFfETSAKtg 
Figure 11.2.5 - Partial alignment of model sequences for each family, calculated from pHMM 
describing the multiple sequence alignment of the complete Rab family in each organism. 
Positions in uppercase occur at p>0.5. The PM/G motifs are highlighted in green, the RabF 
motifs in red boxes or red characters when the position is often occupied by a conservative 
substitution, and the RabSF regions in yellow boxes. Black bars above the alignment 
represent the switch regions 
Taken together, the absence of organism-specific consensus, the conservation of 
RabF regions, the cross-species functional complementation and the conservation of RabSF 
regions make a strong argument for a highly conserved mechanism of effector and general 
regulator recognition, likely to be present at the point of divergence from other small 
GTPases. It also suggests that this family originated by a single divergence event and that 
these interaction mechanisms represent a major constrain to the evolution of Rab proteins. 
Furthermore, the conservation of this effector recognition mechanism is indicative of effector 
conservation, an assumption that is supported by some recent evidence. While exchange 
factors for the Rab family form a very divergent class of proteins, there is a striking 
conservation of these proteins across evolution for known orthologues in the few known 
cases. For example, the mammalian and nematode exchange factors for Rab3 (Rab3GEP 
and Aex3) are highly conserved (Iwasaki et al., 1997; Wada et al., 1997), and so are the 
exchange factors for Ypt51 and Rab5 (Vps9 and Rabex-5) (Hama et al., 1999; Horiuchi et 
al., 1997). 
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11.2.3.4. Prenylation and targeting motifs 
Rab proteins contain one or two C-terminal cysteine residues that undergo post-
translational prenyl modification (Seabra, 2000). These cysteine residues are arranged in a 
variety of prenylation motifs. Some Rabs (HsRab8 and HsRab23), have a single cysteine 
residue, fourth from the C-terminus, sometimes within a CAAX box (C-cys, A-aliphatic, X-
any), a motif commonly observed in the Ras and Rho families (Casey and Seabra, 1996). 
However, most Rabs have two cysteine residues arranged in different double cysteine 
prenylation motifs (e.g. XXCC, XCXC, CCXX, CCXXX, XCCX), both of which are modified 
by geranylgeranyl moieties. Unlike Ras and Rho proteins, the prenylation motif in Rabs does 
not determine which prenyl transferase (and consequently which type of prenyl moiety) will 
modify the C-terminal cysteine residues. All Rabs appear to be substrates for a unique 
enzyme, Rab Geranylgeranyl Transferase (RGGT), following the binding to REP, a general 
regulator of Rabs. 
It is conceivable that the diversity of Rab prenylation motifs arises from lack of 
functional constrains other than those imposed by the geranylgeranylation reaction 
mechanism. When we compared the prenylation motifs in Rabs from all organisms, we 
observed that the number of cysteines is frequently conserved, and in many cases the 
topology of the prenylation motif is also retained (e.g., Ypt1(CC)->Rab1(CC), 
Ypt6(CXC)->Rab6(CXC)). Conservation of these topologies indicates constrains to evolution 
possibly due to the requirement for carboxyl-methylation. The functional significance of Rab 
carboxyl-methylation affecting Rabs ending in CXC but not in CC is not understood 
(Smeland et al., 1994; Bergo et al., 2001). Furthermore, we observed conservation of the 
number of cysteines available for prenylation. This suggests that the number of prenyl 
groups (one or two) may be functionally important, possibly revealing the existence of two 
distinct membrane-association mechanisms or perhaps different membrane targeting 
strategies. 
We observed some unusual Rab proteins in this regard. For example protein 
BAB32953 in A. thaliana exhibits putative N-terminal myristoylation and palmitoylation 
motifs, but no C-terminal prenylation motifs, and these motifs are also found in similar plant 
proteins, indicating a conserved feature. This type of lipid modification is novel within the 
Rab family. Another peculiar Rab protein is Rab24, which is thought to be cytosolic (Erdman 
et al., 2000). These unusual cases may represent recent evolutions of the Rab family, where 
motifs not normally present in this family are recruited to provide for new functions. 
We caution that sequencing errors or artefacts complicate annotation attempts. For 
example, several Rab proteins in D. melanogaster, C. elegans and A. thaliana do not exhibit 
C-terminal prenylation motifs. However, their putative orthologs in other organisms do exhibit 
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prenylation motifs, suggesting either bad quality sequencing or deficient gene identification 
algorithms. 
11.2.3.5. Rab functional groups 
Phylogenetic trees for all the sequences considered here, reconstructed using the 
Neighbour-Joining method, revealed a clear phylogeny of function, as opposed to a 
phylogeny of species (figure II.2.s 1- 4). In other words, Rab proteins of similar function in 
different organisms always co-segregate. As mentioned above, this represents an extension 
of the strict phylogeny of function previously observed in the yeast Ras superfamily 
(Valencia et al., 1991; Garcia-Ranea and Valencia, 1998). Within the clades representing 
each putative Rab "function", we observed a phylogeny of species, with proteins segregating 
according to organism provenience (figure II.2.4). 
Figure II.2.s 1-3 show the trees calculated for each organism Rab family. Some 
proteins always co-segregate, even if they don't conform to the criteria defining isoforms 
(Pereira-Leal and Seabra, 2000). For example, members of the Rab1 sub-family always 
segregate with Rab35 . Based on the tree topology, we can identify 8 possible groups of co-
segregating proteins (figure II.2.4). The proteins in each of these groups are more similar at 
the amino-acid level than any two random Rab proteins . This may represent a higher order 
organisation in the Rab family, above the subfamily level, and may represent either a shared 
ancestry between co-segregating proteins, functional relatedness or both. 
To test the hypothesis that this co-segregation of "unrelated" proteins represents co-
segregation of functional properties, we sought to identify patterns of function and/or cellular 
localisation in each group of figure II.2.4. In group V, which includes the sub-families 5 and 
22, we noted a pattern of sub-cellular localisation and possibly of function. Rab5a has been 
extensively studied, it localises to early endosomes and clathrin coated vesicles and 
regulates endosome budding and fusion (Zerial and McBride, 2001; Bucci et al., 1992; 
Barbieri et al., 1998; Roberts et al., 1999; Rybin et al., 1996; Stenmark et al., 1994). Rab22a 
localises to endosomes and the plasma membrane. Over-expression of Rab22a results in 
the formation of abnormal endosomal structures, which is suggestive of a role in endocytosis 
(Olkkonen et al., 1993). Rab21 also segregates with the sub-families 5 and 22, albeit 
showing less sequence relatedness. Rab21 seems to be specific for polarised cells where it 
localises to apical vesicles and shows partial localisation to an endosomal compartment, 
suggesting it may also be functionally related to Rab5 (Opdam et al., 2000). Interestingly 
other Rab proteins which broadly segregate with Rab5 isoforms also display an endosomal 
localisation, namely Rab17 (Hunziker and Peters, 1998; Zacchi et al., 1998) and Rab20 
(Lutcke et al., 1994), but not Rab24 which is reportedly cytosolic (Erdman et al., 2000). 
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In group III, we also observe a pattern of subcellular localisation to secretory 
granules. Rab37 has recently been identified and localised to secretory granules in mast 
cells (Masuda et al., 2000), and Rab26 has been localised to secretory granules in 
pancreatic acinar cells (Yoshie et al., 2000). Rab27a was the subject of recent work by 
several groups and found to localise to secretory granules (lytic granules) of cytotoxic T 
lymphocytes. Defects in the RAB27A gene in Griscelli Disease lead to haemophagocytic 
syndrome due to loss of CTL activity (Haddad et al., 2001; Stinchcombe et al., 2001). In 
melanocytes, Rab27 is present in melanosomes (lysosome-like pigment-containing 
organelles destined for secretion)(Hume et al., 2001; Wu et al., 2001; Bahadoran et al., 
2001; Haddad et al., 2001). Rab27 appears to recruit MyosinVa to regulate the transport of 
melanosomes to the cell periphery prior to secretion (Hume et al., 2001; Wu et al., 2001; 
Haddad et al., 2001). Rab3 isoforms co-segregate with other members of this group in the 
human and fly Rab tree, but not in the nematode Rab family tree, which is suggestive of a 
more distant relationship. Members of the Rab3 subfamily have been implicated in regulated 
secretory events such as neurotransmitter release and insulin secretion, and associate with 
secretory granules such as synaptic vesicles, secretory granules in mast cells (lezzi et al., 
1999; Tuvim et al., 1999; Al-Matubsi et al., 1999; Raffaniello et al., 1999; Fischer et al., 
1990; Darchen et al., 1990; Oishi et al., 1998), thus exhibiting a similar type of cellular 
localisation as the other members of this group. 
Group VII includes Rab7 and Rab9 isoforms. Both proteins show overlapping 
localisation to late endosomes (Feng et al., 1995; Lombardi et al., 1993; Meresse et al., 
1995). 
In group II there is no pattern of similar subcellular localisation. For example, Rab2 
localises to the ER and Golgi (Tisdale et al., 1992), and Rab4 to endosomes and plasma 
membrane (Sonnichsen et al., 2000). However, there may be a pattern of functional 
similarity in this group. Rab11 and 25 are proposed to be involved in recycling of proteins 
through the recycling endosome (Casanova et al., 1999; Ullrich et al., 1996) and Rab4 is 
also proposed to be involved in endocytic recycling (van der Sluijs et al., 1992). No 
functional data is available for Rab14, but Rab2 has recently been proposed to regulate a 
recycling step in the retrograde Golgi-ER transport (Tisdale, 1999). 
In conclusion, we suggest that there is a recognisable pattern of subcellular 
localisation and possibly of function, which supports the hypothesis of a phylogeny of 
function applying between the subfamily and the family level. 
We next questioned the origin of the sequence relatedness, and functional/ 
localisation similarity underlying the groups shown in figure II.2.4. The simplest explanation 
is that the phylogeny of function also represents the evolutionary history of the Rab family 
and that members of one given branch have a shared ancestry. For example, Rab5 and 
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Rab22 would share the same ancestor, and this ancestral protein would also be the ancestor 
of the budding yeast Ypt5. 
This hypothesis is based on the phylogenetic reconstruction methods, however these 
methods can be biased to functional similarities in highly conserved protein families. 
Therefore, different lines of evidence need to be obtained to substantiate it. Supporting this 
hypothesis is the observation that there is differential conservation in discrete regions such 
as the PM/G and RabF motifs in some cases. For example, human group II proteins Rab25, 
Rab14, and the sub-families Rab11, Rab4 and Rab2, all share identical IGVEF sequence at 
the RabF1 motif, while human group 111 proteins Rab3 and Rab27 isoforms, Rab26 and 
Rab37 display the conserved sequence VGIDF. 
In order to complement this analysis, we searched all available genomic structures of 
human Rab genes for an indication of shared ancestry. If proteins from one branch indeed 
arose from a common ancestor, we expected to find similarities in exon organisation. We 
retrieved available intron-exon boundaries in Rab genes from GenBank, using MapView. In 
many cases the sequencing data is still of low quality, resulting in incomplete or no useful 
information at all. Using a limited number of genes, we observed many common features in 
genomic structures within Rab functional groups. The intron-exon boundaries are either 
absolutely conserved, or are close within a maximum of 5 codons (Figure II.2.6). Some Rabs 
within each group share highly similar genomic structures. For example, Rab11 and Rab25 
are almost identical, while Rab4 and Rab14 are distinguished by the appearance of an intron 
in Rab14 splitting in two the 5th exon in Rab4. Within subfamilies, genomic structures tend to 
be highly conserved (data not shown), a fact already noted by others (Adachi et al., 2000; 
Bhartur et al., 2000; Ramalho et al., 2001; Tolmachova et al., 1999). 
Rab2 Í | 
Rab4 1 1 ) | | 
Rab14 " I I : ' 
I Rab11 I I I 1 
Rab25 1 1 1 I ': 
Rab5 I I I ■ I 
Rab22 H ■ l ' 1 I 
Figure 11.2.6 - Representation of the coding exons (grey boxes) of available "functional 
group members", mapped to a cartoon representing a generalised Rab protein sequence, 
aligned by the conserved PM and G motifs (black boxes). 
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Based on these observations, we cannot discredit the hypothesis that co-segregating 
Rab proteins share a common ancestry. Consequently, the Rab family trees not only 
represent a separation according to function but may also reflect the evolutionary history of 
this family of proteins. A more comprehensive analysis of gene structures of Rab genes in 
different organisms is required to provide more clear evidence for shared ancestry. 
11.2.4. Conclusions 
We have identified and annotated complete Rab families in all eukaryotic organisms 
that had their genome substantially sequenced in May 2001. We propose here criteria for 
annotation of animal and plant Rab families. Our analysis suggests that interactions between 
Rab proteins and their general regulators and specific effectors is conserved across 
evolution, as the sequence determinants of this interactions (RabF motifs and RabSF 
regions) are conserved in all Rab families here studied. 
We addressed the evolution of the Rab family and observed a higher-order 
organisation within the Rab family corresponding to Rab proteins which co-segregate in 
phylogenetic trees. Rabs within these groups exhibit similar function and/or cellular 
localisation and related genomic structures. It is tempting to speculate that early in 
eukaryotic evolution a minimum number of Rab proteins provided the "ancestral" Rab 
regulatory activities. Organism specialisation and multicellularity drove the multiplication of 
Rab family members from the initial set of "ancestral Rabs". These novel Rabs appear to 
have maintained one or more properties that defined their ancestry, allowing us to group 
Rab proteins according to their ancestry, i.e. according to their putative "ancestral Rab 
function". Thus, we propose that these related functions/cellular localisations form an 
intermediate level of classification between family and subfamily, better described as "Rab 
functional groups". One interesting and testable possibility is that this organisation level 
could have predictive value to suggest a function and/or localisation of a given Rab protein. 
Furthermore, we expect more functional groups to be defined as more functional information 
becomes available. 
The minimal set of Rab proteins has been equated with the essential yeast Rab 
proteins (Lazar et al., 1997). These minimal Rab properties may represent localisation to a 
given cellular compartment, interaction with classes of related effectors/regulators, specific 
GTPase characteristics or a combination of these. A better understanding of this issue is 
essential to fully understand the nature of the "ancestral Rab functions", the way that they 
evolved to provide regulators for increasingly complex organisms, and to ascribe general 
functions to novel Rab sequences based solely on their segregation pattern in phylogenetic 
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trees. Furthermore, the understanding of the properties shared by groups of co-segregating 
Rabs identified here, will allow informative correlations between group-specific sequence 
conservation and localisation/function of Rab proteins. 
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11.2.5. Supplementary Material 
Table S.1 - S. pombe Rab family 
Name Accession 
Ypt1 
Ypt2 
Ypt3 
Ypt4 
Ypt5 
Ryh1 
Ypt7 
S04590 
S33900 
S10026 
CAA11239 
S34729 
S12789 
094655 
Table S.2 - S.cerevisiae Rab family 
Name Accession 
Ypt1 
Sec4 
Ypt31 
Ypt32 
Ypt51 
Ypt52 
Ypt53 
Ypt6 
Ypt7 
Ypt10 
Ypt11f 
11 Sequence exhibits large N-terminal extension. 
NP_011148 
NP_011185 
NP_010948 
NP_011305 
S43399 
NP_012939 
NP_014306 
NP_013363 
NP_013713 
NP_009823 
NP 014095 
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Table S.3 - C. elegans Rab family 
Accession Proposed name 
AAC69218 
AAB52431 
AAB16980 
CAB04205 
AAC69020 
CAA77590 
CAA91357 
AAC78494C 
AAC48200 
AAC48203C 
AAB54158 
CAB07678 
CABO1884 
CAB60605 
AAF60884^C 
CAA91296 
CAB54484 
CAA21582CAAX 
CAA21489 
CAA84705^ 
CAB57899 
AAB52888 
CAA87774C 
AAB04568CAAX 
CAA20282* 
AAC470670 
CAB07357 
CAB07356 
AAA81090tCAAX 
CeRabl 
CeRab2 
CeRab3 
CeRabõ 
CeRab6A 
CeRab6B 
CeRab7 
CeRab8 
CeRabl OA 
CeRablOB 
CeRabl 1A 
CeRabl1B 
CeRab14 
CeRab19 
CeRabl8 
CeRab21 
CeRab27 
CeRab28 
CeRab30 
CeRab33 
CeRab35 
CeRab37 
CeRab39 
CeRabYl 
CeRabY2 
CeRabY3 
CeRabY4 
CeRabY5 
CeRabY6 
c Sequence does not contain C-terminal cysteines 
CAAX Sequence contains a single cysteine in the context of a CAAX box 
11 Sequence exhibits large N- or C- terminal extension. 
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Table S.4 - D. Melanogaster Rab family 
Accession Proposed name 
AAF55873 
AAF57381 
AAF58762 
AAF57831 
AAF51265 
AAF53168 
AAF56218 
AAF49101CAAX 
AAF53798 
AAF50924 
AAF55850 
AAF53390 
AAF46057 
AAF50452CAAX 
AAF45341 
AAF51970CAAX 
AAF51708CAAX'^ 
AAF45634 
AAF52477C 
AAF589700 
AAF45371 
AAF46271 
AAF48164^ 
AAF47018 
AAF46585C 
AAF47981C 
AAF56345* 
AAF47546C 
AAF47406 
DmRabl 
DmRab2 
DmRab3 
DmRab4 
DmRab5 
DmRab6 
DmRab7 
DmRab8 
DmRab9 
DmRablO 
DmRabl 1 
DmRab14 
DmRab18 
DmRab19 
DmRab21 
DmRab23 
DmRab26 
DmRab27 
DmRab30 
DmRab32 
DmRab35 
DmRab39 
DmRab40 
DmRabXI/chrowded 
DmRabX2 
DmRabX3 
DmRabX4 
DmRabX5 
DmRabX6 
c Sequence does not contain C-terminal cysteines 
CAAX Sequence contains a single cysteine in the context of a CAAX box 
' Sequence exhibits large N- or C- terminal extension 
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Table S.5 - A. thaliana Rab family 
Accession number Database 
name 
Group type isoform Proposed 
name 
P28185 ARA2 A a AtRabAla 
Q39222 RAB 11 A b AtRabAlb 
BAB09217 A c AtRabAlc 
T04872 A d AtRabAld 
T04539 A e AtRabAle 
BAB10106 A f AtRabAlf 
BAA97069 A g AtRabAlg 
F84750 A h AtRabAlh 
AAF16749 A i AtRabAli 
004486 RAB11C A 2 a AtRabA2a 
AAF79570 A 2 b AtRabA2b 
Q96283 RAB11A A 2 c AtRabA2c 
BAB09761 RAB 11 A 2 d AtRabA2d 
AAF97325 A 3 - AtRabA3 
BAB11663 A 4 a AtRabA4a 
T06105 GB3 A 4 b AtRabA4b 
BAB09048 A 4 c AtRabA4c 
BABO1966 A 4 d AtRabA4d 
BAB09078 A 5 a AtRabAõa 
AAF02165 A 5 b AtRabAõb 
P28187 ARA4 A 5 c AtRabAõc 
G84723 A 5 d AtRabA5d 
P19892 ARA1 A 5 e AtRabA5e 
AAF24834 A 6 a AtRabA6a 
AAF97836C' 1 A 6 b AtRabA6b 
D71440 RAB2A B 1 a AtRabBla 
H85191 RAB2 like B 1 b AtRabBlb 
S71585 GB2 B 1 c AtRabBlc 
U75603 RAB 18 C 1 - AtRabCI 
AAF23245 C 2 - AtRabC2 
T48379 C 3 c AtRabC3 
AAD00111 ATFp8 D 1 - AtRabDI 
P28188 ARA5 D 2 a AtRabD2 
BAA97153 D 2 b AtRabD2b 
CAB78756 RAB1C D 2 c AtRabD2c 
T45901 RAB8 E a AtRabEla 
BAB08351 ARA3 E b AtRabElb 
P28186 ARA5 frag. E c AtRabElc 
T48378 E d AtRabEId 
AAF23246 E e AtRabEle 
BAB32953C ARA6 F a AtRabFla 
T06736c F b AtRabFlb 
P31582 F 2 a AtRabF2a 
T06157 F 2 b AtRabF2b 
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Table S.5 - A. thaliana Rab family (continued) 
Accession number Database Group type isoform Proposed 
name name 
BAB08894C RAB7 Like G 1 AtRabGI 
AAD20423 G 2 AtRabG2 
T04019 RAB7 
Homolog 
G 3 a AtRabG3a 
004157 RAB7 G 3 b AtRabG3b 
BAB02676 G 3 c AtRabG3c 
AAG21568 RAB7D G 3 d AtRabG3d 
AAD43167 RAB7 G 3 e AtRabG3e 
BAB01810 G 3 f AtRabGIf 
BAA97311 H a AtRabHIa 
T01588 H b AtRabMb 
T06095 H c AtRabHIc 
H84610 H d AtRabHId 
T50814 H e AtRabHIe 
c Sequence does not contain C-terminal cysteines 
Sequence exhibits large N- or C- terminal extension 
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Table S.6-H. sapiens Rab family 
A c c e s s i o n Proposed Bock et al. Bock ef a/. 
Name Name Accession 
NP 004152 HsRabIA 1a = 
NP_112243 HsRabIB 1b IGI_M1_CTG16159_31 
NP 002856 HsRab2A 2a = 
IGI_M1_CTG53_358bc HsRab2B 2b = 
NP_002657 HsRab3A 3a = 
NP 002858 HsRab3B 3b = 
IGI_M1_CTG13513_30bc HsRab3C 3c = 
NP 004274 HsRab3D 3d = 
NP_004569 HsRab4A 4a = 
NP_057238 HsRab4B 4b = 
Splice variant of 4a(?) - 4c IGI_M1_CTG4256_3 
NP_004153 HsRab5A 5a = 
NP_002859 HsRab5B 5b = 
NP_004574 HsRab5C 5c = 
NP_002860 HsRab6A 6a = 
NP 067661 HsRab6B 6b = 
CAB66661C HsRab6C 6c IGI_M1_CTG14521_66 
NP_004628 HsRab7 7 = 
NP_005361CAAX HsRab8A 8a = 
NP_057614CAAX HsRab8B 8b = 
NP_004242 HsRab9A 9a = 
NP_057454 HsRab9B 9b IGI_M1_CTG16547_21 
Same as 9a - 9c GI7705963 
NP_057215 HsRablO 10 = 
NP 004654 HsRab11A 11a = 
NP_004209 HsRab11B 11b = 
AC 15676 HsRab12 121 IGI_M1_CTG16793_17 
NP_002861CAAX HsRab13 13 = 
NP_057406 HsRab14 14 = 
AL139022 HsRab15 15 IGI M1 CTG16579_4 
BAB14121 HsRab17 17 IGI_M1_CTG16465_9 
AAF61433CAAX HsRab18 18 = 
IGI M1 CTG66 16^ 1 HsRab19 41 = 
NP_060287 HsRab20 20 = 
NP 055814 HsRab21 21 = 
AAF00047 HsRab22A 22a = 
NP_006859 HsRab22B 22c GI583131 
IGI_M1_CTG66_20b HsRab22C 22b = 
NP_057631C HsRab23 23 = 
BAB13887 ic HsRab24 - -
NP_065120C HsRab25 25 = 
NP_055168 HsRab26 26 = 
NP_004571 HsRab27A 27a = 
NP_004154 HsRab27B 27b = 
NP 004240e HsRab28 28a = 
I I - 37 
Part II - Rab Proteins 
Table S.6-H. sapiens Rab family (continued) 
Accession P r o p o s e d Bock et al. Bock et al. 
Name Name Accession 
Splice variant of 28(?) - 28b P51157 
NP_003920 HsRab29 42 -
NP_055303 HsRab30 30 = 
NP_006825 HsRab32 32a = 
NP_004785 HsRab33A 33 = 
CAB66838 HsRab33B - -
AF322067*, ' HsRab34 34 IGI_M1_CTG15917_25 
NP_006852 HsRab35 35 = 
NP_004905^ HsRab36 36 = 
IGI_M1_CTG16279_23b HsRab37 37 = 
P 5 7 7 2 9 C A A X HsRab38 32b IGI_M1_CTG15576_6 
X99962 HsRab39A 39 Q14964 
IGI_M1_CTG14748_14bc HsRab39B 38 = 
CABO9136CAAX11 HsRab40A 40a 000407 
NP_006813CAAX,1[ HsRab40B 40b = 
O60795b'iCAAX'^ HsRab40C 40c = 
IGI M1 CTG19178 2 HsRab41 43 = 
*Annotated in GenBank as Rab39(direct submission). 
"Accession numbers given in Bock, J.ef a/.. (2001) Nature 409, 839-841. which we could not 
find in any database. We used the sequences kindly provided by the authors. Note that our 
annotation differs from the one made in Bock, J.ef a/.. (2001) Nature 409, 839-841 
I Incomplete sequence 
c Sequence does not contain C-terminal cysteines 
CAAX Sequence contains a single cysteine in the context of a CAAX box 
II Sequence exhibits large N- or C- terminal extension 
= identical accession number 
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III. The Rab Escort Protein Family: 
Sequence and structural divergence in a conserved function 
III. 1. Introduction 
Rab proteins form the largest family of small GTPases, with more than 50 members 
described in mammals to date (Pereira-Leal and Seabra, 2000). Rabs are regulators of 
intracellular trafficking pathways, many have a specific sub-cellular localisation and some 
show tissue specific variation in expression level, reflecting the complexity and variety of 
trafficking events found in mammalian cells (Novick and Zerial, 1997; Olkkonen and 
Stenmark, 1997; Schimmoller et al., 1998; Chavrier and Goud, 1999; Brennwald, 2000; 
Rodman and Wandinger-Ness, 2000). Several studies showed that Rabs are 
geranylgeranylated (Kinsella and Maltese, 1992; Khosravi-Far et al., 1991), but unlike other 
small GTPases they display two cysteine residues at or near the C-terminus, unlike the 
CAAX box that is usually found in other prenylated proteins. Both cysteine residues were 
shown to be geranylgeranylated (Famsworth et al., 1991), and this type of lipid modification 
(di-gemaylgeranylation) was shown to be essential for Rab function (Walworth et al., 1989). 
Geranylgeranylation of Rab proteins is catalysed by RabGeranylgeranyl Transferase 
(RGGT), a heterodimeric enzyme related to other Protein Prenyl Transferases (Seabra et al., 
1992; Seabra et al., 1992) that is unique in its absolute requirement for an accessory protein 
termed Rab Escort Protein, a protein related to RabGDI (Andres et al., 1993; Seabra et al., 
1992). Newly synthesised Rabs bind REP and the REP:Rab complex is the substrate of 
RGGT that catalyses the sequential addition of two geranylgeranyl groups to the C-terminal 
cysteine residues of the Rab protein (Shen and Seabra, 1996). After the transfer, the 
enzyme dissociates from the complex RabGG:REP and REP delivers the prenylated Rab to 
cellular membranes (Alexandrov et al., 1994; Wilson et al., 1996). Thus REP behaves as an 
essential activator of the Rab prenylation reaction (Anant et al., 1998). 
Two REP proteins have been described in mammals, REP1 and REP2, sharing around 70% 
identity. They show similar tissue distribution patterns (Desnoyers et al., 1996) and seem to 
differ only in their affinity towards different Rab proteins (Anant et al., 1998; Seabra et al., 
1995). REPs show a strict nucleotide requirement as they can only interact with Rabs in the 
inactive, GDP bound conformation (Seabra, 1996), thus falling into the category of general 
regulators of Rab function (for review on the biochemistry of Rab geranylgeranylation see 
(Seabra, 2000)). 
REP1 is also known as Choroideremia protein, as its gene was found to be mutated in 
Choroideremia, an X-linked progressive retinal degeneration caused by complete absence of 
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REP1 (MacDonald et al., 1998; Seabra, 1996; Seabra et al., 1993; Seabra et al., 1995; 
Cremers et al., 1990; van den Hurk et al., 1997). Likewise, REP2 is also known as 
Choroideremia-like protein. 
The gene MRS6 in Saccharomyces cerevisiae, identified as a suppressor of the 
respiratory deficient phenotype of the mrs-2 mutant (Ragnini et al., 1994) displayed 
homologies to REP-1/CHM and RabGDI (Waldherr et al., 1993), and was shown to be the 
functional homologue of REP-1 (Jiang and Ferro-Novick, 1994). MRS6 is an essential gene 
(Ragnini et al., 1994) and recent in vivo studies with a temperature-sensitive mutant of 
MRS6 reveals that reduction of MRS6 levels results in accumulation of unprenylated Rabs in 
the cytosol (Bialek-Wyrzykowska et al., 2000). This study, together with the observation that 
at least one Rab protein accumulates unprenylated in cytosol from patients suffering from 
CHM (Seabra et al., 1995), lends further support to the essential role of Rab Escort Proteins 
in the lipid modification of Rab proteins. 
REPs are related to RabGDIs (Rab GDP Dissociation Inhibitors), proteins which form 
a highly conserved family that behave as negative regulators of Rab function, retrieving 
Rabs from cellular membranes into cytosolic complexes and maintaining them in an inactive 
conformation. RabGDIs also display the ability to re-insert Rab proteins into cellular 
membranes. This has led to the suggestion that RabGDI allows recycling of Rabs from an 
acceptor membrane to a donor membrane (Wu et al., 1998; Pfeffer et al., 1995). The 
solution structure of the alpha isoform of RabGDI showed a molecule composed of two 
distinct domains, termed domains I and II. The larger domain (domain I) consists of 20 (3-
sheets and 9 a-helixes. It shows structural similarity to FAD-dependent flavoproteins (Schalk 
et al., 1996) but the functional significance of this has yet to be elucidated. Domain II is 
smaller than domain I and is composed of five a-helixes. 
REPs and RabGDIs sharing above 30% identity form a super-family of proteins 
believed to exhibit a conserved fold (Schalk et al., 1996; Wu et al., 1996). Sequence 
conservation between REPs and RabGDIs is restricted to regions termed SCRs (Sequence 
Conserved Regions) (Waldherr et al., 1993; Wu et al., 1996), in particular to regions SCR1 A, 
SCR1B and SCR3B, which have been termed GDI-CHM consensus domain (GCD) (Schalk 
et al., 1996). Site directed mutageneses and structural studies have identified functionally 
important regions. One is domain II that is critical for Rab extraction from membranes, 
involving positions in both SCR2 and SCR3A (Luan et al., 2000; Gilbert and Burd, 2001), 
and the other is the region responsible for Rab binding, referred to as the "Rab Biding 
Platform", which involves positions in the SCR1A, SCR1B and SCR3 and localises in the 
apex of domain I (Alory and Balch, 2000; Luan et al., 2000; Schalk et al., 1996; Luan et al., 
1999). 
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Although the biochemistry of Rab geranylgeranylation has been extensively 
characterised (Casey and Seabra, 1996; Seabra, 2000), comparatively little is known about 
the structural determinants of REP function. Bauer and co-workers (Bauer et al., 1996) 
performed the first mutational analysis of MRS6, showing that two mutations in the SCRs 
abolished Rab binding. Recent results suggest that MRS6 may also interact with Rab 
proteins through the conserved SCR1 and 3B, which form the "Rab binding platform" in 
RabGDI. Alory and Balch (Alory and Balch, 2000) observed that two mutations in SCR3B 
reduced the ability of MRS6 to bind Ypt1, as did the equivalent mutations in RabGDI. Since 
these regions are highly conserved between REPs and RabGDIs, and both groups of 
proteins are believed to have the same fold, it is possible that the apex of structural domain I 
represents a conserved Rab binding platform. Additionally, the same authors observed that 
two mutations in domain II affected prenylation of Ypt1 in vitro, although showing normal 
Rab binding properties. The authors interpret this as indicating that domain II may be 
involved in physical interactions with RGGT (Alory and Balch, 2000). 
Here we analyse sequence conservation patterns in the REP family, attempting to 
relate and distinguishe members of the REP family and the RabGDI family, and discuss their 
functional significance. 
111.2. Methods 
Known REP sequences were retrieved from GenBank and used to identify novel 
elements of the super-family through T-BLAST querying of GenBank (Altschul et al., 1997), 
pfam database (Sonnhammer et al., 1998; Sonnhammer et al., 1997), and of simple BLAST 
searches in GenBank using statistical models calculated from multiple sequence alignments. 
Sequences were aligned using the Clustal W 1.80 algorithm (thompson et al., 1994), and 
phylogenetic trees reconstructed with the methods of Maximum Parsimony and Neighbour-
Joining (Saitou and Nei, 1987), with and without pairwise gap removal, scoring observed 
divergence, using program phylo_win (Galtier et al., 1996), which that can be found at 
pbil.univ-lyon1.fr/software/phylowin.html. Bootstrapping (Felsenstein, 1985) involved 1000 
trials. 
Identification of tree-determining residues was performed using Sequence Space 
analysis (Cassari et al., 1995), using the program SeqSpace, found at 
industry.ebi.ac.uk/SeqSpace/index.html, and multiple sequence alignment with hierarchical 
clustering (Livingston and Barton, 1993), using the AMAS program found at 
barton.ebi.ac.uk/new.software.html. The software package HMMER 2.0 (available at 
III- 4 
Part III - REP Proteins 
hmmer.wustl.edu) was used to calculate profile Hidden Markov Models (pHMM) and 
generate model sequences. 
Structures were retrieved from the PDB bank and manipulated using the program 
SwissPDBviewer (Guex and Peitsch, 1997) and modelling of protein structures used the 
Swiss-Model comparative modelling server (Guex and Peitsch, 1997; Peitsch, 1995; Peitsch, 
1996), available at www.expasy.ch/swissmod/SWISS-MODEL.html. 
///.3. Results and Discussion 
111.3.1. The REP family 
In order to identify all the available REP sequences, we searched the databases 
using a combination of methods based on profile Hidden Markov Models (^-BLAST and the 
pfam database) using both known sequences and statistical models representing the 
multiple sequence alignments of the known sequences. Identification of novel sequences 
was followed by re-calculation of super-family multiple sequence alignment consensus. The 
Rab Escort Protein sequences found are listed in table 111.1. 
All the sequences were tested for high sequence identity/similarity to known 
members of the family, around the SCRs (sequence conserved regions), to confirm they 
were indeed members of the GDI-REP super-family. 
In order to distinguish between REP and RabGDI sequences, we then compared 
each novel sequence to consensus calculated for both families (data not shown) and asked 
if proteins from this super-family would group according to similarity of function and/or in 
terms of similarity of species. We calculated distance diagrams based in the Clustal W 1.80 
multiple sequence alignment of 11 candidate Rab Escort Protein sequences and 26 
candidate RabGDI sequences from a variety of species. Figure 111.1 shows the Neighbour-
Joining distance diagram of the super-family clearly separating the two functional groups, a 
separation that was consistently observed when other algorithms are used to draw the 
distance diagrams (data not shown). Although there is little or no functional information for 
many of the molecules included in this analysis, the fact that there is consistent separation of 
two groups that include molecules of known distinct function, suggest that this separation 
reflects similarity of function as opposed to similarity of species. This further suggests that 
the positions that separate the two major groups are of functional and/or structural 
significance, and are conserved across evolution. 
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Table 111.1 - REP family members in different species. 
Species Database name(s) Accession Size 
number (aa) 
Schyzosaccharomyces Putative Rab CAA18894 459 
pombe geranylgeranyl-
transferase escort 
protein (REP, GDP 
dissociation inhibitor) 
Saccharomyces MRS6 AAA34796 463 
cerevisiae 
Candida albicans REP BAA36167 640 
Arabidopsis thaliana putative Rab Escort 
Protein 
AAG51329 536 
Oriza Sativa ESTs(AU056916/5) BAA89572 530 
Drosophila REP, REP homolog AAD16891, 511 
Melanogaster AAF57544 
Mus musculas REP1/CHM AF218084 661 
Mus musculus REP2/CHML AF189156 621 
Ratus Norvegicus REP1/CHM/ 
component A of RGGT 
AAA87626 650 
Ratus Norvegicus REP2 - -
Homo sapiens REP1/CHM/TCD 
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Figure 111.1 - Neighbour-Joining dendogram of the GDI/REP superfamily, 
highlighting the complete separation between different functions. 
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Figure 111.1 also highlights the high conservation we observe in the RabGDI family, 
with average identity/similarity between the family members of 62%/ 73%, and the lower 
conservation that the REP/MRS6 family presents, with average identity/similarity within the 
family of 31%/40%. 
Within the Rab Escort Protein containing group we observe a clear hierarchy of 
species as can be seen in figure III.2. We recognise three major groups, corresponding to 
the three kingdoms fungi, plant and animals. Within the animal clade the mammalian 
isoforms form an independent branch of the tree that subdivides not according to species but 
according to isoform, in what seems to represent a phylogeny of function. This type of 
separation was also observed using distance based methods, as can be seen in figure 111.1, 
and may represent subtle functional differences between the proteins in the different 
branches of the tree. 
In order to distinguish between REP and RabGDI sequences, we then compared 
each novel sequence to consensus calculated for both families (data not shown) and asked 
if proteins from this super-family would group according to similarity of function and/or in 
terms of similarity of species. We calculated distance diagrams based in the Clustal W 1.80 
multiple sequence alignment of 11 candidate Rab Escort Protein sequences and 26 
candidate RabGDI sequences from a variety of species. Figure 111.1 shows the Neighbour-
Joining distance diagram of the super-family clearly separating the two functional groups, a 
separation that was consistently observed when other algorithms are used to draw the 
distance diagrams (data not shown). Although there is little or no functional information for 
many of the molecules included in this analysis, the fact that there is consistent separation of 
two groups that include molecules of known distinct function, suggest that this separation 
reflects similarity of function as opposed to similarity of species. This further suggests that 
the positions that separate the two major groups are of functional and/or structural 
significance, and are conserved across evolution. 
Interestingly, we could not find any sequence in the latest release of C. elegans 
genome which could be considered a REP. One hypotheses to explain this is that RabGDI 
could perform both functions. However, the worm RabGDI sequence does not reveal any 
significant difference from other RabGDI sequences, which does not supports this 
hypotheses. More likely this is due to incomplete or bad quality sequencing which made it 
impossible to identify the REP gene. 
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REP2 h.s. 
■REP1 r.n. 
■REP1 m.m. 
■REP1 h.s. 
Figure III.2 - Maximum parsimony tree of the REP family, rooted with yeast RabGDI (not 
shown). Bootstraping involved 100 trials 
111.3.2. Rab Binding: conserved property between REPs and RabGDIs 
III.3.2.1. Reassessment of REP/RabGDI SCRs 
REPs and RabGDIs share the ability to bind Rab proteins, and deliver them to 
cellular membranes (Soldati et al., 1993; Alexandrov et al., 1994; Wilson et al., 1996). REPs 
and RabGDIs display above 30% identity and are believed to have a conserved fold (Schalk 
et al., 1996; Wu et al., 1996). Sequence conservation was previously proposed to be 
restricted to regions termed SCRs (Sequence Conserved Regions) (Waldherr et al., 1993; 
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Wu et al., 1996), and in particular to the regions SCR1A, SCR1B and SCR3B, which have 
been termed GDI-CHM consensus domain (GCD) (Schalk et al., 1996) (figure III.3). 
RabGDI 
Sc_REP/ 
MRS6 
at_REP 
dmJtEP 
hs_REP1 
hs_REP2 
SCR 
1A 1B 
SCR 
2 
SCR 
3A 3B 
Figure III. 3 - Domain organisation of the REP and GDI families 
The solution structure of RabGDI revealed that GCD forms a conserved surface at 
the apex of domain I of RabGDI (see figure III.4) (Luan et al., 2000; Schalk et al., 1996). 
Restricted mutational analysis of RabGDI has identified residues important for Rab binding 
localising to this conserved surface (see figure III.5), which was termed "Rab binding 
platform" (Luan et al., 1999; Luan et al., 2000; Schalk et al., 1996). 
As the definition of the SCRs was made using a limited set of sequences available at 
the time (Ragnini et al„ 1994; Waldherr et al., 1993), and the increase in the number of 
available sequences has indicated that the REP family may be very divergent, we decided to 
asses the definition of the SCRs using the bigger data set presently available. 
We tested the Clustal W 1.80 alignment of all the REP and RabGDI sequences 
represented in figure 111.1 using hierarchical clustering analysis (Livingston and Barton, 
1993), and compared statistical model sequences representing each of the families (Eddy, 
1998) (figure III.6). We found that the majority of the conserved positions, concentrated in 
and around the previously identified SCRs that define the GCD. When we model the 
structures of REPs from each of the three major branches of the phylogenetic trees, and 
map these SCR regions to the structural models we observe a similar localisation (figure 
III.4), suggesting a conserved binding surface defining the interaction to Rab proteins, which 
would be defined by the exposed residues in the SCRs. This suggestion is supported by the 
fact that the MRS6 mutations E286S and R293A abolish binding to Rabs, the same effect 
caused by mutation of the the equivalent positions in RabGDIs (see figure III.5) (Alory and 
Balch, 2000). The suggestion that all Rabs will interact with general regulators in a 
conserved manner, through conserved positions clustering in and around the switch regions 
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(RabF motifs) (Pereira-Leal and Seabra, 2000) is also consistent with the existence of a 
conserved Rab binding platform in RabGDIs and REPS. 
Figure III.4 - Molecular surface of RabGDI (1GND) and modelled human REP-1. SCR 
regions coloured in red (SCR1A), purple (SCR1B), blue (SCR2), green (SCR3A) and orange 
(SCR3B). The residues corresponding to the sequence between SCR1B and SCR2 is 
coloured in dark grey. Images on the right of the image represent about 180° rotation of the 
figure on the left side of the image. 
The Rab binding platform in RabGDI was recently shown to display a high degree of 
flexibility around some positions in SCR3A (Luan et al., 2000). This is consistent with the 
hypothesis that common regions in Rabs are recognised by a structural theme present in 
RabGDIs and REPs, and that the flexibility of this regions allows RabGDIs and REPs to 
accommodate for the variability that is found in the Rab proteins. 
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SCR1A 
GDIaJa.t. HDEEYDVIVLGTGLTECI 18 
GDI s.c. HDQÏTIDTDYDVIVLGTGITECI 23 
REPl_h.s. HADTLPSEFDVIVIGTGLPESI 22 
HM6_s.c. MLSPERRPSHAIRRPSFFSrTQNPSPLWPHLAGIEDPLPATTPDKVDVLIAOTGHVESV 60 
SCR1B 
GDIajD.t. LSGIHSVNGKKVLHHDRNPYXGGESSSITP 48 
GDI_3.C. LSGLLSVDGKKVLHIDKQDHÏGGEAASVT S2 
REPl_h.s. IAAACSRSGRRVLHVDSRSYYGGN1USFSF3GLLSIJLKEYQEHSDIVSDSPVHO.DQILEN 82 
HRS6 B.C. LAAALAUQGSNVLHIDKNDYYODTSATLT 89 
GDIa_b.t. L-EGPPE THGRG RDWNVDLIPKFLHANGQLVKHLI.YTEVTRYLDF 102 
GDI_s.c. H-PISKEERE SKFGKD RDHNVDLIPKFLMANGELTNILIHTDVTRYVDF 110 
RÏPl_h.s. A-EDTTEQPKKNRITYSQIIKEG RRFNIDLVSKLLYSRGLLIDLLIKSNVSRYAEF 2S7 
HRS6_s.c. VNEGSVSCYKNAKLYVSTLIGSGKYSSRDFGIDLSPKILFAKSDLLSILIKSRVHQYLEF 159 
SCR2 
GDIa_b . t. KWEGSFVYKGGKIYKVPSTETEALASNLMGHFEKRRFRKFLVFVANFDENDPKTFEGVD 162 
GDI_3.c. KQVSG3YVFKQGKIYKVPANEIEAIS3PLHGIFEKRRHKKFLEBIS3YKEDDLSTHQGLD 170 
RIPl_h.s. KNITRILAFREGRVECOTCSRADVFNSKQLTHVEKRIILHKFLTFCHEY-EKYPDEYKGY- 315 
HRS6_s.c. Q3L3NFHTYFJJDCFEKLTNTKQEIFTDI3MLPLHTKRNL1IKFIKFVLMB-EAQTEI¥QPY- 217 
SCR3A 
GDIa b 
GDI B.c. 
REP1 b 3. 
HR36_ ." C. 
GDIa b t. 
GDI s.c. 
REP1 b 9. 
HRS6 
PQMTSHRDVY-RKFDLGQDVIDFTGHALALYRTDDYLDQPCLETINRIKLYSE3LARYGK 221 
LDKNTHDEVY-YKFGLGNSTKEFIOHAHALWTNDDYLQQPARP3FERILLYCQ3VARYGK 229 
-EEITFYEYL-KTQKLTPMLQYIVHHSIAHTSET ASSTIDGLKATKNFLHCLGRYGN 370 
-AERTHSDFLGEKFKLEKPQVFELIFSIGLCYDLN VKVPEALQRIRRYLT3FDVYGP 273 
SCR3B 
3PYLYPLYG-LGELPUGFARL3AIYGGTYMLNKPVDDIIHEN—GKWGVK3EG-EVARC 277 
3PYLYPHYG-LGELPQGFARL3AIYGGTYMLDTPIDEVLYKKDTGKFEGVKTKL-GTFKA 287 
TPFLFPLYG-QGELPQCFCRHCAVFGGIYCLRHSVQCLWDKESRKCKAIIDQFGQRIIS 429 
FPALCSKYGGPGELSQGFCRSAAVGGATYKLMEKLVSFNPTT KVATFQDGS-KVEVS 329 
Figure 111.5- Alignment of selected residues of some species of REPs and GDIs. Sequence 
conserved regions (SCRs) are indicated above the alignment and positions that have been 
shown to be involved in REP binding are highlighted in red. 
III.3.2.2. Role of REP C-terminus in Rab binding 
It has been argued that in REPs, the SCR regions are not sufficient for Rab binding, 
but REP-specific C-terminal sequences are also required (Bauer et al., 1996). This was 
based on the fact that deletion of C-terminal portions MRS6 failed to support growth of yeast, 
antibodies against MRS6 were not able to immunoprecipitate Ypt1 in strains expressing this 
deletion mutant and that by yeast two hybrid binding assays no binding was detected using 
just the first 322 a.a. of MRS6, but could be detected if the first 570 a.a. were used. 
However, inspection of the modelled structure of IMRS6 indicates that it is unlikely that the 
mutant proteins would fold properly, as the two expected domains of MRS6 do not correlate 
in a linear from with the sequence. The authors did not address this issue. Although they 
show that in smaller C-terminal deletions the truncated protein is produced, the fact that 
point mutations in human REP-1, found in patients suffering from CHM result in complete 
absence of detectable protein in samples from patients (MacDonald et al., 1998), and that 
the deletion of the C-terminal portions of MRS6 places all the protein in the 100,000xg pellet 
(Miaczynska et al., 1997) suggests that the C-terminus plays an important role in the folding 
stability of REP proteins. 
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111.3.3. Where do isoprenoids bind in REP and RabGDI? 
Binding of Rab proteins implies, both for REPs and RabGDIs, the ability to interact 
with the prenyl chains of the lipid modified Rab protein, and to shield them from the aqueous 
environment of the cytosol. Both molecules must contain a hydrophobic region that can 
accommodate two (or in some cases just one) 20 carbon geranylgeranyl isoprenoids. The 
nature of this hydrophobic regions has remained illusive. 
Inspection of the structure of RabGDI and of structural models of different REP 
proteins reveals no evident hydrophobic patch. This suggests that binding of prenylated 
Rabs will involve conformational changes in REPs and RabGDIs. Supporting the ability of 
REP to undergo structural rearrangements are the different affinities of free REP and REP 
complexed with Rab to RGGT, which have been interpreted as resulting from different REP 
conformations (Anant et al., 1998). Different affinities for RGGT have also been reported for 
the prenylated and unprenylated REP:Rab complex, but it is not clear if this can also reflect 
changes in the REP:Rab complexes, or only in conformational changes in RGGT caused by 
binding to GGPP (Anant et al., 1998; Alexandrov et al., 1998; Thoma et al., 2000). Any 
structural rearrangement however will have to accommodate for a variety of C-terminus 
lengths, i.e., distance between the common Rab fold that binds the Rab binding platform, 
and the lipid modifiable/modified cysteines. 
111.3.4. Prenylation of Rab proteins: unique REP property 
Unlike RabGDI, REP may bind unprenylated Rab proteins and mediate their 
prenylation by RGGT. Sequence or structural motifs that are unique of REP proteins are 
then likely to determine any of these REP specific properties. 
III.3.4.1. REP specific regions 
To identify REP specific sequences we combined three different approaches: 
sequence space analysis, statistical models based on profile Hidden Markov Models and 
hierarchical conservation analysis. The results of this analysis are summarized in figure III.6, 
an alignment of single majority rule consensus calculated for each family, highlighting the 
positions that are specifically conserved in each family. 
Bauer and collaborators (Bauer et al., 1996) observed three conserved regions 
between human REP1 and REP2 and yeast REP (MRS6). Our analysis that considers more 
REP sequences and different methods failed to identify such conservation in the REP family, 
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as can be see in figure III.7. Instead we were surprised to observe that very few REP 
specific positions could be detected. Most of these positions tended to cluster in the SCR 
regions, which was another surprise since we expected that unique REP functions would be 
determined by positions in regions that were not conserved in RabGDI. 
In evolutionary terms this may reflect the existence of few "functional regions" in 
REPs and RabGDIs that the different families evolved and use to mediate interactions with 
different binding partners or to accommodate for family specific functions or functional 
variations. 
One example of a family specific functional variation may be Rab binding. In both 
families binding to Rabs is mediated by the RabGDI/CHM conserved (GCD) domain, 
however In these regions there are several positions that are differentially conserved 
between the two functional families (see figure 111.6). These differences could underlie the 
fact that although RabGDI can only bind prenylated Rabs, while REP also has to bind 
unprenylated Rabs, and it has to accommodate the addition of the two lipid groups during 
the prenylation reaction. This possibility could be easily tested in vitro by replacing the 
RabGDI GCD with that of REP and test the binding of non-prenylated Rabs to the mutant 
RabGDI. A non-exclusive alternative to explain the differential conservation in the GCD is 
the requirement for regulation of the prenylation machinery by other molecules that could 
interact with or even modify some of these consensus positions. 
One example of a "functional domain" that has different functions in RabGDIs and 
REPs is Domain II. This domain has been proposed to be involved in RabGDI recycling of 
Rabs and in REP binding to the RGGT. 
In RabGDI, mutations in this region result in increased levels of Rabs associated with 
membranes and reduced cytosolic pool, while another set of mutations results in the 
accumulation of a sub-set of Rab proteins in the cytosol, suggesting that Domain II mediates 
Rab membrane delivery and retrieval (Gilbert and Burd, 2001). However the precise nature 
of these mutations was not identified by the authors. In another study, combined mutations 
in SCR3A (also in domain II) and the Rab binding platform (R226A/R248A and 
Y227A/R248A) impair the ability of RabGDI to retrieve Rabs from membranes (Luan et al., 
2000). Together, this results suggest that domain II plays a role in recycling Rabs from and 
to cellular membranes, possibly via interactions with the previously postulated Rab 
Recycling Factor (RRF) (Luan et al., 1999). SCR3A (represented in green in figure III.4) 
includes a flexible domain that according to Luan and co-workers interacts with the putative 
RRF (Luan et al., 2000). 
SCR3A is one of the least conserved SCRs and contains at least 8 REP specific 
positions (see figure III.7). REPs have been shown to deliver and extract Rabs to and from 
cellular membranes after prenylation (Alexandrov et al., 1994; Wilson et al., 1996; Pfeffer et 
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al., 1995), and to associate with cellular membranes in vitro and in vivo (Miaczynska et al., 
1997), Hume and Seabra, personal communication). Mutations in MRS6 putative domain II 
(R195, K199D, T185D, L226Y, D269A, V270R, Y271F) have no effect on yeast growth, 
except for R195A (Alory and Balch, 2000). However, the mutations R195A and L226Y 
severely affect in vitro prenylation of Rab proteins, without affecting Rab binding. This 
observation may suggest that positions in the putative domain II of REP mediate interactions 
with RGGT. It is interesting to note that none of these two positions correspond to REP 
specific positions: R195 is highly conserved in the super-family, and L226 is not a conserved 
position. 
However parallels between yeast growth and Rab prenylation may not be 
appropriate. Although REP function is essential in yeast (Ragnini et al., 1994), different 
studies point to prenylation of Rab proteins being only transiently required to maintain 
cellular viability, and that only a small proportion of Rab protein needs to be, at any time, 
prenylated (Bialek-Wyrzykowska et al., 2000; Alory and Balch, 2000). 
Even though the results of Allory and Balch (Alory and Balch, 2000) concerning the 
interaction of MRS6 with RGGT are inconclusive, it is still possible that domain II, where both 
R195 and L226 localise, may mediate interactions with RGGT, but further mutational 
analysis should be designed based on analysis of patterns of sequence conservation within 
each family. 
111.3.4.2. REP-specific insert region 
The most obvious difference between REPs and RabGDIs is the expansion of the 
intervening sequence between SCR1B and SCR2, (figure III.3). The length of this sequence 
varies between 10 and 140 a.a. Their sequences are not conserved and no obvious putative 
function can be assigned just based on homology as querying of databases reveals no 
meaningful homology (data not shown). 
When we model the structures of different REP proteins based on the known 
structure of oc-RabGDI (see panel A of figure III.8), the REP specific insertion is always 
placed between the equivalents of domains I and II of RabGDI, either as secondary structure 
elements or as what seems to be an independent folding unit in mammalian REPs. The fact 
that no significant homologies are detected between the mammalian REP insert and other 
sequences in the databases may mean that it represents a novel fold. 
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Figure ///.6 - Alignment of model sequences emited from pHMM statistical models 
calculated for the REP and RabGDI family. Positions that are common to both families are 
highlighted in grey. Positions that are family specific are highlighted in red (RabGDI family) 
and green (REP family). Uppercase positions are emitted at p>0.5. 
I l l - 15 
Part III - REP Proteins 
REP a .t. 
REPo. s. 
REP1 m.ra. 
REPlr-n. 
REPlJh.s. 
REP2_h. s . 
REP2_m.m. 
REP_d.m. 
REP_c. a. 
REP_s.c. 
REP_s.p. 
- S- -DSWENDTS ETKPILLWRALYVQELVKVE- 4 72 
-DHLEKNSEENKE SVKPTLLWSCVYVQEIIQGT- 4 75 
-VEKPRILWALYFNMRDSSDI- 572 
-VEKPRLLWALYFNMRDSSDI- 557 
31- 560 
31- 562 
--LRKPRLLWALYFNMRDSSGV- 561 
---SDAQIIFSSYFTIAAQSSK- 425 
N^^^MNN^mNNDFVMNAQGTTTPVL^WSFKLGSSLINFVPKDKLEIVCKLGYVEKTFINP- 488 
NDEEIVQLTGNGHT- - IVNSVKLGQSFKEYVPR(fcQFI.FKLYYTQY*HPPF 4 9 7 
CDDLEIIVQVDETLNQLR --- 422 
- N - - - EQ 
- N - - - EQ 
- 1 1 - . . EQ 
- E - - - EE 
- K - - - DE 
Q-
REP a.t. 
REP_o. s. 
REPl_m.m. 
REPlr.n. 
REPlJi.s. 
REP2_h.B. 
REP2_m.m. 
REP d.m. 
REP_c. a. 
REP_s.c. 
REPs.p. 
NGE FG-GTISSMPSPDGNLNYNEIVESAVKLYEKLMG-SEEL 512 
SG TALSCPIPDENMDYRSILESTKMLFTDICP-NEEF 511 
SRDCYNDLP-SNVYVCSGPDCNLGNDNAVQQAEIVFQKICP-NEDF 616 
SRDCYNDLP-SNVYVCSGPDSGLGNDNAVKQAETLFQQICP-NEDF 601 
SRSCYNDLP- SNVYVCSQPDCQLailDNAVXQAETLFQBICP-NKDF 6 04 
SRSSYNGLP-SNVYVCSaPDCQLaNIHAVKQABTLFQBIPP-TBKF 606 
SRSSYCGLP-SNVYICSGPDWGLGSEHAVKQAETLFQEIFP-SEEF 605 
SP AA-EHIYYTDPPTYELDYDAAIANARDIFGKMFP-DADF 464 
DLSNIFKPTKTNNIVYKDVEDAN-NEIIFTNMPSSELSYDGIITDVKSIYQRITGTTDDF 547 
GVWSSFFDVNQDLEKKYIPGASDNaVIÏTlMPSABISTOBWTAAKVLYKKIVOSDDDF 557 
HIDYDDTLHSAKSLFYEILGQNNTF 447 
REPa.t. 
REP_o. s . 
REPlra.m. 
REPl_r.n. 
REPl_h. s. 
REP2_h. s . 
REP2_m.m. 
REP_d.m. 
REP_c. a. 
REP_s.c. 
REP_s.p. 
-TEEEND GGVEIED 536 
530 
FKEETSPAENT  
LPRNSAPKYAS --DNDSDS-- --AE-
CPAPPNPEDII LDGDSS QQEVSESSVIPETNSETP 651 
CPAPPNPEDIV--- --- LDGDSS QQEVPESSVTPETNSETP 636 
CPPPPNPElfc LDQDSL QPEASBS' A PEANSETF 
CPPPPNPE^ ---- --- FDGDDK 2PEAp(praWMAKLESS 641 
CPPPPNPEDII FEAEG- 621 
-PSALNEHTLPEDLRAQL 4 97 
507 
LPRAPDPEEIV VDGED  
FDVDFEDEEDEYDRNNQPWQPKRSSWGGIVGGGSITSLTALREQHNENNHSDNAIDSD 
FDLDFEDEXS ~flHËHB~ IQASQ VANABQt ENAIDDD 586 
LQREGLFDED-- --DE 4 59 
REP_a.t. 
REP_o. s . 
REPl_m.m. 
REPlr.n. 
REPl_h. s . 
REP2_h. s . 
REP2_m.ra. 
REP_d.m. 
REP_c. a. 
REP_s.c. 
REP_s.p. 
KESTVLGDSEEPSE--
KESTVLGNPEEPSE--
KESTNLGNLEESSE--
EESKNLESPEKHLQN-
665 
650 
6 53 
656 
HDMQQATQEMDIQE 511 
EDEDEDINDMNDNEEEDDHGRGPEPFGADEMEL 640 
DDVN MEGS GE FVGEMEI 603 
Figure 111.7 - Alignment of the C-terminal portion of the REP family. Proposed RCR are 
highlighted in colour, for the sequences they were defined for, in bold. With eleven 
sequences no significant conservation is detected in this regions 
The REP-specific insert region, representing a unique REP element, is a natural 
candidate for RGGT binding. We looked into the sequences of RGGTs in different organisms 
to identify any feature that could be correlated with the variation in size of the REP insert 
region. 
We observed before that mammalian RabGGTase alpha sub-unit (aRGGT) exhibit 
two insertions relative to the yeast counterparts, corresponding to two structural domains: an 
IgG like domain, and a LRR domain (Zhang et al., 2000). As MRS6 shows the smaller REP 
insertion, we wondered if the size o the REP-specific insertion did correlate with the 
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appearance of the RGGT extra domains. Sequence comparison of RGGT a subunits 
revealed that the increase in size of the REP insertion observed in plants and mammals 
relatively to fungi REPs, parallels the appearance of insertions in alignment of the 
sequences of different RGGTa, which correspond to the structural motifs found in 
mammalian RGGTa (data not shown). 
Modelling of the structures of RGGTa in selected species places these insertions as 
variations of the LRR and IgG-like domains (figure 111.8, panels B). It is tempting to 
speculate either an interaction between the two insertion domains or a regulatory 
mechanism that requires the presence of the extra domains/ secondary structure motifs in 
both proteins. One way to test this hypothesis would be through cross-species 
complementation experiments with different REPs and RGGTa. 
Ill.4. Conclusion 
We analysed patterns of sequence conservation in the REP family of essential 
activators of the prenylation of Rab proteins, for a data set of eleven proteins all eukaryotic 
kingdoms: fungi, plants and animals. Previous analysis of this family of proteins had relied in 
a small data sets (n=3), comprising only human and S. cerevisiae proteins. The REP family 
is less conserved than the RabGDI family, and a separation into three sub-families, 
corresponding to the three major clades is suggested by our phenetic analysis, but no 
functional data is available that can support this claim. Structural diversity in the REP family 
is further illustrated by the variable size of the REP specific insertion between SCR1B and 
SCR2. 
We observed what appears to be a correlation between the size increase of the REP-
specific insert and the appearance of extra domains in RGGT, which we speculate may 
signify a physical interaction between insert domains of REP and RGGT. Interestingly, the 
size of this REP-specific insert does not correlate with the tree of life. 
We found that even with an increased data set, the sequence conserved regions 
(SCRs) previously defined for the REP/RabGDI super-family still are the major conserved 
regions between the two proteins, particularly the regions SCR1A, SCR1B and SCR3B that 
define the RabGDI/Choroideremia consensus domain (GCD). These regions when mapped 
to the crystal structure of RabGDI or of modelled structures of REP-1 (see figure III.4) form a 
conserved surface on the apex of domain I. Mutational analysis both in RabGDIs and MRS6 
indicates these regions may be involved in Rab binding. The fact that the GCD defines the 
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Rab binding surface is suggestive of a very conserved mechanism of Rab recognition 
between members of the two families, and across species 
(A) (B) 
Figure III.8 - (A) modelled structures of the modelled structures ofREPs from A. thaliana, H. 
sapiens, D. melanogaster and S. cerevisiae. The insert domain in REP-1 is highlighted in red 
(B) modelled structures of ccRGGT of the same species except for the human protein where 
it represent a crystal structure (accession number 1QBQ). The LRR and IgG-like domain are 
highlighted in green and blue respectively 
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When we looked for specific structural determinants of REP function, by looking for 
REP specific sequences, we didn't observe any REP specific motifs, and actually refute the 
previous definition of their existence by others, but instead observe that specific REP 
positions cluster inside the SCRs, in between super-family conserved positions. In the 
absence of mutational analysis studies we can only speculate that these REP-specific 
positions underlie REP-specific functions, and that these functions may have arisen by 
divergence from a common ancestor that already had these defined functional domains. 
Further structural and biochemical studies of REP proteins are still required to 
understand the structural basis of REP function. 
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IV. 1. Analysis and preparation of stable complexes 
between Rab GTPases, Rab Escort Protein and Rab 
Geranylgeranyl Transferase 
Reproduced from: José B. Pereira-Leal, Anita R. Gomes and Miguel C. Seabra (2001) Methods 
in Molecular biology, in press 
IV.1.1. Introduction 
Rab proteins are small Ras-like GTPases that regulate vesicular trafficking 
events in the cell. More than 50 Rabs have been described in mammalian cells 
(Pereira-Leal and Seabra, 2000) each with a specific sub-cellular localisation, 
reflecting the functional specificity of Rabs to specific trafficking steps (Lazar et al., 
1997; Novick and Zerial, 1997; Schimmoller et al., 1998; Chavrier and Goud, 1999). 
Rabs contain two cysteine residues at or near the carboxyl terminus, arranged in a 
variety of motifs. Both cysteine residues are modified by the attachment of 
geranylgeranyl groups via thioether bonds, in a reaction catalysed by Rab 
Geranylgeranyl Transferase (also known as GGTase type II, RGGT) (Seabra, 2001). 
This enzyme is a tightly bound heterodimer, composed by 60 kDa oc-subunit and a 38 
kDa p-subunit, both related to the a- and p-subunits of the other known protein 
prenyltransferases, Famesyl Transferase (FTase) and Caax Geranylgeranyl 
Transferase (also known as GGTase type I). 
RGGT is unique among prenyl transferases. It cannot catalyse prenylation of 
Rabs on its own, but requires the presence of an additional component designated 
Rab Escort Protein (REP). REP binds unprenylated Rabs and the complex REP:Rab 
is the true substrate for the enzyme. Unlike what happens with other prenyl 
transferases, substrate recognition is not mediated by the prenylation motif of the 
substrate. RGGT binds the REP:Rab complex and then catalyses the covalent 
addition of two geranylgeranyl groups to the carboxyl terminal cysteines of the Rab, 
in a sequential process that is unique for RGGT. After prenylation diGG-Rab remains 
associated with REP (Andres et al., 1993), presumably because the addition of two 
GG groups renders the protein too hydrophobic to exist in aqueous solution. DiGG-
Rab can then be directly delivered to their target membranes by REP (Alexandrov et 
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al., 1994). REP has the dual function of acting as an essential activator of the 
prenylation reaction and escorting newly prenylated Rabs to the membranes. 
This chapter describes in vitro methods to form and purify prenylated and 
unprenylated complexes of Rab and REP, and to form and purify complexes of 
prenylated Rab, REP and RGGT. The methods presented in this chapter were 
optimised for REP1 and Rabia, but they should be easily adaptable to other Rabs 
and REPs. These complexes are used in our lab to study the structural and 
biochemical factors that determine the assembly of both REP:Rab and the catalytic 
complexes, and to analyse membrane delivery of Rab proteins. 
IV.1.2. Materials 
IV.1.2.1. Geranylgeranvl Pyrophosphate 
Tritium-labelled and unlabelled geranylgeranyl pyrophosphate are comercially 
available from several sources and are always stored at -20°C. We typically use: 
-unlabelled all-frans-GGPP (Sigma, G-6025). 
-[1-3H] all-frans-GGPP, 15-30 Ci/mmol (DuPont-New England Nuclear, NET-
1052). 
IV.1.2.2. Analytical scale preparation and purification of REP:Rab complexes 
Stock solutions: 1 M sodium HEPES pH 7.2, 1 M MgCI2, 1 M DTT, 
recombinant 6xHisREP1 and recombinant 6xHisRab1 a. 
SMART System Gel Filtration buffer (GF buffer): 50 mM sodium HEPES pH 
7.2, 1 mM DTT. 
SMART System chromatography system (Amersham Pharmacia) and gel 
filtration column Superdex 200 3.2/30 (Amersham Pharmacia). 
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IV.1.2.3. Analytical scale preparation and purification of REP:Rab-GG complex 
Stock solutions: 1 M sodium HEPES pH 7.2, 1 M MgCI2, 1 M DTT, 175 mM 
(10%) NP-40 protein grade (Calbiochem, 492017), 1 M TrisCI pH 8, 4 M NaCI, 
recombinant 6xHisREP1, recombinant 6xHisRab1a, recombinant RGGT. 
SMART System monoQ buffer A: 50 mM TrisCI pH 8.0, 1 mM DTT. 
SMART System monoQ buffer B: 50 mM TrisCI pH 8.0, 1 mM DTT, 1 M NaCI. 
SMART System chromatographic system (Amersham Pharmacia) and ion 
exchange column monoQ PC 1.6/5 (Amersham Pharmacia). 
IV.1.2.4. Analytical scale preparation and purification of REP:RabGG:RGGT 
complex 
1. Stock solutions: 1 M sodium HEPES pH 7.2, 1 M MgCI2, 1 M DTT, 175mM (10%) 
NP-40 protein grade (Calbiochem, 492017), 1 M TrisCI pH 8, 4 M NaCI, 
recombinant 6xHisREP1, recombinant 6xHisRab1aCS (mutant Rabia with the C-
terminal cysteine residue mutated to a serine), recombinant RGGT. 
2. SMART System monoQ buffer A: 50 mM TrisCI pH 8.0, 1 mM DTT. 
3. SMART System monoQ buffer B: 50 mM TrisCI pH 8.0, 1 mM DTT, 1 M NaCI. 
4. SMART System chromatography system (Amersham Pharmacia) and ion 
exchange column monoQ PC 1.6/5 (Amersham Pharmacia) 
3 
IV.1.2.5. Analytical scale preparation and purification of REP:Rab>r H1GG 
complex 
1. Stock solutions: 1 M sodium HEPES pH 7.2, 1 M MgCI2, 1 M DTT, 175 mM 
(10%) NP-40 protein grade (Calbiochem, 492017), recombinant 6xHisREP1, 
recombinant 6xhisRab1a, recombinant RGGT. 
2. G75 Sephadex Gel Filtration buffer (G75): 50 mM sodium HEPES pH 7.2, 50 mM 
MgCI2, 1 mM DTT, 0.05 mM NP40, 100 mM NaCI. 
3. Disposable 2 ml Bio-Rad columns, 1 ml G75 Sephadex matrix (Amersham 
Pharmacia, 17-0051-01). 
4. India His-Probe-HRP (Pierce, 15165ZZ). 
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5. 1.2 urn glass fibre filters (Whatman, 1822025). 
IV.1.2.6. Large scale preparation and purification of REP:RabGG:RGGT 
complex 
1. Stock solutions: 1 M sodium HEPES pH 7.2, 1 M MgCI2, 1 M DTT, 175 mM 
(10%) NP-40 protein grade (Calbiochem, 492017), 1 M TrisCI pH 8, 4 M NaCI, 
recombinant 6xHisREP1, recombinant 6xHisRab1aCS, recombinant RGGT. 
2. FPLC monoQ buffer A: 50 mM TrisCI pH 8.5, 1 mM DTT. 
3. FPLC monoQ buffer B: 50 mM TrisCI pH 8.5, 1 mM DTT, 1 M NaCI. 
4. FPLC chromatography system (Amersham Pharmacia) and ion exchange column 
monoQ HR 5/5 (Amersham Pharmacia) 
IV.1.3. Methods 
IV. 1.3.1. Expression and purification of recombinant proteins 
We have previously described in detail the protocols used in our lab to 
express and purify recombinant Rabs, REPs and RGGT (Armstrong et al., 1995; 
Seabra and James, 1998). Rabia is expressed as an N-terminal six histidine-tagged 
fusion protein in E. Coli and purified by affinity chromatography using a N i 2 + -
sepharose resin. RGGT is expressed in Sf9 insect cells after co-infection with 
baculovirus coding for both subunits, purified by cation exchange chromatography 
followed by gel filtration chromatography (see Note 1). REP is also expressed in Sf9 
insect cells, produced as a C-terminal six histidine-tagged fusion protein and purified 
by N r affinity chromatography. 
IV.1.3.2. Analytical scale preparation and purification of REP:Rab complexes 
REP and Rab form stable complexes held together mainly by electrostactic 
interactions (Anant et al., 1998; Alexandrov et al., 1998). An important consideration 
is therefore the concentration of salt used in the preparation of the complex and the 
methodology to be used to purify the complex away from the free recombinant 
proteins. We developed a method based on gel filtration chromatography. REP 
migrates upon gel filtration with an apparent molecular weight of 150 kDa, both in the 
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free and complexée! forms. As such, it is advisable to always use limiting REP 
concentrations to avoid contamination of the complex with free REP. The yield from 
this method is not great. This is a simple way to address the binding of the two 
molecules in a semi-quantitative way but it is unlikely to be useful for preparative 
purposes. 
1. Mix, in a final volume of 50 pi, 50 mM sodium HEPES pH 7.2, 5 mM MgCI2, 1 mM 
DTT, 4 pM Rabia, 2 uM REP-1. 
2. Incubate for 15 min at 37 °C. 
3. Load the reaction mixture onto a Superdex 200 3.2/30 column (Amersham 
Pharmacia) pre-equilibrated with GF buffer and run at a flow rate of 50 pl/min. 
Fractions of 100 pi are collected between 0.75 and 1.95 ml. Elution of proteins 
from the column is monitored by absorbance at 280 nm. The complex elutes at 
around 1.6 ml corresponding to a predicted Mw of 150 Kda. 
4. Run an aliquot of each fraction on SDS-gel electrophoresis and visualise proteins 
by silver (or Coomassie) staining. In the presence of REP1, Rabia co-elutes with 
REP, indicating the formation of the complex. 
IV.1.3.3. Analytical scale preparation and purification of REP:RabGG complex 
After prenylation, the resulting REP:RabGG complex is more stable than the non-
prenylated complex (Shen and Seabra, 1996; Anant et al., 1998). The REP:RabGG 
interaction involves both ionic as in the REP:Rab complex and hydrophobic 
interactions probably due to interactions between the prenyl groups and hydrophobic 
amino acids in REP. 
The first step in the formation of the REP:RabGG complex is in vitro prenylation. 
Rab geranylgeranylation occurs upon incubation of REP and Rab with 
geranylgeranyl pyrophosphate (GGPP) and RGGT. Detailed protocols for in vitro 
geranylgeranylation of Rabs were published in a previous book in this series (Seabra 
and James, 1998) (see Note 2). After the reaction, the mixture is separated by ion 
exchange chromatography and Rabia co-elutes with REP1 indicating the formation 
of the prenylated complex. This separation procedure has the advantage of not only 
separating the REP:RabGG complex from the uncomplexed proteins, but also to 
separate the complex from any non-prenylated REP:Rab complex as the presence of 
salt in the elution buffer promotes the dissociation of the latter complex. REP elution 
does not change significantly between free and complexed forms so the use of 
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limiting concentrations of REP in the reaction mixture as suggested above is 
recommended. Also, one should use optimal conditions for the in vitro prenylation 
reaction to maximise the amount of RabGG obtained. The majority of the reaction 
product is REP:RabGG complex but some ternary complex REP:RabGG:RGGT is 
produced. However, the ternary complex elutes differentially and is therefore easily 
separated away (Fig. 1). 
1. Mix the following components on ice, in a final volume of 50 pi: 50 mM sodium 
HEPES pH 7.2, 5 mM MgCI2, 1 mM DTT, 0.05 mM NP-40, 20 pM Rabia, 5 pM 
REP1, 5 pM RGGT, 50 pM GGPP. 
2. Incubate at 30°C for 1 hour. 
3. Load the reaction mixture on a 0.1 ml monoQ column pre-equilibrated in monoQ 
(SMART system) buffer A. 
4. Wash the column with 0.3 ml of monoQ (SMART system) buffer A, follow with a 4 
ml linear gradient from 0%-35% monoQ (SMART system) buffer B and then a 0.7 
ml linear gradient from 35%-100%, all at a flow rate of 0.3 ml/min collecting 0.2 
ml fractions. 
5. Run an aliquot of each fraction on a 12% SDS-PAGE gel and visualise proteins 
by silver (or Coomassie) staining. Free Rab elutes in the flow through and a small 
fraction binds weakly to the column and is eluted at very low salt concentrations 
(fractions 7 and 8). The dimeric complex REP:RabGG elutes between fractions 
17 and 20 with RGGT eluting in fractions 21 and 22 (Fig IV.1.1). 
IV.1.3.4. Analytical scale preparation and purification of REP:RabGG:RGGT 
complex 
As discussed above, the ternary REP:RabGG:RGGT complex is not stable and is 
therefore difficult to purify. We have shown previously that a mutant Rabia, 
RablaCS (C-terminal cysteine residue mutated to a serine residue) that can only 
undergo single geranylgeranylation forms a much tighter complex with REP than 
wild-type doubly geranylgeranylated Rabia, RablaCC (Shen & Seabra, 1996). By 
using this mutant as the substrate of the prenylation reaction, we favour the 
formation of the heterotrimeric complex. Apparently, RGGT has higher affinity for the 
REP:Rab-monoGG complex than to the REP:Rab non-modified complex and the 
equilibrium is shifted to the formation of ternary complex (unpublished observations). 
The procedure is identical to the one described above. When RablaCS is used, we 
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observed that REP and Rab co-elute with RGGT in fractions 21 and 22, with some 
dimeric complex eluting, as before, between fractions 17 and 20. 
lv.1.3.5. Analytical scale Preparation and Purification of REP:Rabr H1GG 
complexes 
REP:Rab[3H]GG complexes can be formed by modifying Rab in vitro in the 
presence of radiolabeled tritiated GGPP. Radiolabelling allows to monitor the 
formation of the reaction product and to follow the prenylated Rab in subsequent 
studies. The prenylated REP:Rab[3H]GG is purified by manual gel filtration as it is 
undesirable to contaminate the chromatography systems with radioactivity. 
In order to ensure that all prenylated Rabs are bound to REP, the same 
principles apply. We perform in vitro reactions by incubating excess Rab with RGGT 
and GGPP under limiting REP conditions. The free Rab that is not prenylated can 
then be easily separated from the REP:Rab[3H]GG complex by gel filtration. It would 
also be possible to use limiting amounts of Rab and excess REP to insure that all 
Rabs would be prenylated and bound to REP. There are two main reasons why this 
is not a good idea. First, it has been shown that excess REP inhibits the 
geranylgeranylation reaction, probably as a result of the formation of non-productive 
REP:RGGT complexes (Anant et al., 1998). Secondly, the separation of free REP 
from the prenylated Rab:REP complex would be impossible by gel filtration as both 
free REP and REP:RabGG complex elute with the same apparent molecular weight 
on gel filtration chromatography. 
1. Mix, on ice, in a final volume of 50 \i\ the following reagents: 50 mM sodium 
HEPES pH 7.2, 5 mM MgCI2, 1mM DTT, 0.05 mM NP-40, 10 uM Rab, 2.5 uM 
REP1, 0.7 uM Rab GGTase, 20 ^M GGPP (0.2 uM [3H]GGPP mixed with 19.8 
UM unlabeled GGPP). 
2. Incubate at 37°C for 45 minutes. 
3. At 4°C, load the reaction mixture in a G75 Sephadex column (1ml) previously 
equilibrated in G75 buffer. Run the column by adding 20 x 50 u.l of G75 buffer and 
collecting the respective 20 x 50 JJ.1 fractions (see Note 3). 
4. Quantify each fraction as described previously (Seabra & James, 1998). Briefly, 
precipitate the proteins in a mixture of EtOH/HCI (10:1), filter the precipitable 
radioactivity on 1.2 urn glass fiber filters, add 5 ml of scintillation fluid and count in 
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the scintillation counter. 
5. Run aliquots from each fraction on 12% SDS-gel electrophoresis. Visualise the 
proteins by silver staining on one gel. Use a replicate gel for western blotting with 
the India-His probe. This probe will allow visualisation of histidine-tagged Rab 
and REP proteins. If necessary, use a third gel for autoradiography to visualise 
Rab[3H]GG (see Note 4). 
6. REP:Rab[3H]GG complex elutes in fractions 8-10 away from the free Rab that 
elutes in fractions 12-15, but co-eluting with RGGT. These fractions are pooled 
and used in subsequent in vitro studies (see Notes 5 and 6). 
Figure IV.1.1 - Separation of the REP:RabGG and REP:RabGG:RabGGTase 
complexes by ion exchange chromatography. Silver stained SDS-PAGE (4-15%) 
IV.1.3.6. Large scale preparation and purification of REP:RabGG:RGGT 
complexes 
This method is essentially a scale-up of procedures 3.3 and 3.4. As discussed 
above, both ternary and dimeric complex are produced. The choice of wild-type 
Rabia versus RablaCS will determine the enrichment in either the ternary or binary 
complex. If wild type Rab is used (RabCC), then the formation of the dimeric complex 
is favoured. If on the other hand, a mutant Rabia with only one prenylatable cysteine 
(RablaCS) is used, then the heterotrimeric complex is favoured. We describe here 
the conditions to form the ternary complex REP:RabGG:RGGT. 
1. Mix, on ice, in a final volume of 500 ul the following reagents: 50 mM sodium 
HEPES pH 7.2, 5 mM MgCI2, 1 mM DTT, 0.05 mM NP-40, 20 uM Rab, 5 uM 
REP1, 5 [iM RGGT, 50 uM GGPP. 
2. Incubate at 30°C for 1 hour 
3. Load reaction mixture in a monoQ column previously equilibrated in monoQ 
(FPLC) buffer A 
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4. Wash the column with 3 ml of monoQ (FPLC) buffer A, then run a 20 ml linear 
gradient from 0%-30% of monoQ (FPLC) buffer B at a flow rate of 1 ml/min, 
collecting fractions of 1.5 ml until 30 ml. 
5. Run an aliquot of each fraction on a 12% SDS-PAGE gel, and visualise by silver 
(or Coomassie) staining. Ternary complex typically elutes around 24 ml under 
these conditions and no further purification is usually needed (the complex is 
stable enough to allow a further purification/concentration step if required for 
specific applications) (see Note 7). 
IV.1.4. Notes 
1. Others have successfully expressed geranylgeranyl transferase in bacteria (K 
Alexandrov, personal communication). It is potentially a simpler way of 
expressing RGGT but a direct comparison of the properties of both recombinant 
enzymes is not available yet. 
2. It is advisable, when working with Rab proteins, to use the utmost care in always 
maintaining the proteins on ice and avoiding freeze-thawing cycles. Rab proteins 
will undergo partial proteolysis in the carboxyl terminus and generate a truncated 
protein without the prenylatable cysteines. These truncated proteins will 
effectively act as a competitor to the binding of REP in the prenylation reaction. 
3. The equilibration of the column and subsequent purification steps should be 
performed at 4°C to avoid aggregation of the complex. 
4. Blotting with India His-Probe allows a direct comparison between REP and Rab 
to determine whether fractions have equimolar amounts of both proteins. 
5. The reaction can be scaled up to the amount of product desired, but the 
separation should always be performed as mentioned (50 pi of reaction mixture 
per 1 ml-G75 column). 
6. The complexes should be stored at 4°C with 1mg/ml of BSA as a carrier protein. 
They are stable for 5 days under these conditions. 
7. The heterotrimeric complex can be kept froozen at -80 °C, although repeated 
freezing and thawing is not advisable. 
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IV.2 - Requirement for GTP hydrolysis prior to 
REP:Rab complex formation 
IV. 2.1 - Introduction 
Rab proteins require lipid modification for membrane association and function 
(Seabra, 2000; Seabra, 1998). This lipid modification (prenylation) is accomplished 
by the enzyme Rab GeranylGeranyl Transferase (RGGT) which requires an 
accessory component for proper activity, Rab Escort Protein (REP) (Seabra et al., 
1992; Armstrong et al., 1993; Andres et al., 1993) (see part 1.1.5 and I.2). 
REPs are essential activators of the prenylation reaction, binding non-
prenylated Rab proteins and presenting them to RGGT for prenylation. After lipdi 
transfer, Rab is still in complex with REP which delivers it to cellular membranes 
(Alexandrov et al., 1994; Wilson et al., 1996). 
The first step in Rab prenylation is the formation of the Rab:REP complex 
(Anant et al., 1998; Shen and Seabra, 1996). REPs are sensitive to the nucleotide 
status of the Rab proteins and can only bind in the GDP bound form, being unable to 
bind Rabs in the GTP bound form (Seabra, 1996). Since the GTP and GDP 
association and dissociation constants are in the same order of magnitude (Zerial 
and Huber, 1995), and it has been estimated that there is a 10 fold excess of free 
GTP over free GDP in the cytosol (Bourne et al., 1991), this would imply that Rab 
proteins bind GTP during or after synthesis, and fold into a conformation in which 
they cannot bind REP. With a hydrolysis rate in the order of 10"2 to 10"3 min"1, it is 
expected that it would be possible to find at any given moment a pool of unprenylated 
Rab proteins in the cell, slowly hydrolysing GTP to GDP before binding REP and 
being prenylated. To our knowledge no such pool has been identified in the majority 
of cell types tested. 
Seabra proposed the existence of a Rab GTPase Activating Protein 
(RabGAP) that would act on non-prenylated, newly synthesised Rab proteins and 
accelerate the transition between the non-prenylated, GTP bound form and the GDP 
bound form in complex with REP (Seabra, 1996). This RabGAP would necessarily be 
able to act on non-prenylated Rab proteins. At the time this work was started, the 
only mammalian RabGAP identified was specific for the lipid modified form of 
members of the Rab3 sub-family (Fukui et al., 1997). However, a precedent for 
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RabGAPs acting on non-prenylated Rab proteins had been established in yeast 
(Strom et al., 1993), and also in mammalian systems (Tan et al., 1991). 
Here attempt to identify a RabGAP that acts on non-prenylated Rab proteins, 
as its existence would support its requirement for Rab prenylation. 
IV.2.2 - Materials and Methods 
To prepare complexes or Rabia with labelled GTP, 60 u.M of recombinant 
protein were incubated for 30 minutes at 37° C in Exchange Buffer, consisting of 25 
mM Tris:CI pH= 7.5, 50 mM NaCI, 10 mM EDTA, 250 mM (NH4)S04 and 600 u.M 
[32P-y-GTP] (sa=220 dpm/pmol). After this the reaction mixture was twice diluted in 
2ml ice cold Stop Buffer and concentrated in a Centricon 10 to Rab1a:[32P-y-GTP]= 
50 u.M. The Stop Buffer consisted of 50 mM Tris:CI pH= 7.5, 50 mM NaCI, 10 mM 
MgCI2, 1 mM DTT. 
To measure GTPase activity, the sample to be assayed was incubated 
Rab1a:[32P-y-GTP] in GAP buffer for 5 minutes at 37° C, the reaction was then 
stopped by addition of ice cold 5% activate charcoal in 80 mM "phosphoric acid", 
which serves the purpose of denaturing the proteins in the reaction mixture and 
precipitating guanine nucleotides, and agitated for 5 minutes at room temperature. 
The reaction was then centrifuged to pellet the charcoal and the amount of free 
labelled phosphate in the supernatant determined by scintillation counting. The 
composition of the GAP buffer was 20 mM HEPES pH 7.2, 5 mM MgCI2, 1 mM DTT, 
0.5 mg/ml BSA, 1 mM ATP, 20 |iM Rab1a:[32P-y-GTP]. 
Frozen samples from porcine liver were thawed in ice cold lyses buffer and 
then homogenized, on ice, using a Polytron PT 1200 (Kinematica). The lysis buffer 
composition was 20 mM TrisCI pH 8.0, 2 mM MgCI2, 1 mM DTT, 1 mM EDTA, 20 mM 
NaCI, 1 mM PMSF, and 0.5 mg/ml of aprotinin, leupeptin and pepstatin. The 
homogenate was spun at 500xg and the supernatant (SO.5) then centrifuged at 
100,000xg to prepare a soluble fraction (S100) that was used for subsequent 
purification steps. All chromatographic purifications were performed using a FPLC 
machine from Pharmacia. Ion Exchange chromatography used a 10 ml colum of 
cationic exchanger matrix Q Sepharose HP and a buffer system of 25 mM TrisCI pH 
8.5, 1 mM DTT, in a gradient of 0 to 1 M NaCI. Hydroxylapatite Chromatography was 
performed at pH 7.0 with a gradient of 20 to 400 mM K2H:KH2 buffer. 
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Recombinant protein purification and in vitro prenylation assays were 
performed as described before (Seabra and James, 1998). 
The cDNA coding for canine Rabia was used as the template for site directed 
mutagenesis. Point mutations were generated by Polymerase Chain Reaction, and 
sub-cloned into the vector pEGFP-3C (CLONTECH Laboratories Inc). The resulting 
plasmids encode fusion proteins that contain each Rab mutant attached to the 
COOH terminus of enhanced green fluorescent protein (EGFP) 
HeLa cells were grown in DME supplemented with 10% Fetal Calf serum at 
37°C with 5% C02 . Cells for transfection were grown on cover slips for 24h, 
transfection using the liposomal transfecting reagent Fugene 6 (Roche) and then 
fixed 48 hours later. For immunofluorescence, coverslip grown cells were washed in 
PBS and then fixed in 3% paraformaldehyde in PBS for 15 min. Excess fixative was 
removed by extensive washing in PBS and quenched by incubation with 50 mM 
NH4CI for 10 min. Fixed cells were then observed using a Leica DM-IRBE confocal 
microscope and the images processed using Leica TCS-NT software associated with 
the microscope. All images are single sections on the z-plane. 
IV.2.3 - Results 
IV.2.3.1 - Partial Purification of a RabGAP activity that acts on non-prenylated 
Rabia 
At the time this work was initiated, only one mammalian RabGAP had been 
cloned, Rab3-GAP. We chose Rabia as the purification substrate as a RabGAP 
activity acting on non-prenylated Yptlp (the Rabia yeast ortholog) had been 
described before (Tan et al., 1991). 
To prepare Rab1a:[32P-y-GTP] we had to optimise the conditions of complex 
formation since in our initial experiments we observed that only a small fraction of 
Rab1 was being complexed with [32P-y-GTP] and there was contamination of the 
complexes with protein-free GTP and [32P-y-GTP]. Although excess GTP (and GDP) 
appeared not to have any effect in our GAP assays (data not shown), protein-free 
[32P-y-GTP] created a high background in our experiments. We tested a variety of 
conditions and managed to obtain routinely an efficiency of loading of more than 
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70%, recovering about 80% of the initial protein, and reducing the contamination of 
protein-free [32P-y-GTP] and GTP to undetectable levels (data not shown). 
We started our purification using porcine brain as the protein source, and 
detected a RabGAP activity that acted on non-prenylated Rabia (data not shown). 
Due to supply problems we had to switch to another tissue, porcine liver, which was 
easier to obtain. A RabGAP activity was detected in porcine liver extracts that was 
partially precipitated by centrifugation at 100,000xg (figure IV.2.1). 
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Figure IV.2.1 - Porcine Liver contains a RabGAP activity that acts on non prenylated 
Rabia. Intrinsic stands for hydrolysis in the absence of a RabGAP activity, Lys for 
lysate, SO. 5 for supernatant of a 500xg centrifugation of Lys, S100 for supernatant of 
a 100,000xg centrifugation of SO.5 and P100 the resuspended pellet of the same 
centrifugation. 
We sought to solubilise the activity precipitated at 100,000xg using a variety 
of detergents in the resuspension buffer and different salt concentrations. Salt 
extraction was not successful at concentrations up to 1.25M NaCI. Of the detergents 
tested (Cholic acid,Tween20, NP40, CHAPS and Octyl-b-D-Glucopyranoside) all but 
NP-40 inhibited the GTPase activity assay (data not shown), and NP-40 was not 
effective in extracting the precipitated activity nor in decreasing the precipitation of 
this activity after centrifugation at 100,000xg (data not shown). Faced with this result 
we decided to concentrate solely on the soluble activity and test different 
chromatographic techniques in order further purify it. 
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Anionic exchange chromatography, using Q-sepharose resin, proved to be 
the most successful first column. Two peaks were purified from this column, peak 1 
that did not bind the column and eluted in the first fractions, while peak 2 eluted at 
roughly 150 mM NaCI. We labelled the two peaks, respectively QA and QB. Both 
activity peaks represented a purification of 0.6 and 2.2 times respectively. 
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Figure IV.2.2 - Anionic exchange chromatography of porcine liver soluble fraction 
separates two distinct activity peaks. Absorbance at 280 nm is represented as a blue 
line, conductivity as a doted black line and the activity as a red line. 
We next subjected both QA and QB activity peaks to hydroxylapatite column 
chromatography. QA fractionated in two further activity peaks, labelled H1 and H2 
(figure IV.2.3 and table IV.2.1). Peak H2 corresponded to a -34 fold purification of 
QB, but H1 was probably an artefact, as it contained little or no protein and was not 
reproducible. Peak QB also fractionated in two further peaks, labelled H3 and H4, 
corresponding to 10 and 3.4 fold purification, respectively (figure IV.2.4 and table 
IV.2.1). 
It proved very difficult to further purify any of the hydroxylapatite column 
activity peaks, since they were extremely labile and would loose detectable activity 
after more than one round of freeze-thawing or a few hours at 4°C (data not shown). 
Additionally all the separation procedures tested resulted in either loss of activity (in 
a way that could not be reconstituted by mixing fractions) or just dilution of the 
starting activity rather than enrichment (data not shown). We tested several types of 
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purification procedures in the S100, both the QA and QB and in all the H peaks: 
ammonium sulphate fractionation, affinity chromatography with Rab1 :GTP-yS, cationic 
exchange chromatography, heparin, and hydrophobic interaction chromatography 
with no success, no matter the starting material or order of he purification procedures 
(data not shown). 
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Figure IV.2.3 - Activity profile of the eluate of a hydroxylapatite column 
chromatography of Q-sepharose activity peak QA. Activity is represented in red, 
protein concentration in blue and the conductivity is shown as a doted line. 
We sought to characterise the partial purified enzyme activities in order to 
determine if better assay conditions would allow us to proceed further with their 
purification. We first determined the best concentration of RabGAP activity to use in 
the GTPase activity assays by titrating the enzyme in the reaction mixture. We 
observe an initial linear increase of activity with increasing enzyme concentration in 
the assay (figure IV.2.6). At volumes bigger than 12 u.l of partially purified enzyme we 
observe a slight decrease in activity. One explanation for this is the existence of 
some inhibitory reagent that, acting on the Rab protein, reaches a concentration that 
produces a detectable inhibition. The nature of this inhibitor is unclear to us. 
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Figure IV.2.4 - Activity profile of the eluate of a hydroxylapatite column 
chromatography of Q-sepharose activity peak QA. Activity is represented in red, 
protein concentration in blue and the conductivity is shown as a doted line. 
35 
30 -
1 25 
a? 
a: 20 
••ê" 15 
o 
* 10 
JL 
I 
Intrinsic 
S100 QA H3 H4 QB H1 H2 
Figure IV.2.5 - Partial purified RabGAP activities. The blue doted line represents 
intrinsinc hydrolysis (in the absence of added RabGAP activity). 
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Table IV.2.1 - Purification table of the partial purification of the different RablGAP 
activities 
Total vol Tot Total Specific Yield Fold 
(ml) protein activity Activity purification 
(mg) 
S100 10 130.4 21777 167 1 1 
QA 12 73.1 9503 105 0.43 0.6 
H3 6 6.0 10026 1671 0.46 10 
H4 6 5.8 3271 564 0.15 3.4 
S100 10 130.4 21777 167 1 1 
QB 9 21.4 7854 367 0.36 2.20 
H2 9 2.6 5675 5675 0.67 33.9 
vol QA (nl) 
Figure IV.2.6 - Enzyme titration of QA activity peak, showing initial linear response 
to enzyme concentration and revealing a possible inhibition at higher concentrations 
of extract. 
Having determined the best amount of partially purified RabGAP activity to 
use in the assays, we titrated the substrate so as to calculate the Henry-Michaelis-
Menten constant, an indirect measure of the affinity of the RabGAP to Rab1a:GTP. 
This information is useful to determine minimum concentration of substrate required 
to be present in the assay. The results of this experiment are presented in figure 
IV.2.7. Finally, we determined the intrinsic hydrolysis rate of Rabia in order to insure 
that our method produced constants in the same order of magnitude as published for 
Rabia (figure IV.2.8). 
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Figure IV.2.7 - Substrate saturation curve for QA activity peak. KM= 8 jiM +/- 3.4 at 
r2=0.97. 
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Figure IV.2.8 - Time curve of GTP hydrolysis in the presence and absence of 
RabGAP activity QA. Intrinsinc: t1/2=122.3 min, k=0.006 min1. QA activated: t1/2=21.8 
min, k=0.034 min'1. 
Also we determined the RabGAP activated hydrolysis rate in order to 
compare it with those published for other mammalian and yeast RabGAPs (figure 
IV.2.8). These experiments indicate that the conditions we had selected for the 
GTPase activity assay are satisfactory (20 \iM Rab1a:GTP and 10-15 JLLI of enzyme 
activity). Also, the intrinsic hydrolysis rate determined for Rabia of 0.006 min"1 is 
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within the order of magnitude of the same constant determined by others (0.009 min"1) 
(Touchot et al., 1989), which suggests our assay worked well. 
Thus our inability to further purify this RabGAP activity cannot be attributed to 
assaying it far from ideal conditions. It is possible that the fact that we were using 
frozen as opposed to fresh tissues resulted in loss of enzyme activity. It was 
impossible for us to obtain fresh organs since the abattoirs that supplied us were too 
distant and sample collection implied a full day of travelling and sample washing and 
freezing. In fact in some cases we obtained tissues which completely lacked 
RabGAP activity. Although other possibilities could be discussed here, the fact that 
such activity was observed by others (Tan et al., 1991) suggests this was the major 
problem in this purification. 
At this point we decided not to proceed with the purification attempts. Instead 
we concentrated on addressing the requirement for a RabGAP prior to prenylation 
in different way. 
IV.2.3.2 - RabGAP insensitive Rab1 mutants are prenvlated in vivo 
Becker and colleagues (Becker et al., 1991) identified two positions in Yptlp 
that when mutated render the protein either totally insensitive (141M) or partially 
insensitive (D44N) to a partially purified YptlGAP, while retaining normal GTP 
binding properties (figure IV.2.9). Mutation of the corresponding positions in Rab3a 
(V55E and D58V) also reduced or eliminated sensitivity to a partially purified 
Rab3GAP (Burstein et al., 1993). 
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Figure IV.2.9 - RabGAP-insensitive single point mutations mapped to canine Rabia 
sequence, highlighting the sequence motifs (RabF) and structural motifs 
(extrapolated from the crystal structure ofRab3a, PDB entry 3RABA). 
These mutants are not prenylated in vitro (Wilson and Maltese, 1993) but 
D44N was shown to be prenylated in vivo (Wilson et al., 1996). If both GAP 
insensitive mutations were shown to be prenylated in vivo, then this would imply that 
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they could bind normally to REP even in the absence of RabGAP catalysed GTP 
hydrolysis. 
Figure IV.2.10 - GFP-Rab1(D47N) and (I44M) do not accumulate unprenylated in 
the cytosol but associate with the Golgi in a way that is not distinguishable form the 
wild type protein. Left - Confocal section of HeLa cells transfected with pEGFP-
Rabla Right - phase-contrast. 
We chose to ask if the mutant proteins would associate with their target 
membranes, as this would indicate normal processing by RGGT. We made 
Enhanced Green Fluorescent Protein (EGFP) fusion constructs for both mutants (N-
terminal fusions with GFP have are assumed undergo normal processing as they 
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associate with their target membranes, which wouldn't happen if they were not 
prenylated) and transfected them to NIH 3T3 (not shown) and HeLa cells (figure 
IV.2.10). The wild type protein and the mutant proteins were indistinguishable. In 
both cases we observed normal Golgi localisation, both in permeabilised and non-
permeabilised cells, and failed to detect unusual levels of soluble protein in the 
transfected cells. This suggests that the mutants proteins are being prenylated with 
the same efficiency at steady state as the wild type protein. 
The results of this experiment suggest that inability to bind RabGAPs does 
not impair membrane association and hence prenylation of Rabia. 
IV.2.4 - Discussion 
To test if GTP hydrolysis catalysed by a RabGAP is required prior to REP 
binding and prenylation, we attempted to purify a RabGAP that acted on non-lipid 
modified Rabia. This was based on the assumption that as Rab3GAP, all 
mammalian RabGAPs were prenylation-sensitive. We detected such activity but were 
unable to purify it to homogeneity. However, since this work was started, several 
mammalian RabGAPs were identified which are active on non-lipid modified Rab 
proteins (Xiao et al., 1997)(see 1.1.4.2). Moreover, the prenylation requirement of 
Rab3GAP has been contested (Clabecq et al., 2000). Additionally, the complete 
RabGAP complement of the budding yeast has been identified, and none of its 
members display a requirement for lipid modification of its substrates (Strom et al., 
1993). This leaves GAPCenA, a RabGAP for Rab6 isoforms, as the only mammalian 
RabGAP with clear preference for lipid modified Rab proteins (Cuif et al., 1999). Our 
initial assumption that mammalian RabGAPs were prenylation sensitive and that the 
identification of a RabGAP which acted on non-lipid modified Rab proteins supported 
its requirement prior to prenylation was thus proved wrong. 
Next we introduced mutations in Rabia that were known to reduce or abolish 
its sensitivity to RabGAP action (Becker et al., 1991; Burstein et al., 1993). We 
expressed these mutants as EGFP fusion proteins in mammalian cells and observed 
that they associate with the ER and Golgi compartments. Since mutations in the 
prenylation motif of Rab proteins renders them cytosolic, association with the proper 
cellular compartment of our mutant Rab proteins indicates that they are properly lipid 
modified. Thus a RabGAP does not seem to be required for the formation of the 
RabREP complex. 
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In conclusion it seems unlikely that GTP hydrolysis is required prior to the 
formation of the Rab:REP complex. Since concentration effects are expected to 
favour the formation of the Rab:GTP complex, then some mechanism must exist that 
prevents this. One possibility is that a chaperone binds the newly synthesised protein 
and stabilises it in the nucleotide free conformation and somehow also forces it to 
assume a GDP bound conformation. There is no evidence that suggest that REP can 
bind nucleotide free Rabs and that it can act as a chaperone for the newly 
synthesised polypeptide. On the other hand one molecule has been identified which 
has some properties similar to those described above: MSS4 (see part 1.1.6.3) (Moya 
et al., 1993). MSS4 and its yeast ortholog DSS4 have broad substrate specificity, 
suggesting that their function is important for a large number or even all Rab proteins 
(Burton et al., 1994). They can bind and stabilise unprenylated Rab proteins in the 
nucleotide free conformation, with a 1:1 stoichiometry, which suggests that 
MSS4/DSS4 substrates are the nascent Rab proteins (Nuoffer et al., 1997). 
Furthermore Rab prenylation seems to be only transiently required to maintain 
cellular viability, and only a small proportion of Rab protein needs to be, at any time, 
prenylated (Bialek-Wyrzykowska et al., 2000; Alory and Balch, 2000) - accordingly, 
deletion of the DSS4 gene is not lethal (Moya et al., 1993). It remains to be 
determined if deletion of the DSS4 gene results in the accumulation of unprenylated 
Rab proteins in the cytosol. 
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IV.3. Structural determinants of Rab:REP binding: 
Rab fami ly conserved mot i fs def ine a conserved b ind ing sur face to REP-1 
This work was done in collaboration with Dr. Molly Strom in the laboratory. 
IV. 3.1. Introduction 
Rab proteins are Ras-like small GTP-binding proteins which regulate vesicular 
trafficking pathways. More than fifty Rab proteins have been identified in mammalian cells, 
forming the largest family of the Ras-like small GTPases (Pereira-Leal and Seabra, 2000). 
Rab proteins localise to specific sub-cellular membrane compartments and in some cases 
also show specific patterns of tissue expression, reflecting the variety of trafficking events 
found in mammalian cells (Zerial and McBride, 2001; Olkkonen and Stenmark, 1997; Guo et 
al., 2000). 
Rabs are hydrophilic proteins, however their function depends on association with 
the cytoplasmic leaflet of cellular membranes . Membrane association is mediated by the 
covalent modification of C-terminal cysteine residues with geranylgeranyl isoprenoids 
(Seabra, 2000). This is accomplished by the enzyme Rab Geranylgeranyl Transferase 
(RGGT), a protein prenyl transferase which requires an accessory protein for proper 
function: Rab Escort Protein (REP) (Seabra, 2000). REP binds newly synthesised Rab 
proteins, and it is the Rab:REP complex that is the true substrate for RGGT (Anant et al., 
1998). RGGT binds the REP:Rab complex and catalyses the transfer of one or two 
geranylgeranyl groups to one or two cysteines available in the prenylation motif, in what is 
believed to be a sequential reaction since there is only one lipid binding site in the enzyme 
(Anant et al., 1998; Desnoyers and Seabra, 1998). After lipid transfer, the enzyme 
dissociates from the REP:Rab complex and REP is believed to deliver the prenylated Rab to 
cellular membranes (Alexandrov et al., 1994). 
REPs are related to Rab GDP Dissociation Inhibitors (RabGDIs), general regulators 
of Rab function which are though to recycle prenylated Rabs from and to cellular 
membranes (Pfeffer et al., 1995). Mammals exhibit two REP isoforms, REP-1 and REP-2. 
They are -70% identical and display similar tissue expression patterns (Desnoyers et al., 
1996; Seabra, 2001). In contrast, the budding yeast only possess one, MRS6. The essential 
role of REP for prenylation is illustrated by the accumulation of unprenylated Rab proteins in 
yeast where REP function is deficient, and the fact that its deletion is lethal (Bialek-
Wyrzykowska et al., 2000). Also, mutations in the human REP-1 gene result in 
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Choroideremia, an X-linked progressive retinal degeneration (Cremers et al., 1990; Seabra, 
1996). Improper compensation by REP-2 is a likely cause for the disease, possibly due the 
accumulation of a sub-set of unprenylated Rabs. Consistently, one Rab protein (Rab27) was 
found to be selectively unprenylated in lymphoblasts from Choroideremia patients (Seabra et 
al., 1995). Furthermore, Rab27 is expressed in the same layers of the rat eye which are 
observed to degenerate in Choroideremia patients (Seabra et al., 1995). 
Comparison of the primary amino acid sequence of REP's and RabGDIs revealed 
three regions of conservation (SCRs - sequence conserved regions) (Ragnini et al., 1994; 
Waldherr et al., 1993). Furthermore, site directed mutagenesis has identified positions in the 
SCR1a, SCR1b and SCR3b of RabGDI as the main determinants for Rab binding (Schalk et 
al., 1996; Wu et al., 1998; Wu et al., 1996). The solution structure of the a isoform of 
RabGDI, which revealed a two domain organisation of the molecule, showed that SCR1a, 
SCR1b and SCR3b regions localize at the apex of domain 1, forming the "Rab binding 
platform" (Schalk et al., 1996; Wu et al., 1998; Wu et al., 1996). Finally, the same residues 
involved in RabGDI:Rab binding are involved in Mrs6p:Ypt1p binding, further suggesting a 
conserved Rab binding mechanism between REPs and RabGDIs (Alory and Balch, 2000; 
Bauer et al., 1996) 
As to the critical elements in the Rab for binding to different general regulators, the 
picture is not so clear. Beranger and co-workers (Beranger et al., 1994) tested the role of 
different regions of Rab6 for interaction with RabGDI and REP by substituting predicted 
structural elements with the cognate regions from H-Ras. They observed that RabGDI 
binding is blocked by substitutions of the hypervariable domain, of the loop3/p3 region, or of 
the effector domain (which includes switch I residues), but that processing by RGGT (and 
hence REP binding) is unaffected by these substitutions. Rab6 prenylation was affected only 
by a combined hyper-variable domain and loop 3/(33 substitution, or by substituting the N-
terminal sequence of Rab6 up to the beginning of the switch II region (which includes loop 
3/(33), with the corresponding Ras residues. In contrast, Wilson and co-workers (Wilson et 
al., 1996) observed that the Switch I point mutation Rab1bD44N cannot bind aRabGDI in 
vitro, but is prenylated in vitro and in vivo at 40- 50% efficiency compared to the wt Rablb. 
Recently, Overmeyer and co-workers (Overmeyer et al., 1998) showed that residues in the 
a2 helix, which localises in the switch II region, are essential both for Rablb prenylation and 
for REP:Rab binding in vitro. Finally, Sanford and co-workers (Sanford et al., 1995) showed 
that the N-terminal amino acids in Rab5 are essential for efficient prenylation. Taken 
together, the observations made by these groups are in part contradictory and do not give a 
clear picture about how Rabs bind REPs or RabGDIs. 
We have recently identified sequence motifs that distinguish the mammalian Rab 
proteins from other mammalian small GTPases, which we named RabF motifs (Pereira-Leal 
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and Seabra, 2000). This conserved protein sequences localise in and around the switch 
regions. As all Rab proteins bind REPs and RabGDIs in an nucleotide sensitive way, we 
proposed that conserved positions in the RabF motifs would define a general regulator 
binding surface in Rab proteins. This hypothesis is consistent with the data available for the 
Rab binding platform in RabGDI and MRS6 that suggest a conserved mechanism of Rab 
binding. 
In collaboration with Dr. Molly Strom in the laboratory, here we test this model by site 
directed mutagenesis, using REP-1 and Rab3a, and identify Rab conserved positions which 
are critical for REP binding. 
IV.3.2. Materials and Methods 
Human Rab3a was cloned in frame to the LexA E. Coli DNA binding protein in 
pBTM116 (generous gift of S. Fields). Rat REP-1 was cloned into pGADGH so that REP-1 
was fused in frame to the activation domain of GAL4. Mutations in Rab3a were created 
using Polymerase Chain Reaction (Pfu) mutagenesis, using pBTM116-Rab3a as template. 
Yeast strain L40 (MATa trpl Ieu2 his3 LYS2::lexA-HIS3 URA3::lexA-lacZ) was then 
transformed with combinations of pBTM116-Rab3a and pGADGH-REP1 constructs and 
colonies were assayed for their ability to grow 3-aminotriazole (SIGMA) and for p-
galactosidase activity as described in (Durfee et al., 1993). Expression levels of the different 
constructs was assayed by western blotting. 
Sequence alignments were performed using Clustal W 1.80 (Thompson et al., 1997) 
using default parameters. Modelling of the structure of the Rab3:GDP complex was 
performed using the SWISS-Model automated comparative modelling server (Guex and 
Peitsch, 1997; Peitsch, 1996; Peitsch, 1995), based on the structure of the Rab6:GDP 
complex (1D5C) (Chattopadhyay et al., 2000). 
IV. 3.3. Results and Discussion 
In order to determine the positions in Rab3a which may be critical for REP binding, 
we decided to use a site directed mutagenesis approach, and test the resulting mutant Rab 
proteins in a Rab:REP binding assay. Based on our previous identification of Rab-specific 
sequence motifs (RabF motifs), we hypothesised that positions in these motifs would be 
critical for REP binding (Pereira-Leal and Seabra, 2000). Further, we eliminated positions 
that were more likely to be buried inside the protein and concentrated solely on potentially 
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exposed positions. To do so, and in the absence of crystal structures for our model Rab 
(Rab3a) in a REP-binding competent conformation, we modelled the structure of the 
Rab3a:GDP complex by homology modelling to identify potentially exposed residues within 
the RabF motifs, and positions which by their chemical nature and/or localisation could also 
be considered candidate REP-binding residues. The positions we selected are indicated in 
red in figure IV.3.1. 
Figure IV.3.1 - Mapping of the mutated positions (in red) used in this study to a cartoon 
representing the molecular surface ofRab3a. 
We then established a REP:Rab binding assay using on the yeast two hybrid system. 
This system is particularly suited for this type of study as it permits the screening of large 
number of mutations, it isolates REP:Rab binding from the end product of the prenylation 
reaction which is used in other studies as indicative of REP binding, and finally, it permits the 
testing of the binding of the two proteins in vivo. 
We tested the mutant Rab proteins in this assay and observed that of the chosen 
positions, only mutations in D58 and F59 (Switch I), and I87N/T86N and R93 (Switch II) 
resulted in the abolishing of REP:Rab binding in our assay (see table IV.3.1). When we map 
these mutations into the structure of Rab3a, we observe that all localise to a surface of the 
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molecule which includes the Switch I and II regions. This is consistent with the observation 
that REPs can only bind Rabs in a GDP bound conformation (Seabra, 1996). 
Table IV.3.1 - Yeast two hybrid Rab3a:REP binding assay results. For the p-galactosidase 
Induction:* represents blue colour after 30 mins, ++ represents blue colour after 15 mins, 0 
represents blue colour after 3 hours. 
Rab mutant (3-galactosidase Growth on 3-aminotriazole 
induction 
wt 
Y21A 
D58A 
F59A 
K69A 
R70A/D68L 
T86A 
I87A/T86N 
R85A 
Y91A 
R93A 
pBTM 
+ 
+ 
0 
0 
+ 
+ 
++ 
0 
++ 
+ 
0 
0 
<50mM 
<50mM 
<5mM 
<5mM 
<50mM 
<50mM 
S 100 mM 
< 5mM 
> 100 mM 
<50mM 
< 5mM 
< 5mM 
Figure IV.3.2 - Positions involved in REP binding (in blue), mapped to cartoon representing 
the molecular surface of Rab3a. 
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We observed that all Rab3 mutants were well expressed (figure IV.3.4), thus 
indicating that the protein is made and is stable. The negative signal we observed in some 
mutants then is not due to lack of protein expression, but is due to the inability of the mutant 
Rab protein to bind REP-1 in this assay. 
Figure IV.3.3 - Expression of REP-1 and Rab3 in the yeast two hybrid REP:Rab binding 
assay 
RabFl RabF2 RabF3 RabF4 RabF5 
Figure IV.3.4 - Alignment of select human proteins, indicating the REP-binding positions 
(arrows - top), the positions of the RabF motifs (black bars - bottom), and the identities 
(yellow) and similarities (green) in these regions 
We identified three novel positions involved in REP binding (D58, F59, R93), and 
confirmed the importance of the exposed residue I87, in accordance with the results of 
Overmeyer and co-workers (Overmeyer et al., 1998). Positions F79 and R93 are almost 
invariably conserved, and position I87, although not absolutely conserved, is frequently 
occupied by a conserved substitution. However, position D58 although in the majority of the 
IV- 29 
Part IV - REP.Rab 
cases is occupied by either an aspartic acid residue or a glutamic acid residue (similar 
chemical nature), in a few cases can be occupied by a non-conservative substitution (fig 
IV.3.4). One of these cases is Rab5, which has an alanine residue in this positions. 
Interestingly, Rab5 was previously shown to be a poorer substrate for REP binding than 
Rabia (Anant et al., 1998). Furthermore, in our assay we observed a weaker signal 
whenever we tested Rab5 (not shown). However, mutations in the positions in Rab5a 
corresponding to the Rab3a F59 and R93, abolish the binding to REP-1, like they do in 
Rab3a (not shown). 
These results suggest that although there is a number of positions that are 
conserved and define the core "REP binding platform", it is possible that different Rabs may 
display different variations in this binding. It would be interesting to test the effect of 
naturally occurring variations to the RabF motifs that some Rabs display. For example, Rab5 
has a D->A substitution in RabF1, while Rab21 and Rab22 have an S->A substitution in the 
corresponding position (figure IV.3.4). The differential binding of Rabs to REPs could for 
example account for the accumulation of unprenylated Rab27 in CHM patients that only 
possess functioning REP-2 (Seabra et al., 1995). Furthermore, it could also account for the 
differential binding in vivo of Rabs to different RabGDI isoforms (Erdman and Maltese, 
2001). We tested the effect of the same Rab mutations in the binding of Rab3a to RabGDI 
(data not shown), and although the assay had a strong background signal, the results were 
similar to those obtained for Rab3a:REP binding, which is consistent with the proposed 
conserved mode of interaction between RabGDI and Rabs, and MRS6 and Rabs (Alory and 
Balch, 2000). 
One interesting consequence from this work is the observation that both Switch I and 
Switch II will contribute to REP binding. This suggests that Rabs cannot simultaneously bind 
REPs and other proteins which require interactions with the switch regions, for example 
proteins which need to bind the switch regions to sense or alter the nucleotide status of the 
Rab. This is consistent with the observation that binding to RabGDI inhibits GDP dissociation 
from Rab proteins, a reaction catalysed by exchange factors which require interactions with 
the switch regions (Sasaki et al., 1991; Ullrich et al., 1993; Wittinghofer, 1998). Also, it 
consistent with the proposal that membrane association and RabGDI dissociation precedes 
GDP-GTP exchange (Ullrich et al., 1994). 
When we compare the positions assayed here with those addressed in other studies, 
we observed that while we used modelling techniques to predict the structure of a Rab 
proteins in a REP-binding competent conformation and thus select only exposed residues, 
other studies have used mutations that were not exposed (for example Y89 in Rablb used in 
(Overmeyer et al., 1998). This mutations are not likely to be involved in REP binding. 
However, they may play a role in the folding and stability of the Rab. In this case, the inability 
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to bind REP and/or be prenylated cannot be interpreted as proof of involvement in direct 
interactions with REP. 
The method here described can be used to systematically analyse these issues, but 
it has one important limitations in which it is not quantitative: it can only be interpreted when 
yes or no answers are required. We are now following these results by studying the effect of 
the Rab mutations in the kinetics of in vitro Rab3a prenylation. Furthermore, the identification 
of the REP-binding positions will be now used as constrain for in silico docking of the 
structures of RabGDI and REP-1 with Rab3 by Richard Jackson at University College 
London, from which a prediction of the interaction surface between the two molecules can be 
inferred. In combination with patterns of sequence conservation these results can then be 
used to address systematically the differential binding of Rabs to REP and RabGDI isoforms, 
which may help us understand the Choroideremia, and the regulation of Rab membrane 
association by REPs and RabGDIs 
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Part V - Concluding Remarks 
The main objective of this thesis was to study the structural determinants of Rab 
prenylation and function. 
Part II concentrates on the Rab family of small GTP-binding proteins. In chapter 11.1 a 
study of primary structure conservation in the mammalian Rab family is presented and a 
sequence definition of a Rab protein is obtained. This is the first time that criteria for 
inclusion of novel proteins in the Rab family is presented, which will be useful for future 
assignments of GTPases. Also, a working criteria for the definition of sub-families is 
presented, which hopefully will help to clarify the ruling confusion in the nomenclature of the 
mammalian Rab family. We have been working with the HUGO nomenclature commission, 
using the criteria here defined, to help to rationalise the designations in the databases. 
Finally, the study of primary structure in Rab proteins led to the proposal of a novel 
mechanism for interaction with specific effectors and general regulators like REP. This 
proposal is supported by the available experimental evidence, and represents a departure 
from the accepted model that all small GTPases obey the rules determined for the Ras 
family. It is a Rab-specific mechanism that is testable, and provides a conceptual framework 
for further studies on the structural determinants of Rab function and lipid modification. 
In chapter II.2 the analysis of sequence conservation patterns in the Rab family is 
taken a step further. Complete Rab families are identified and annotated in six different 
organisms which had their genomes sequenced in its entirety. For the first time a general 
criteria for the annotation of Rab proteins is proposed. Furthermore, in collaboration with Ian 
Moore at the Department of Plant Sciences of Oxford University, a classification system for 
plant Rabs is proposed. The evolutionary analysis of Rab proteins revealed that the 
interaction mechanisms proposed in chapter 11.1 can be generalised to Rab proteins in other 
organisms. Existing experimental information suggests that this prediction is accurate. A new 
level of organisation in the Rab family is uncovered in the animal and fungi Rab families, 
which we termed "Rab functional groups". This new hierarchy reflects the evolutionary 
history of the Rab family in general and of a given Rab protein in particular, and reveals that 
Rabs arising from common protein ancestors maintain the basic property(ies) of the putative 
ancestral protein. This clustering of Rab proteins in groups paves the ground for analysis, 
both computational and experimental, of what are the functional properties shared by the 
different Rab proteins, what are the minimal Rab functional properties which are required in 
an eukaryotic cell, what are the structural determinants of the conserved functional 
properties and will in the future permit a better understanding of the evolution of trafficking 
pathways in the cell. 
One unexpected observation made in chapter II.2 came from the analysis of the 
prenylation motif usage across evolution. Prenylation motifs for homologous Rabs in 
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different organisms are conserved in the number of prenylatable cysteine residues, and in 
many cases in the topology of the motif. This suggests that the prenylation motifs of Rab 
proteins may play a role in the function of these proteins, determining the way these proteins 
reach their target membranes and/or how they associate with the membranes. There are 
obvious experiments that can be done to test these predictions, including swapping 
prenylation motifs between Rab proteins and testing trafficking and targeting to the 
membranes, and also the effect of the type of prenylation motif in the efficiency of membrane 
association. Some of these experiments are now being done in the lab. 
Part III concentrates on the REP/GDI superfamily of general regulators of Rab 
proteins in order to identify the primary and tertiary structure determinants of functional 
overlapping and difference between REPs and GDIs. Sequence and structure analysis, 
correlated with the restricted experimental information, supports that the proposed "Rab 
binding platform" of RabGDI is conserved in REP proteins. Furthermore, several REP 
specific positions were identified, providing a framework for future structure-function studies 
in members of this family. 
Part IV concerns the formation of the REP:Rab complex. Chapter IV. 1 describes 
methods designed and optimised for the formation and purification of such complexes in 
vitro. In this chapter we describe methods, which are simple, quick and allow different scale 
preparations. Moreover, it is the first time where methods to purify all the individual 
complexes corresponding to the different stages of the prenylation reaction is reported, 
providing tools for structural studies of the Rab prenylation reaction. 
Chapter IV.2 addresses the requirement for GTP hydrolysis prior to the formation of 
the REP:Rab complex. I attempted to purify a RabGAP that acted on non-prenylated Rab 
proteins, as at the time it made sense to think that all RabGAPs that acted later on the Rab 
cycle would have a strict requirement for prenylation. While this project was being pursued, 
several reports appeared in the literature which questioned the RabGAP requirement for lipid 
modified Rabs. Furthermore, I was not able to purify the RabGAP activity for non-prenylated 
Rabia, possibly due to problems with the starting material used. I have to conclude that this 
particular project was ill designed. A better way would have been to address the requirement 
for a RabGAP, and not try to find the RabGAP. Available evidence suggests an alternative 
mechanism that involves MSS4, a molecule that appears to have all the characteristics 
required to behave as a chaperone for unprenylated Rab proteins. Further experiments need 
to be done however to rule out the RabGAP requirement, test if MSS4 is a chaperone for 
newly synthesised Rab proteins, or if other, yet unidentified molecules, play a role in 
maintaining or bringing newly synthesised Rabs into a REP-binding competent conformation. 
Finally, in chapter IV.3 I test the prediction made in chapter 11.1, that the RabF motifs 
will determine the interface between REP and Rab when these two proteins are in complex. 
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In the absence of any known structure of a Rab protein in the GDP bound conformation and 
of REP proteins, I calculated homology structural models for this protein complex that were 
then docked in silico by Richard Jackson at University College London. The initial docking 
models required the creation of more constrains to the docking procedures, and based on 
both my primary structure analysis of Rab and REP proteins, and with Molly Strom in the lab 
we created mutants that were used in a yeast-two hybrid based binding assays and in vitro 
prenylation reactions. The results of these experiments suggest an interface between the 
two proteins that is consistent with the predictions made in parts II and III. This work 
provides the groundwork and a methodology to address now the differential binding of two 
REP proteins in mammals for different Rab proteins, an important issue to understand 
human disease that arises when REP1 is mutated. 
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